10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016

or

[   ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________________ to __________________________

Commission File Number 000-54881

LITHIUM EXPLORATION GROUP, INC.
(Exact name of registrant as specified in its charter)

Nevada	06-1781911
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
3800 N. Central Avenue, Suite 820, Phoenix AZ	85012
(Address of principal executive offices)	(Zip Code)

480.641.4790
(Registrant’s telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
[   ] YES        [X] NO

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
[X] YES        [   ] NO

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]		Accelerated filer [ ]
Non-accelerated filer [ ]	(Do not check if a smaller reporting company)	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
[   ] YES        [X] NO

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court.
[   ] YES        [   ] NO

APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

119,772,784 common shares issued and outstanding as of July 27, 2016.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION		3
Item 1.	Financial Statements	3
Item 2.	Management's Discussion and Analysis of Financial Condition or Plan of Operation	42
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	72
Item 4.	Controls and Procedures	72
PART II - OTHER INFORMATION		73
Item 1.	Legal Proceedings	73
Item 1A.	Risk Factors	75
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	75
Item 3.	Defaults Upon Senior Securities	75
Item 4.	Mine Safety Disclosures	75
Item 5.	Other Information	75
Item 6.	Exhibits	76
SIGNATURES		79

PART I - FINANCIAL INFORMATION

Item 1.           Financial Statements

The condensed consolidated unaudited financial statements of our company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars.

LITHIUM EXPLORATION GROUP, INC.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

March 31, 2016

(Unaudited)

Lithium Exploration Group, Inc.
Condensed Consolidated Balance Sheets

		March 31,			June 30,
		2016			2015
		(Unaudited)			(Restated)
ASSETS
Current
Cash and cash equivalents	$	7,301		$	64,098
Receivable		-			13,421
Loan receivable		-			20,000
Prepaid expenses		2,788			2,788
Current assets held for sale (Note 12) .		23,351			14,713
Total current assets		33,440			115,020
Total Assets	$	33,440		$	115,020
LIABILITIES AND DEFICIT
Current
Accounts payable and accrued liabilities (Note 9)	$	171,606		$	65,962
Derivative liability – convertible promissory notes (Note 6)		1,352,033			1,646,448
Derivative liability – warrants (Note 6)		395,536			143,375
Due to related party (Note 7 and 9)		115,000			115,000
Convertible promissory notes – net of unamortized discount
(Note 6)		811,265			533,994
Accrued interest – convertible promissory notes (Note 6)		124,350			60,022
Current liabilities held for sale (Note 12)		6,439			6,696
Total Current Liabilities		2,976,229			2,571,497
Commitments and contingencies
DEFICIT
Lithium Explorations Group, Inc. Stockholders’ Deficit
Capital stock (Note 3)
Authorized:           100,000,000 preferred shares, $0.001 par value           10,000,000,000 (June 30, 2015 – 2,000,000,000)           common shares, $0.001 par value
Issued and outstanding:
Nil preferred shares (June 30, 2015 – Nil)		-			-
13,670,617 common shares (June 30, 2015 – 7,574,353)		13,663			7,575
Additional paid-in capital		47,890,759			47,383,232
Accumulated other comprehensive loss		(37,432	)		(29,484	)
Accumulated deficit		(50,457,687	)		(49,504,350	)
Total Lithium Exploration Group, Inc. Stockholders’ Deficit		(2,590,697	)		(2,143,027	)
Non-controlling interest		(352,092	)		(313,450	)
Total Deficit		(2,942,789	)		(2,456,477	)
Total Liabilities and Deficit	$	33,440		$	115,020

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Lithium Exploration Group, Inc.
Condensed Consolidated Statements of Operations And Comprehensive Income (Loss)
(Unaudited)

		Three Months			Three Months						Nine Months
		Ended			Ended			Nine Months			Ended
		March 31,			March 31, 2015			Ended March 31,			March 31, 2015
		2016			(Restated)			2016			(Restated)
Revenue	$	-		$	-		$	-		$	-
Operating Expenses:
Mining (Notes 3 & 5)		-			16,212			5,000			31,212
Selling, general and administrative (Notes 3 & 5)		63,979			359,236			373,393			944,964
Impairment Loss		-			624,429			-			624,429
Total operating expenses		63,979			999,877			378,393			1,600,605
Loss from operations		(63,979	)		(999,877	)		(378,393	)		(1,600,605	)
Other income (expenses)
Interest expense (Note 6)		(97,758	)		(297,288	)		(699,719	)		(1,333,192	)
Gain (loss) on change in the fair value of derivative liability (Note 6)		112,247			(1,835,099	)		576,533			1,083,198
Amortization of debt discount		(78,688	)		101,726			(399,010	)		(1,483,168	)
Bad-debt write off		-			-			(20,000	)		-
(Loss) gain on disposal of business operations		(96	)		-			7,468			-
Equity in income (loss) of unconsolidated affiliate		-			(6,469	)		-			(324	)
Other Income		-			80,524			-			80,524
Loss before income taxes		(128,274	)		(2,956,483	)		(913,121	)		(3,253,567	)
Provision for Income Taxes (Note 4)		-			-			-			-
Net loss for the period		(128,274	)		(2,956,483	)		(913,121	)		(3,253,567	)
Loss from discontinued operations		(290	)		(24,078	)		(78,860	)		(305,966	)
Net loss		(128,564	)		(2,980,561	)		(991,981	)		(3,559,534	)
Less:Net loss attributable to the non-controlling interest		(142	)		(11,798	)		(38,642	)		(149,923	)
Net loss attributable to Lithium Exploration Group, Inc. Common shareholders		(128,422	)		(2,968,763	)		(953,339	)		(3,409,611	)
Basic and Diluted loss per Common Share	$	(0.01	)	$	(7.43	)	$	(0.09	)	$	(15.28	)
Basic and Diluted Weighted Average Number of Common Shares Outstanding		11,742,168			399,318			10,696,351			223,184
Comprehensive loss:
Net loss		(128,564	)		(2,980,561	)		(991,980	)		(3,559,534	)
Foreign currency translation adjustment		275			(13,997	)		(7,947	)		(21,831	)
Comprehensive loss		(128,289	)		(2,994,558	)		(999,927	)		(3,581,365	)
Comprehensive loss attributable to non-controlling interest		(142	)		(11,798	)		(38,642	)		(149,923	)
Comprehensive loss attributable to Lithium Exploration Group, Inc.		(128,147	)		(2,982,760	)		(961,285	)		(3,431,442	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Lithium Exploration Group, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Deficit

(Unaudited)

	Common Shares						Accumulated Other
					Additional Paid-in		Comprehensive			Accumulated						Stockholders’
					Capital		Loss			Deficit			Non-controlling			Deficit
	Number of		Amount		$’		$’			$’			Interest			$’
	Shares		$’		(Restated)		(Restated)			(Restated)			$’			(Restated)
Balance – June 30, 2015 (restated)	7,574,353	$	7,574	$	47,383,232	$	(29,485	)	$	(49,504,348	)	$	(313,450	)	$	(2,456,477	)
Common shares issued for debt conversion	6,088,220		6,088		145,078		-			-			-			151,166
Common shares issued for the reclassification of derivative liability on convertible notes	-		-		302,262		-			-			-			302,262
Common shares issued for fractional shares adjustment	8,044		1		-		-			-			-			1
Disposal of business operations	-		-		60,187		-			-			-			60,187
Foreign exchange translation	-		-		-		(7,947	)		-						(7,947	)
Net loss for the period	-		-		-		-			(953,339	)		(38,642	)		(991,981	)
Balance – March 31, 2016	13,670,617	$	13,663	$	47,890,759	$	(37,432	)	$	(50,457,687	)	$	(352,092	)	$	(2,942,789	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Lithium Exploration Group, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)

					Nine Months
		Nine Months			Ended
		Ended			March 31,
		March 31,			2015
		2016			(Restated)
Cash Flows from Operating Activities
Net loss from continuing operations	$	(913,121	)	$	(3,253,567	)
Loss from discontinued operations		(78,860	)		(305,966	)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in income of investment held for sale		-			324
Common shares issued for consulting fees		-			118,991
Non-cash Interest expense		629,248			1,126,957
Gain on disposal of business operation		(7,468	)		-
Impairment Loss		-			624,429
Bad debt written-off		20,000			-
Common shares issued for interest expenses		-			103,048
Gain on change in the fair value of derivative liability		(576,533	)		(1,083,198	)
Amortization of debt discount		399,010			1,483,168
Common shares issued for investor relations		-			5,000
Changes in operating assets and liabilities:
Receivable, net		13,421			-
Prepaid expenses		-			16,610
Due to related party		-			115,000
Accrued interest		70,471			103,187
Accounts payable and accrued liabilities		105,644			47,178
Net cash used in operating activities from continuing operations		(338,188	)		(898,840	)
Net cash provided by (used in) operating activities from discontinued operations		51,338			(8,212	)
Net cash used in operating activities		(286,850	)		(907,052	)
Cash Flows from Financing Activities
Repayment to related party		-			(45,332	)
Proceed from issuance of convertible promissory notes, net		238,000			954,000
Net cash provided by financing activities		238,000			908,668
Effect of foreign exchange		(7,947	)		(21,831	)
Decrease in cash and cash equivalents		(56,797	)		(20,215	)
Cash and cash equivalents - beginning of period		64,098			57,632
Cash and cash equivalents - end of period	$	7,301		$	37,417
Supplementary disclosure of cash flow information:
Cash paid during the period for:
Interest	$	-		$	2,205
Income taxes	$	-		$	-
Supplementary non- cash Investing and Financing Activities:
Non-cash investing and financing activities:
Common stock issued for debt conversion and interest	$	151,166		$	1,499,202
Common stock issued on cashless exercise of warrants	$	-		$	2,442,770
Derivative liability re-classed to additional paid in capital	$	302,262		$	2,312,157
Debt discount on issuance of convertible note and warrants	$	230,005		$	901,327
Initial derivative liability on note issuance and warrants	$	836,980		$	2,018,791
Interest reclassed to convertible note	$	5,680		$	-
Re-classification of discontinued assets and liabilities to
additional paid in capital	$	60,188		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Lithium Exploration Group, Inc.

Notes to Condensed Consolidated Interim Financial Statements

March 31, 2016

(Unaudited)

1.   Organization

Lithium Exploration Group, Inc. (formerly Mariposa Resources, Ltd.) (the “Company”) was incorporated on May 31, 2006 in the State of Nevada, U.S.A. It is based in Phoenix, Arizona, USA. The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America, and the Company’s fiscal year end is June 30.

Effective November 30, 2010, the Company changed its name to “Lithium Exploration Group, Inc.,” by way of a merger with its wholly-owned subsidiary Lithium Exploration Group, Inc., which was formed solely for the change of name.

A wholly owned subsidiary, 1617437 Alberta Ltd. was incorporated in the province of Alberta, Canada on July 8, 2011. Effective October 2, 2013, the subsidiary changed its name to Alta Disposal Ltd.

On October 18, 2013, the Company acquired 51% interest in Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Ltd.). Effective September 4, 2015, the Company entered into an Asset Purchase Agreement with Cancen Oil Canada whereby the Company agrees to sell all right, title and interest of Alta Disposal Morinville Ltd. assets for total purchase price of CAD$10,000 approximately USD$7,466.

On March 1, 2014, the Company through its 100% subsidiary Alta Disposal Ltd. acquired 50% interest in Tero Oilfield Services Ltd. (the “Tero”) On May 1, 2015, the Company entered into a Share Purchase Agreement with an individual and disposed its 50% interest in Tero.

The Company is engaged principally in the acquisition, exploration, and development of resource properties. Prior to June 25, 2009, the Company had the right to conduct exploration work on 20 mineral mining claims in Esmeralda County, Nevada, U.S.A. On July 31, 2009, the Company acquired an option to enter into a joint venture for the management and ownership of the Jack Creek Project, a mining project located in Elko County, Nevada. On September 25, 2009, the joint venture was terminated and the Company entered into an agreement with Beeston Enterprises Ltd., under which the Company was granted an option to acquire an undivided 50% interest in eight mineral claims located in the Clinton Mining District of British Columbia, Canada. On December 16, 2010, the Company entered into an Assignment Agreement to acquire an undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada (see Note 5). On November 8, 2011, the Company entered into a letter agreement with Glottech-USA. Pursuant to the terms of the agreement, the Company was granted an exclusive license to use and distribute the technology within the Swan Hills region of Alberta as well as a non-exclusive right to distribute the technology within Canada.

2.   Significant Accounting Policies

Basis of presentation and consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

These interim financial statements as of and for the nine months ended March 31, 2016 and 2015 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the nine months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to March 31, 2016 and 2015 in these footnotes are unaudited.

These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015.

The condensed consolidated balance sheet as of June 30, 2015 was restated during the period ending September 30, 2015 and has been carried forward for the period ending March 31, 2016, and do not include all disclosures required by the accounting principles generally accepted in the United States of America.

Principal of Consolidation

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework.

Use of Estimates

The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments.

Cash and Cash Equivalents

Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $7,301 and $64,098 in cash and cash equivalents at March 31, 2016 and June 30, 2015, respectively.

10

2.   Significant Accounting Policies - Continued

Concentration of Risk

The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of March 31, 2016 and June 30, 2015, the Company had no deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts.

Prepaid expenses

Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period.

Start-Up Costs

In accordance with FASC 720-15-20 “Start-Up Costs,” the Company expenses all costs incurred in connection with the start-up and organization of the Company.

Mineral Acquisition and Exploration Costs

The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves.

Concentrations of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

Net Income or (Loss) per Share of Common Stock

The Company has adopted FASC Topic No. 260, “Earnings Per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.

Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive.

11

2.   Significant Accounting Policies - Continued

Foreign Currency Translations

The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ deficit as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized.

Translation of Foreign Operations

The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows:

-      assets and liabilities are translated at period-end exchange rates prevailing at that reporting date; and
-      income and expenses are translated at average exchange rates for the period.

Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations.

The relevant translation rates are as follows: For the period ending March 31, 2016 closing rate at 0.771 CDN$: US$, average rate at 0.7468 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$.

Comprehensive Income (Loss)

FASC Topic No. 220, “Comprehensive Income,” establishes standards for reporting and display of comprehensive income and its components in a full set of general-purpose financial statements. As at March 31, 2016 and June 30, 2015, the Company had no material items of other comprehensive income except for the foreign currency translation adjustment.

Risks and Uncertainties

The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure.

12

2.   Significant Accounting Policies - Continued

Environmental Expenditures

The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures.

Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.

Warrants

The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the unaudited condensed consolidated statements of operations and comprehensive Income (Loss).

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption.

Fair Value of Financial Instruments

ASC 820, “Fair Value Measurements and Disclosures” requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities;

Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and

Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

13

2.   Significant Accounting Policies - Continued

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments.

The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

Revenue Recognition

The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required.

Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured.

Income Taxes

The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.

Receivables

Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts.

Recent Accounting Pronouncements

In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.

In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.

14

2.   Significant Accounting Policies - Continued

FASB Statements:

In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented.

Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.

3.   Capital Stock

On January 19, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 20 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective February 25, 2015.

On July 13, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 200 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective March 31, 2016. Upon effect of the reverse stock split the issued and outstanding shares pre-split as at March 31, 2016 were 2,734,123,494 and the post-split were 13,670,617. The Company’s authorized capital will not be affected by the reverse stock split. The split is reflected retrospectively in the accompanying financial statements.

Authorized Stock

At inception, the Company authorized 100,000,000 common shares and 100,000,000 preferred shares, both with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

On April 8, 2009, the Company increased the number of authorized shares to 600,000,000 shares, of which 500,000,000 shares are designated as common stock par value $0.001 per share, and 100,000,000 shares are designated as preferred stock, par value $0.001 per share.

On October 25, 2012, the Company designated 20,000,000 series A convertible preferred stock with a par value of $0.001 per share and stated value of $100 per share. The designated preferred stock is convertible at the option of the holder, at any time beginning one year from the date such shares are issued, into common stock of the Company with a par value of $0.001. All shares of common stock of the Company, shall be of junior rank to all series A preferred stock in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. All other shares of preferred stock shall be of junior rank to all series A preferred shares in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company.

On January 3, 2014, the Company designated 2,000,000 series B convertible preferred stock with a par value $0.001 per share, issuable only in consideration of the extinguishment of existing debt convertible in to the Company’s common stock with a par value of $0.001. The designated preferred stock shall be issued on the basis of 1 preferred stock for each $1 of convertible debt. The series B convertible preferred stock shall be subordinate to and rank junior to all indebtedness of the Company now or hereafter outstanding.

On October 17, 2014, the Company amended its Articles of Incorporation, which amendment was filed with the Nevada Secretary of State on October 17, 2014, to increase the authorized capital of its common shares from 500,000,000 common shares, par value $0.001 to 2,000,000,000 common shares, par value $0.001.

The Company's authorized capital consists of 2,000,000,000 common shares and 100,000,000 preferred shares, all with a par value of $0.001.

15

3.   Capital Stock – Continued

Effective June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of preferred stock as series A preferred stock. The series A preferred stock, par value $0.001, will rank senior to the Company’s common stock, carrying general voting rights with the common stock at the rate of 62 votes per share. The series A preferred stock will be deemed cancelled within 1 year of issuance and are not entitled to share in dividends or other distributions. So long as any shares of series A preferred stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of series A preferred stock will be required for any change to the Company’s Articles of Incorporation.

Effective September 9, 2015, the Company increase the authorized capital of its common shares from 2,000,000,000 common shares, par value $0.001 to 10,000,000,000 common shares, par value $0.001.

Share Issuances

Common Stock Issuance

For the period ended March 31, 2016:

On July 8, 2015, the Company issued 125,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On July 10, 2015, the Company issued 201,465 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On July 21, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On July 22, 2015, the Company issued 100,000 common shares at a deemed price of $0.05 per share for promissory note conversion (Note 6).

On July 29, 2015, the Company issued 298,269 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On August 17, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On September 11, 2015, the Company issued 80,801 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On September 11, 2015, the Company issued 434,084 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On September 15, 2015, the Company issued 438,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On September 18, 2015, the Company issued 486,623 common shares at a deemed price of $0.02 per share for promissory note conversion (Note 6).

On September 18, 2015, the Company issued 475,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On September 18, 2015, the Company issued 394,231 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On October 8, 2015, the Company issued 8,044 common shares at a deemed price of $0.0001 per share to the depository trust as a result of the reverse stock split round-up.

On October 28, 2015 the Company issued 554,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

16

On March 24, 2016 the Company issued 500,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

On March 28, 2016 the Company issued 600,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On March 29, 2016 the Company issued 450,748 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

On March 30, 2016 the Company issued 450,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

Issuances of Preferred Shares

On June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of Preferred Stock as Series “A” Preferred Stock. The Series “A’ Preferred Stock, par value $0.001, ranks senior to the common stock and carries general voting rights with the common stock at the rate of 62 votes per share. The Series “A” Preferred Stock will be deemed cancelled within 1 year of issuance and is not entitled to share in dividends or other distributions. So long as any shares of Series “A” Preferred Stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of Series “A” Preferred Stock will be required for any change to articles of incorporation.

On July 6, 2015, the Company issued 130,000 Series “A” preferred shares in consideration of the release and discharge of a first ranking general security interest over all current and future assets of Alta Disposal Ltd. that was granted to secure to the promissory note entered into on July 22, 2014. These shares were issued at par value of $0.001. These shares were subsequently cancelled on December 5, 2015 therefore the net impact on share capital is nil.

4.   Provision for Income Taxes

The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.

Exploration stage deferred tax assets arising as a result of net operating loss carryforwards have been offset completely by a valuation allowance due to the uncertainty of their utilization in future periods. Operating loss carryforwards generated during the period from May 31, 2006 (date of inception) through March 31, 2016 of approximately $13,287,598 will begin to expire in 2026. Accordingly, deferred tax assets were offset by the valuation allowance that increased by approximately $464,277 and $1,130,089 during the periods ended March 31, 2016 and June 30, 2015 respectively.

The Company follows the provisions of uncertain tax positions as addressed in FASC 740-10-65-1. The Company recognized approximately no increase in the liability for unrecognized tax benefits.

17

4.   Provision for Income Taxes - Continued

The Company has no tax position at March 31, 2016 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the periods presented. The Company had no accruals for interest and penalties at March 31, 2016. The Company’s utilization of any net operating loss carry forward may be unlikely as a result of its intended exploration stage activities. The tax years for June 30, 2015, June 30, 2014, June 30, 2013 and June 30, 2012 are still open for examination by the Internal Revenue Service (IRS).

		For the nine months ended March 31, 2016
		Amount			Tax Effect (35%)
Net loss	$	913,121		$	319,592
Shares issued for consulting fees, mining expenses, investor relation and director fees
Interest expense		(699,718	)		(244,901	)
Gain on derivative liability		576,533			201,787
Amortization of debt discount		(399,010	)		(139,654	)
Impairment		7,468			2,614
Total		398,393			139,438
Valuation allowance		(398,393	)		(139,438	)
Net deferred tax asset (liability)	$	-		$	-

		For the nine months ended March 31, 2015
		Amount			Tax Effect (35%)
Net loss	$	3,253,567		$	1,138,749
Shares issued for consulting fees, mining expenses, investor relation and director fees		(118,990	)		(41,647	)
Shares issued for interest expenses		(103,048	)		(36,067	)
Amortization of discount		(1,483,168	)		(519,109	)
Interest expense		(1,333,192	)		(466,617	)
Impairment Loss		(624,429	)		(218,550	)
Gain on derivative liability
		1,083,198			379,119
Total		673,938			235,878
Valuation allowance		(673,938	)		(235,878	)
Net deferred tax asset (liability)	$	-		$	-

18

5.   Mineral Property Costs

Mineral Permit (Assignment Agreement with Lithium Exploration VIII Ltd.)

On December 16, 2010, the Company entered into an Assignment Agreement to acquire the following:

a.)	An undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada.
b.)	All of the assignor’s right, title and interest in and to the Option Agreement.

In consideration for the Assignment, the Company agreed to pay US$90,000 by way of cash or stock of equal value (consisting of amounts previously paid by the Assignor pursuant to the Option Agreement). The full $90,000 (consisting of option payments ‘i’ and ‘v’ below) was expensed and included in the December 31, 2011 accounts payable balance. The Option shall be in good standing and exercisable by the Company by paying the following amounts on or before the dates specified in the following schedule:

i.)	CDN $40,000 (paid) upon execution of the agreement;
ii.)	CDN $60,000 (paid) on or before January 1, 2012;
iii )	CDN $100,000 on or before January 1, 2013 (amended and paid);
iv.)	CDN $300,000 on or before January 1, 2014 (not paid); and
v.)	Paying all such property payments as may be required to maintain the mineral permits in good standing.

The Optionee shall provide a refundable amount of CDN$50,000 (paid) to the Optionor by November 2, 2010, which shall be applied by the Optionor towards work assessment expenses acceptable to the Government of Alberta, with any unused portion to be applied against payments required to maintain the permits underlying the property in good standing.

On December 31, 2012, the Company entered into an agreement to amend the original payment requirement of CDN$100,000 due on January 1, 2013 to the following payments: CDN $20,000 (paid) cash payment due on January 1, 2013 and CDN $80,000 by a 15% one year promissory note starting January 1, 2013. The promissory note is interest free until March 31, 2013. After then, interest will accrue on the principal balance then in arrears at the rate of 15% per annum. No payments shall be payable until December 31, 2013. At any time, the Optionor may elect to convert the remaining balance of CDN $80,000 plus accrued interest into common shares of the Company at 75% of the closing market price of the Company’s common shares on the election day. The full CDN$100,000 (US$95,008) (consisting of cash payment of CDN$20,000 (US$19,164) and note payable of CDN$80,000 (US$75,844) was expensed. The note is subject to be measured at its fair value in accordance with ASC 480-10-25-14. The fair value at issuance was CDN$106,667 (US$101,125) as of June 30, 2013. An additional $26,667 was charged to mining expense during the year June 30, 2013. An interest expense of CDN$3,058 (US$2,899) was accrued as at June 30, 2013. On July 3, 2013, the Optionor elected to convert the promissory note of CDN $80,000 (US$75,844) plus accrued interest of CDN$3,058 (US$2,899) for the total amount of CDN $83,058 (US$78,743) into 239 common shares of the Company at a price of US$330 per share. The January 1, 2014 payment was not paid by the Company, and subsequent to the schedule payment date, the agreement was terminated.

Glottech Technology

On March 17, 2011 and subsequently amended on November 18, 2011, the Company entered into a letter agreement to acquire one initial unit of proprietary and patented mechanical ultrasound technology for use in water purification, inclusive of its process of separating from water, as the primary fluid stock, the salt and other minerals and by –products contained therein, with Glottech – USA.

To acquire the unit, the Company must make the following payments:

a)	US$25,000 upon execution of the agreement (paid);
b)	US$75,000 within 180 days of execution of the agreement (paid);
c)	US$700,000 within 10 days of receipt of invoice from Glottech –USA LLC if the payment in b) is made (paid).
d)	The Company also granted an option to acquire 500 shares for $1.00 to Glottech – USA upon receipt of the operational ultrasonic generator that they are building for Lithium Exploration Group. The 500 shares are to be paid from outstanding shares owned by Alex Walsh, company CEO. During the year ended June 30, 2011, the option resulting in additional mining expenses of $4,940,000 was valued using the fair market value of the shares to be issued. On October 1, 2012, Alex Walsh and GD International entered into an agreement to transfer 500 common shares owned by Alex Walsh to GD International. The shares were received by GD International on October 29, 2012.

19

5.   Mineral Property Costs - Continued

Commencing as of the end of an initial sixty day testing and training period following satisfactory delivery and physical setup of the technology, and continuing thereafter for as long as the technology remains in the possession of the Company, the Company shall pay continuing monthly royalties in an amount equal to $2.00 per physical ton of water processed pursuant to the usage of the technology.

On June 12, 2012, the Company filed a complaint with the court of common pleas of Chester County, Pennsylvania against Glottech – USA, LLC, Eldredge, Inc., and the Eldredge Companies, Inc. The complaint seeks an order of the court granting possession of the unit, in its current state, to the Company.

Effective August 14, 2012, the Company entered into an option agreement with GD Glottech-International, Limited (“GD International”) to protect our license and distribution rights in the event that GD-Glottech-USA, LLC (“GD USA”) is unable to perform and honor the obligations contingent to a letter agreement dated November 8, 2011.

Pursuant to the terms of the option agreement, we are required to provide an initial deposit of $150,000 to be held in escrow for the option to obtain a license on the patent rights, as set forth in the option agreement. A further $15,000 was required for exercising the option agreement and it will be credited to future fees when patents rights are exercised. We exerised this option agreement on September 1, 2012 and released the funds to GD International.

On October 1, 2012, the Company entered into a sales agency agreement with GD International. The agreement shall replace all agreements entered previously. Pursuant to the agreement, the Company is appointed as GD International’s sales agent for the technology within the territory. As a consideration, 10,000 common shares of the Company shall be issued to GD International (issued: see d) above). GD International retains all right, title and interest in the technology. The term of this agreement will be an initial period of five years. The term shall be automatically renewable thereafter for successive five year periods provided that the Company has sold not less than 25 or more technology units during each applicable five year period.

On May 2, 2013, the Company entered into an agreement to retain the future use of the unit. Pursuant to the agreement, the Company must make the following payments:

a)	US$20,000 within three days of execution of the agreement (paid);
b)	US$30,000 within three days upon the testing of the unit has been successfully completed.

20

6.   Convertible Promissory Notes

Summary of convertible promissory note at March 31, 2016 and June 30, 2015 is as follows:

		June 30,			Principal		Interest		Total converted			Total		March 31, 2016
		2015			Issued		Converted to					repaid
							Principal
February 13, 2013	$	67,913		$	-	$	-	$	(33,680	)	$	-	$	34,233
March 15, 2014		29,394			-		5,681		(29,938	)		-		5,137
July 22, 2014		540,498			-		-		(52,872	)		-		487,626
August 22, 2014		37,242			-		-		(5,200	)		-		32,042
February 6, 2015		75,000			-		-		(26,475	)		-		48,525
February 24, 2015		100,000			-		-					-		100,000
March 3, 2015		29,000			-		-		(3,000	)		-		26,000
August 3, 2015		-			36,000		-		-			-		36,000
September 9, 2015		-			30,000		-		-			-		30,000
September 30, 2015		-			27,000		-		-			-		27,000
November 06,2015		-			12,000		-		-			-		12,000
December 01, 2015		-			18,000		-		-			-		18,000
December 01, 2015		-			18,000		-		-			-		18,000
December 03, 2015		-			17,000		-		-			-		17,000
January 27, 2016		-			24,750		-		-			-		24,750
January 27, 2016		-			5,000		-		-			-		5,000
March 01, 2016		-			13,200		-		-			-		13,200
March 24, 2016		-			12,100		-		-			-		12,100
March 28, 2016		-			40,700		-		-			-		40,700
	$	879,047		$	253,750	$	5,681	$	(151,165	)	$		$	987,313
Less: Unamortized debt discount	$	(345,053	)										$	(176,047	)
Total note payable, net of debt discount	$	533,994											$	811,265
Current portion	$	533,994											$	811,265
Long term portion	$	-											$	-

21

6.   Convertible Promissory Notes – Continued

The Company during the period and subsequently has extended the maturity dates on few of the Convertible Promissory Notes.

On August 3, 2015 the Company issued an aggregate of $36,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. On May 19, 2016, JDF Capital Inc. signed an extension of the maturity of the note due February 3, 2016. The note now matures on February 3, 2017 with the same terms and conditions.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $52,720 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	269.35%
Risk free rate:	0.17%

The initial fair values of the embedded debt derivative of $33,231 was allocated as a debt discount up to the proceeds of the note with the remainder $19,489 was charged to current period operations as interest expense.

The note matured during the period however, no repayment was made. An agreement was entered into by the investor and the Company and the maturity of the note has been extended by a year.

On September 9, 2015, the Company issued an aggregate of $30,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $54,495 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	275.84%
Risk free rate:	0.39%

The initial fair values of the embedded debt derivative $30,000 was allocated as a debt discount up to the proceeds of the note with the remainder $24,495 was charged to current period operations as interest expense.

22

6.   Convertible Promissory Notes – Continued

On September 30, 2015, Company issued an aggregate of $27,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $306,808 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	375.79%
Risk free rate:	0.33%

The initial fair values of the embedded debt derivative $27,000 was allocated as a debt discount up to the proceeds of the note with the remainder $279,808 was charged to current period operations as interest expense.

On November 6, 2015, the Company issued an aggregate of $12,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $115,109 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	383.46%
Risk free rate:	0.47%

The initial fair values of the embedded debt derivative of $12,000 was allocated as a debt discount up to the proceeds of the note with the remainder $103,109 charged to operations as interest expense.

On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

23

6.   Convertible Promissory Notes – Continued

Dividend yield:	0%
Volatility	392.28%
Risk free rate:	0.51%

The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense.

On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	392.28%
Risk free rate:	0.51%

The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense.

On December 3, 2015, the Company issued an aggregate of $17,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $27,706 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	394.55%
Risk free rate:	0.57%

The initial fair values of the embedded debt derivative of $17,000 was allocated as a debt discount up to the proceeds of the note with the remainder $10,706 charged to operations as interest expense.

24

6.   Convertible Promissory Notes – Continued

On January 27, 2016, the Company issued an aggregate of $24,750 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $45,731 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	383.68%
Risk free rate:	0.47%

The initial fair values of the embedded debt derivative of $22,846 was allocated as a debt discount with the remainder $22,885 charged to operations as interest expense.

On January 27, 2016, the Company issued an aggregate of $5,500 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $9,239 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	383.68%
Risk free rate:	0.47%

The initial fair values of the embedded debt derivative of $4,615 was allocated as a debt discount with the remainder $4,623 charged to operations as interest expense.

On March 01, 2016, the Company issued an aggregate of $13,200 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

25

6.   Convertible Promissory Notes – Continued

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $29,217 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.68%

The initial fair values of the embedded debt derivative of $13,200 was allocated as a debt discount up to the proceeds of the note with the remainder $16,017 charged to operations as interest expense.

On March 24, 2016, the Company issued an aggregate of $12,100 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $17,671 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.64%

The initial fair values of the embedded debt derivative of $6,515 was allocated as a debt discount with the remainder $11,156 charged to operations as interest expense.

On March 28, 2016, the Company issued an aggregate of $40,700 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $36,293 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

26

6.   Convertible Promissory Notes – Continued

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.65%

The initial fair values of the embedded debt derivative of $21,915 was allocated as a debt discount with the remainder $14,378 charged to operations as interest expense.

During the three and nine months period ended March 31, 2016 the Company amortized the debt discount on all the notes of $78,688 and $399,010 to operations as interest expense, respectively.

During the three and nine months period ended March 31, 2015 the Company amortized the debt discount on all the notes of $(101,727) and $1,483,168 to operations as interest income and expense, respectively.

Derivative Liability- Debt

The fair value of the described embedded derivative on all debt was valued at $1,352,033 and $1,646,448 at March 31, 2016 and June 30, 2015, respectively, which was determined using the Black Scholes Model with the following assumptions:

	March 31, 2016	June 30, 2015
Dividend yield:	0  %	0  %
Volatility	346.6 – 453.3  %	258.89  %
Risk free rate:	0.39%-0.66  %	0.11% - 0.64  %

At March 31, 2016 and 2015, the Company adjusted the recorded fair value of the derivative liability on debt to market resulting in non-cash, non-operating gain of $828,693 and loss of $904,458 for the nine months ended March 31, 2016 and 2015, respectively and for the three months ending March 31, 2016 and March 31, 2015, the non-cash, non-operating loss of $241,359 and $723,955 was recorded respectively.

During the nine months ended March 31, 2016 the Company issued 6,088,220 no of shares of the Company common stock in settlement of $151,165 of convertible note and interest.

During the nine months ended March 31, 2016 the Company reclassed the derivative liability of $302,262 to additional paid in capital on conversion of convertible note.

27

6.   Convertible Promissory Notes – Continued

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of March 31, 2016 and June 30, 2015:

		Derivative
		Liability (convertible
		promissory notes)
Balance, June 30, 2014	$	3,066,171
Initial fair value at note issuances		1,227,384
Fair value of liability at note conversion		(3,174,990	)
Mark-to-market at June 30, 2015		527,883
Balance, June 30, 2015	$	1,646,448
Initial fair value at note issuances		836,980
Fair value of liability at note conversion		(302,262	)
Mark-to-market at March 31, 2016		(829,133	)
Balance, March 31, 2016	$	1,352,033
Net gain for the period included in earnings relating to the liabilities held at March 31, 2016	$	829,133

Derivative Liability- Warrants

Along with the promissory notes, the Company issued warrants that bear a cashless exercise provision. The warrants also include anti-dilution protection with respect to lower priced issuances of common stock or securities convertible or exchangeable into common stock, which provision resulted in derivative liability treatment under ASC 480. The warrants are recorded at fair value using the Black-Scholes option pricing model and marked-to-market at each reporting period, with the changes in the fair value recorded in the consolidated statement of operations and comprehensive income (loss).

28

6.   Convertible Promissory Notes – Continued

During the nine months ended March 31, 2016 no warrants were issued along with convertible note.

The fair value of the described embedded derivative on all warrants was valued at $395,535 at March 31, 2016 and $143,375 at June 30, 2015 which was determined using the Black Scholes Model with the following assumptions:

	March 31, 2016	June 30, 2015
Dividend yield:	0  %	0  %
Volatility	248.0 – 272.2  %	288.96  %
Risk free rate:	.87 – 1.21  %	1.01 - 1.63  %

	Warrants			Weighted	Weighted
	Outstanding			Average	Average
				Exercise	Remaining
				Price	life
Balance, June 30, 2014	15,204		$	242.57	2.62 years
Warrants issued	19,104			236.92	4.46 years
Exercised	(5,927	)		257.08	-
Cancelled	-			-	-
Expired	(1,289	)		240.00	-
Balance, June 30, 2015	27,092		$	100.98	3.79 years
Warrants issued	-			-	-
Exercised	-			-	-
Cancelled	-			-	-
Expired	-			-	-
Balance, March 31, 2016	27,092		$	100.99	3.04 years

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of March 31, 2016 and June 30, 2015:

		Derivative
		Liability (warrants)
Balance, June 30, 2014	$	5,416,000
Initial fair value of warrant derivatives at note issuances		791,407
Fair value of warrant exercised		(2,730,022	)
Mark-to-market at June 30, 2015 – warrant liability		(3,334,009	)
Balance, June 30, 2015	$	143,376
Initial fair value of warrant derivatives at note issuances		-
Fair value of warrant exercised		-
Mark-to-market at March 31, 2016 – warrant liability		252,160
Balance, March 31, 2016	$	395,536
Net loss for the period included in earnings relating to the liabilities held at March 31, 2016	$	252,160

29

6.   Convertible Promissory Notes – Continued

At March 31, 2016 and 2015, the Company adjusted the recorded fair value of the derivative liability on warrants to market resulting in non-cash, non-operating loss of $252,160 and gain of $1,987,656 for the nine months ended March 31, 2016 and 2015, respectively. Non-cash, non-operating gain of $354,046 and loss of $1,111,145 was recorded for the three months ended March 31, 2016 and March 31, 2015 respectively.

During the nine months ended March 31, 2016 the Company reclassed the derivative liability on warrants of $0 to additional paid in capital on exercise of warrants.

7.   Related Party Transactions

During the nine months ended March 31, 2016, the Company incurred consulting fees of $1,115 (June 30, 2015 - $157,086) with directors and officers out of which there were no stock payments (June 30, 2015 - $58,990 were paid by issuance of 2,167 shares of the Company common stock).

As of March 31, 2016, the Company repaid to a director for a non-interest bearing demand loan of $nil (Note 9) (June 30, 2015 – payable $47,537).

These transactions are in the normal course of operations and are measured at the exchange amount of consideration established and agreed to by the related parties.

8.   Going Concern and Liquidity Considerations

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As at March 31, 2016, the Company had a working capital deficiency of $2,942,788 (June 30, 2015 - $2,456,477) and an accumulated deficit of $50,457,687 (June 30, 2015 - $49,504,350). The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the next twelve months.

The ability of the Company to emerge from the exploration stage is dependent upon, among other things, obtaining additional financing to continue operations, explore and develop the mineral properties and the discovery, development and sale of ore reserves.

In response to these problems, management intends to raise additional funds through public or private placement offerings.

These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

9.   Commitments and Contingencies

Employment Agreements

On January 12, 2014, the Company entered into an employment agreement with a director and officer. Commencing on January 12, 2014, the director and officer will be employed for 24 months ending on January 12, 2016. Pursuant to the agreement, annual salary of US$120,000 is payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock.

30

9.   Commitments and Contingencies - Continued

Consulting Agreements

On January 1, 2014, the Company entered in a consulting agreement with a consultants to provide services as members of the Board of Directors in regards to the Company’s management and operations. The compensation for the services to be provided will be $12,000 payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. The consulting agreement was amended on October 22, 2014 to include an additional aggregate of $30,000 payable as of October 22, 2014 in cash or in shares of the Company’s common stock, and changed the term of agreement from 12 months to 10 months. Effective November 1, 2014, the consultant resigned as member of the Board of Directors.

On April 28, 2014, the Company entered into a consulting agreement with a consultant to provide services as members of the Board of Directors in regards to the Company’s management and operations. Pursuant to the terms of the agreement, the consultant will receive compensation of $12,000 in unregistered restricted common shares of the Company's common stock at a deemed value of $200.0 per share, issuable on May 15, 2014, effective April 28, 2014 to April 27, 2015. The consultant resigned as member of the Board of Directors and these shares were not issued.

On May 30, 2014, the Company entered into a consulting agreement with a consultant to provide services as member of the Board of Directors in regards to the Company’s management and operation. The compensation for the services to be provided will be $10,000 per month payable in common stock of the Company from a period of six months from the effective date of May 30, 2014.

On August 1, 2014, the Company entered into a consulting agreement with a consultant to provide advice relative to corporate and business services and to perform other related activities. Pursuant to the terms of the agreement, the Company will issue 500 common shares of the Company valued at $68,000. These shares were issued in full effective October 22, 2014.

Lease Commitment

On May 15, 2014, the Company entered into a sublease agreement for a term of twenty four and one half months and expiring on May 31, 2016. Future minimum rental payments required under operating lease (exclusive of other additional rent payments) are $4,563.

Litigation

From time to time we may be a defendant and plaintiff in various other legal proceedings arising in the normal course of our business. Except as disclosed above, we are currently not a party to any material legal proceedings or government actions, including any bankruptcy, receivership, or similar proceedings. In addition, we are not aware of any known litigation or liabilities involving the operators of our properties that could affect our operations. Furthermore, as of the date of this Annual Report, our management is not aware of any proceedings to which any of our directors, officers, or affiliates, or any associate of any such director, officer, affiliate, or security holder is a party adverse to our company or has a material interest adverse to us.

10.  Loan Receivable

Secured Bridge Loan Agreement

On December 18, 2013, the Company entered into an agreement with GD Glottech International Ltd (“GDGI”) whereby the Company loaned to GDGI the sum of $20,000. GDGI will repay the total amount of the loan plus interest in the amount of $333.34 (representing a 10% annual interest rate), within sixty (60) days from the receipt of the loan funds or within five (5) days of Sonic Cavitation, LLC receiving a 5% Capital Contribution.

On April 21, 2014, the Company entered into an amended agreement with Sonic Cavitation, whereby Sonic Cavitation agreed to facilitate the construction of one sonic cavitation generator. The Company agreed to pay Sonic Cavitation a consulting fee of $20,000 upon execution of the agreement and forgive the sum of $20,000 debt upon delivery of the prototype by Sonic Cavitation. The agreement has been executed, however the delivery of the prototype has not yet fulfilled.

During the nine months ending March 31, 2016, the directors of the company decided that the loan is irrecoverable and has been written off to $nil.

31

11. Discontinued Operations

On September 4, 2015, the Company entered into an Asset Purchase agreement whereby the Company sells the net assets of Alta Disposal Morinville Ltd. (of which the Company had acquired 51% interest on October 18, 2013) for total purchase price of CDN$10,000.

Operating results for the period ended March 31, 2016 and 2015 for Alta Disposal Morinville Ltd. are presented as discontinued operations and the assets and liabilities classified as held for sale are presented separately in the consolidated balance sheet.

A breakdown of the discontinued operations is presented as follow:

Consolidated Statements of Operations and Comprehensive Loss

		March 31, 2016			March 31, 2015
		(unaudited)			(unaudited)
Revenue	$	-		$	54,476
Selling, general and administrative	$	(78,860	)		(363,442	)
Loss from discontinued operations	$	(78,860	)	$	(305,966	)

Consolidated Balance Sheets		March 31, 2016		June 30, 2015
		(unaudited)		(restated)
Current assets:
Cash and cash equivalents	$	5,731	$	46,731
Receivable, net		653		28,160
Prepaid expenses		683		-
GST Receivable		16,284		-
Impairment of net assets		-		(60,178	)
	$	23,351	$	14,713
Current liabilities:
Accounts payable	$	6,439	$	6,696

32

12. Subsequent Events

On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,000, with an issuance discount of $2,500 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On May 16, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,250, with an issuance discount of $2,750 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On August 12, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $42,500, with an issuance discount of $4,250 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On September 1, 2016, our company entered into letter agreements with five separate investors with the intent to buyout their notes and warrants. Pursuant to the terms of the agreement, the investors have agreed to a standstill period until September 16, 2016. The buyout will take place over a six month period of time and will result in an aggregate of $252,856 in debt being retired, an aggregate of $195,500 in warrants being retired and an aggregate buyout amount of $460,000 will be paid over the period. Additionally the Company will also issue an aggregate of $232,500 in new convertible debt. Conversion Price for note will be 65% of the lowest trading price of the Common Stock as reported on the OTC Markets electronic quotation service or such marketplace. Note will have no prepayment penalties and can be purchased from the holder at face value.

On September 2, 2016 our company entered into a bridge loan in the amount of $50,000 with 10% interest per annum due November 2, 2016.

The following conversions took place subsequent to the period ending March 31, 2016.

On April 4, 2016 the Company issued 160,043 common shares at a deemed price of $0.0126 per share for promissory note conversion.

 On April 4, 2016 the Company issued 650,000 common shares at a deemed price of $0.026 per share for promissory note conversion.

On April 4, 2016 the Company issued 641,025 common shares at a deemed price of $0.0252 per share for promissory note conversion.

On April 5, 2016 the Company issued 227,770 common shares at a deemed price of $0.011 per share for promissory note conversion.

On April 6, 2016 the Company issued 490,027 common shares at a deemed price of $0.01807 per share for promissory note conversion.

On April 7, 2016 the Company issued 267,396 common shares at a deemed price of $0.0075 per share for promissory note conversion.

33

12. Subsequent Events – continued

On April 8, 2016 the Company issued 591,620 common shares at a deemed price of $0.009329 per share for promissory note conversion.

On April 8, 2016 the Company issued 769,230 common shares at a deemed price of $0.0126 per share for promissory note conversion.

On April 11, 2016 the Company issued 500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 12, 2016 the Company issued 776,000 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 13, 2016 the Company issued 775,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 13, 2016 the Company issued 669,222 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 13, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion.

On April 11, 2016 the Company issued 575,327 common shares at a deemed price of $0.010985 per share for promissory note conversion.

On April 14, 2016 the Company issued 790,000 common shares at a deemed price of $0.007500 per share for promissory note conversion.

On April 14, 2016 the Company issued 803,725 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 14, 2016 the Company issued 846,153 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 17, 2016 the Company issued 1,128,205 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 18, 2016 the Company issued 819,493 common shares at a deemed price of $0.010595 per share for promissory note conversion.

On April 19, 2016 the Company issued 850,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 19, 2016 the Company issued 1,041,960 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 19, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion.

On April 20, 2016 the Company issued 750,000 common shares at a deemed price of $0.0075 per share for promissory note conversion.

34

12. Subsequent Events – continued

On April 21, 2016 the Company issued 469,119 common shares at a deemed price of $0.010595 per share for promissory note conversion.

On April 21, 2016 the Company issued 1,048,416 common shares at a deemed price of $0.007500 per share for promissory note conversion.

On April 22, 2016 the Company issued 1,140,474 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 22, 2016 the Company issued 1,100,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 22, 2016 the Company issued 256,410 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 26, 2016 the Company issued 923,077 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 26, 2016 the Company issued 1,600,000 common shares at a deemed price of $0.00715 per share for promissory note conversion.

On April 28, 2016 the Company issued 1,500,000 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 28, 2016 the Company issued 1,007,941 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 29, 2016 the Company issued 769,231 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 29, 2016 the Company issued 1,214,575 common shares at a deemed price of $0.0076 per share for promissory note conversion.

On April 29, 2016 the Company issued 1,529,480 common shares at a deemed price of $0.007500 per share for promissory note conversion.

On April 29, 2016 the Company issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion.

On May 2, 2016 the Company issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion.

On May 2, 2016 the Company issued 1,514,380 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 3, 2016 the Company issued 1,586,538 common shares at a deemed price of $0.0026 per share for promissory note conversion.

35

12. Subsequent Events – continued

On May 3, 2016 the Company issued 1,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 5, 2016 the Company issued 2,302,321 common shares at a deemed price of $0.00145 per share for promissory note conversion.

On May 5, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 5, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 9, 2016 the Company issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion.

On May 9, 2016 the Company issued 5,500,000 common shares at a deemed price of $0.00115 per share for promissory note conversion.

On May 9, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00125 per share for promissory note conversion.

On May 9, 2016 the Company issued 6,100,000 common shares at a deemed price of $0.00075 per share for promissory note conversion $4575.

On May 10, 2016 the Company issued 3,200,000 common shares at a deemed price of $0.000750 per share for promissory note conversion.

On May 10, 2016 the Company issued 3,100,000 common shares at a deemed price of $0.000975 per share for promissory note conversion.

On May 10, 2016 the Company issued 6,600,000 common shares at a deemed price of $0.00075 per share for promissory note conversion.

On May 11, 2016 the Company issued 6,000,000 common shares at a deemed price of $0.00075 per share for promissory note conversion.

On May 11, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On May 12, 2016 the Company issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion.

On May 12, 2016 the Company issued 4,000,000 common shares at a deemed price of $0.000845 per share for promissory note conversion.

On May 13, 2016 the Company issued 9,717,385 common shares at a deemed price of $0.00055 per share for promissory note conversion.

On May 12, 2016 the Company issued 7,900,000 common shares at a deemed price of $0.0065 per share for promissory note conversion.

Subsequent to the issuance of June 30, 2015 financial statements, management determined that the warrants issued were incorrectly valued and derivative liability on the conversion option embedded in convertible notes was not recognized and during the nine months period ending March 31, 2016, these warrants were revalued and a derivative liability on the conversion option was calculated. As a result of revaluation of the warrants, the consolidated balance sheet for the year ending June 30, 2015, the consolidated statements of operations and comprehensive income (loss) and consolidated statement of cash flows for the nine months period ending March 31, 2015 and consolidated statements of changes in stockholders’ deficit for the period ending June 30, 2014 and June 30, 2015 were restated.

The Company has evaluated subsequent events from April 1, 2016, through the date of this report, and determined there are no other items to disclose.

36

13. Restatement to previously issued financial statements

The following tables reflect the corrections to the affected line items in the previously issued financial statements as of and for the years ended June 30, 2015 and for the period ended March 31, 2015.

13. Restatement to previously issued financial statements - continued

Effect on Condensed Consolidated Balance Sheet

		Year ended June 30, 2015
		As previously			Effect of			As Restated
		reported			Restatement
ASSETS
Current
Cash and cash equivalents	$	64,099		$	-		$	64,098
Receivable		13,421			-			13,421
Loan receivable		20,000			-			20,000
Prepaid expenses		2,788			-			2,788
Current assets held for sale		14,713			-			14,713
Total current assets		115,021			-			115,020
Total Assets	$	115,021		$	-		$	115,020
LIABILITIES AND DEFICIT
Current
Accounts payable and accrued liabilities	$	65,962		$	-		$	65,962
Derivative liability – warrants		3,134			140,241			143,375
Derivative liability – convertible promissory notes		-			1,646,448			1,646,448
Due to related party		115,000			-			115,000
Convertible promissory notes		300,887			233,107			533,994
Accrued interest – convertible promissory notes		60,022			-			60,022
Liabilities of discontinued operations		6,696			-			6,696
Total Current Liabilities	$	551,701		$	2,019,796		$	2,571,497
STOCKHOLDERS DEFICIT
Capital stock
Nil preferred shares		-			-			-
7,574,353 common shares		7,575			-			7,575
Additional paid-in capital		43,165,743			4,217,489			47,383,232
Accumulated other comprehensive loss		(29,484	)		-			(29,484	)
Deficit accumulated during the exploration		(43,267,064	)		(6,237,285	)		(49,504,349	)
Total Lithium Exploration Group, Inc. Stockholders’ Deficit		(123,230	)		(2,019,796	)		(2,143,027	)
Non-controlling interest		(313,450	)		-			(313,450	)
Total Deficit		(436,680	)		(2,019,796	)		(2,456,477	)
Total Liabilities and Deficit	$	115,021		$	-		$	115,020

37

13. Restatement to previously issued financial statements - continued

Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)

		Nine months ended March 31, 2015
		As previously reported			Effect of Restatement			As Restated
Revenue	$	57,476		$	(57,476	)	$	-
Operating Expenses:
Mining (Notes 3 & 5)		31,212			-			31,212
Selling, general and administrative (Notes 3 & 5)		1,308,405			(363,441	)		944,964
Impairment Loss		624,429			-			624,429
Total operating expenses		1,964,046			(363,441	)		1,600,605
(Loss) from operations		(1,906,570	)		(305,965	)		(1,600,605	)
Other income (expenses)
Interest expense (Note 6)		(2,818,008	)		1,484,816			(1,333,192	)
Other Income		80,524			-			80,524
Gain on change in the fair value of derivative liability (Note 6)		3,638,090			(1,763,485	)		1,874,605
Fair Value of Warrants issued		(962,309	)		170,902			(791,407	)
Amortization of discount on debt discount		-			(1,483,168	)		(1,483,168	)
Equity in income of investment held for sale		(324	)		-			(324	)
Loss before income taxes		(1,968,597	)		(1,284,971	)		(3,253,567	)
Provision for Income Taxes (Note 4)		-			-			-
Loss from continuing operations		(1,968,597	)		(1,284,971	)		(3,253,567	)
Loss from discontinued operations		-			(305,966	)		(305,966	)
Net loss		(1,968,597	)		(1,590,937	)		(3,559,534	)
Less: Net loss attributable to the non-controlling interest		(149,923	)		-			(149,923	)
Net loss attributable to Lithium Exploration Group, Inc. Common shareholders	$	(1,818,674	)	$	(1,590,937	)	$	(3,409,611	)
Basic and Diluted loss per Common Share		0.04			(15.24	)		(15.28	)
Basic and Diluted Weighted Average Number of Common Shares Outstanding		44,636,800			(44,413,616	)		223,184

38

13. Restatement to previously issued financial statements - continued

Comprehensive loss :
Net loss		(1,968,597	)		(1,590,937	)		(3,559,534	)
Foreign currency translation adjustment		(21,831	)		-			(21,831	)
Comprehensive loss		(1,990,428	)		(1,590,937	)		(3,581,365	)
Comprehensive loss attributable to non-controlling interest		(149,923	)		-			(149,923	)
Comprehensive loss attributable to Lithium Exploration Group, Inc.	$	(1,840,505	)	$	(1,590,937	)	$	(3,431,442	)

Effect on Condensed Consolidated Statements of Cash Flows

		Nine months ending March 31, 2015
		As previously			Misstatement			As Restated
		reported			Adjustment
Cash Flows from Operating Activities
Net loss from continuing operations	$	(1,968,597	)	$	(1,284,971	)	$	(3,253,567	)
Loss from discontinued operations		-			(305,966	)		(305,966	)
Adjustments to reconcile net loss to net cash used in operating
activities:
Equity in income of investment held for sale		324			-			324
Common shares issued for consulting fees		118,990			-			118,990
Common shares issued for investor relations		5,000			-			5,000
Interest expense		2,611,775			(1,484,818	)		1,126,957
Amortization of discount on derivative liabilities		-			1,483,168			1,483,168
Bad debt written-off		-			-			-
Common shares issued for interest expenses		103,048			-			103,048
Gain on change in the fair value of derivative liability		(3,638,090	)		1,763,485			(1,874,605	)
Fair value of warrants issued		962,309			(170,902	)		791,407
Due to related party		115,000			-			115,000
Impairment Loss		624,429			-			624,429
Changes in operating assets and liabilities:
Receivable, net		(7,412	)		7,412			-
Prepaid expenses		19,074			(2,464	)		16,610
Accrued interest		103,185			2			103,187
Accounts payable and accrued liabilities		52,968			(5,790	)		47,178
Net cash used in operating activities from continuing operations		(887,997	)		(843	)		(898,840	)
Net cash used in operating activities from discontinued operations		-			(8,212	)		(8,212	)
Net cash used in operating activities		(897,997	)		(9,055	)		(907,052	)

39

13. Restatement to previously issued financial statements - continued

Cash Flows from Financing Activities
Repayment of related party		(45,332	)		-			(45,332	)
Proceed from issuance of convertible promissory notes		954,000			-			954,000
Net cash provided by financing activities		908,668			-			908,668
Effect of foreign exchange		(21,831	)		-			(21,831	)
Decrease in cash and cash equivalents		(11,160	)		(9,055	)		(20,215	)
Cash and cash equivalents - beginning of period		69,732			(12,100	)		57,632
Cash and cash equivalents - end of period	$	58,572			(21,155	)	$	37,417
Supplementary disclosure of cash flow information:
Cash paid during the period for:
Interest	$	2,205			(2,205	)	$	-
Income taxes	$	-					$	-
Supplementary non- cash Investing and Financing Activities:
Non-cash investing and financing activities:
Common stock issued for debt conversion	$	2,536,097		$	(1,036,895	)	$	1,499,202
Transfer of beneficial conversion feature to fair value of note	$	518,808		$	(518,808	)	$	-
Common stock issued on cashless exercise of warrants	$	779,600		$	1,663,170		$	2,442,770
Derivative liability re-classed to additional paid in capital	$	-		$	2,312,157		$	2,312,157
Debt discount on convertible note and warrants	$	-		$	901,327		$	901,327
Initial derivative liability on note issuance	$	-		$	2,018,791		$	2,018,791

Effect on Condensed Consolidated Statements of Changes in Stockholders’ Deficit

		Year ended June 30, 2015
		As previously		Misstatement
		reported		Adjustment			As Restated
Additional Paid in Capital
Beginning Balance	$	38,573,856	$	538,043		$	39,111,899
Common shares issued for debt conversion		3,636,984		(1,457,586	)		2,179,398
Common shares issued for exercise of warrants		767,879		1,962,041			2,729,920

40

13. Restatement to previously issued financial statements - continued

Common shares issued for reclassification of derivative liability on convertible notes		-			3,174,990			3,174,990
Closing Balance	$	43,165,743		$	4,217,488		$	47,383,231
Accumulated deficit
Beginning Balance	$	(40,821,871	)	$	(6,166,108	)	$	(46,987,979	)
Net Income (Loss) for the year		(2,445,193	)		(71,176	)		(2,516,369	)
Closing Balance	$	(43,267,064	)	$	(6,237,283	)	$	(49,504,347	)
Total Equity
Beginning Balance	$	(2,355,136	)	$	(5,628,065	)	$	(7,983,201	)
Common shares issued for consulting fees		118,990						118,990
Common shares issued for investor relations		68,000						68,000
Common shares issued for exercise of warrants		767,981			1,962,039			2,730,020
Common shares issued for debt conversion		3,644,405			(1,457,585	)		2,186,820
Common shares issued for reclassification of derivative
liability on convertible notes		-			3,174,990			3,174,990
Common shares issued to trust		38			-			38
Foreign exchange translation		(23,715	)					(23,715	)
Net Income (Loss) for the year		(2,657,243	)		(71,176	)		(2,728,419	)
Closing Balance	$	(436,680	)	$	(2,019,797	)	$	(2,456,477	)

41

Item 2.           Management's Discussion and Analysis of Financial Condition or Plan of Operation

FORWARD-LOOKING STATEMENTS

This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Our unaudited financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this quarterly report.

Unless otherwise specified in this quarterly report, all dollar amounts are expressed in United States dollars and all references to “common stock” refer to shares of our common stock.

As used in this quarterly report, the terms “we”, “us”, “our company”, mean Lithium Exploration Group, Inc. a Nevada corporation, and our wholly owned subsidiary, Alta Disposal Ltd., an Alberta, Canada corporation, our partially owned subsidiary, Alta Disposal Morinville Ltd., an Alberta, Canada corporation, unless otherwise indicated.

Corporate History

We were incorporated on May 31, 2006 in the State of Nevada under the name “Mariposa Resources, Ltd.”. Effective November 30, 2010, we changed our name to “Lithium Exploration Group, Inc.,” by way of a merger with our wholly-owned subsidiary Lithium Exploration Group, Inc., which was formed solely for the change of name.

Our executive offices are located at 3800 N Central Avenue, Suite 820, Phoenix, AZ 85012, and our telephone number is (480) 641-4790. We also have an office at 840 6th Ave SW Suite 300, Calgary, Alberta T2P 3E5. The phone number for our Calgary office is 403-930-1925.

On October 18, 2013, our company, through our then wholly owned subsidiary, Alta Disposal Ltd. (formerly 1617437 Alberta Ltd.), an Alberta, Canada corporation, completed the acquisition of 51% of the shares of Blue Tap Resources Inc. for total payment of CAD$466,547. As of September 30, 2013, CDN $300,000 (US$294,908) was paid regarding the acquisition. As a result of the share acquisition, Blue Tap Resources Inc. is now a partially owned subsidiary of our company through our wholly owned subsidiary, Alta Disposal Ltd. On January 22, 2014, Blue Tap Resources Inc. changed its name to Alta Disposal Morinville Ltd.

On August 20, 2013, we entered into a letter of intent with Tero Oilfield Services Ltd., a private company, pursuant to which Tero agreed to sell up to 75% of the issued and outstanding common shares of Tero to our company in exchange for payment in the amount of $1,500,000.

On March 1, 2014, Alta Disposal Ltd., our wholly-owned subsidiary, entered into a share purchase agreement with Tero and Garry Hofmann, the sole shareholder of Tero. Pursuant to the agreement, Mr. Hofmann agreed to sell and we agreed to purchase 50% of the issued and outstanding common shares of Tero in exchange for an aggregate of CAD$1,000,000. As part of the share purchase by Alta Disposal, on February 22, 2014, Tero declared a dividend in the amount of $307,104, payable to Mr. Hofmann by way of a promissory note. As a result of the share purchase agreement, Tero is now a partially owned (50%) subsidiary of our company.

Additionally, Alta Disposal, Tero and Mr. Hofmann entered into an option agreement entitling Alta Disposal to purchase up to an additional 25% of the issued and outstanding common shares of Tero from Mr. Hofmann exercisable at a price of $500,000 for a period of one year. We have subsequently sold our interest in Tero on May 1, 2015 as further described below.

42

On October 17, 2014, we amended our Articles of Incorporation, which amendment was filed with the Nevada Secretary of State on October 17, 2014, to increase the authorized capital of our common shares from 500,000,000 common shares, par value $0.001 to 2,000,000,000 common shares, par value $0.001. Our authorized capital consists of 2,000,000,000 common shares and 100,000,000 preferred shares, all with a par value of $0.001.

On January 19, 2015, we received written consent from our company’s board of directors to effect a reverse stock split of our issued and outstanding shares of common stock on a basis of 20 old shares of common stock for 1 new share of common stock. Stockholders of our company originally approved the reverse stock split on October 14, 2014 at a special meeting. Our authorized capital will not be affected by the reverse stock split.

On May 1, 2015, our company entered into a share purchase agreement with an individual and disposed of our 50% interest in Tero in consideration of $300,000.

On June 22, 2015, in accordance with our articles of incorporation, our board of Directors has designated 250,000 of our 100,000,000 authorized shares of Preferred Stock as Series “A” Preferred Stock. The Series “A’ Preferred Stock, par value $0.001, will rank senior to our common stock, carrying general voting rights with the common stock at the rate of 62 votes per share. The Series “A” Preferred Stock will be deemed cancelled within 1 year of issuance and are not entitled to share in dividends or other distributions. So long as any shares of Series “A” Preferred Stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of Series “A” Preferred Stock will be required for any change to our Articles of Incorporation.

On July 9, 2015 our board of directors approved a settlement agreement dated June 25, 2015 among our company, JDF Capital Inc., and our wholly owned subsidiary, Alta Disposal Ltd. Previously, pursuant to a General Security Agreement dated July 22, 2014, JDF Capital Inc. was granted a first ranking security interest over all current and future assets of Alta Disposal Ltd. in full guarantee of $708,000 loan to our Company. Pursuant to the Settlement Agreement, JDF Capital Inc. and its assign, Blue Citi LLC, have agreed to release and discharge their general security interest in consideration of the issuance of 130,000 shares of Series “A” Preferred Stock. The 130,000 shares of Series “A” Preferred Stock were relinquished and cancelled by agreement with Blue Citi effective December 5, 2015.

Effective September 4, 2015, our company entered into an Asset Purchase Agreement with Cancen Oil Canada whereby we sold all right, title and interest of Alta Disposal Morinville Ltd. assets for total purchase price of CAD$10,000 (approximately USD$7,531.25) .

On July 13, 2015 our company's directors approved an increase to our authorized capital from 2,000,000,000 shares of common stock, par value $0.001 to 10,000,000,000 shares of common stock, par value of $0.001 per share and a reverse stock split on a basis of up to 200 old shares of common stock for one (1) share of common stock. The increase of authorized capital and stock split was approved by shareholders on July 13, 2015. A Definitive Schedule 14C was filed with United States Securities and Exchange Commission ("SEC") on August 6, 2015. On September 9, 2015, we filed with the Nevada Secretary of State a Certificate of Amendment increasing our authorized capital from 2,000,000,000 shares of common stock, par value $0.001 to 10,000,000,000 shares of common stock, par value of $0.001 per share. The reverse split became effective with the Over-the-Counter Bulletin Board at the opening of trading on September 30, 2015. Effective September 30, 2015, our new CUSIP number is 53680P308.

Other than as set out herein, we have not been involved in any bankruptcy, receivership or similar proceedings, nor have we been a party to any material reclassification, merger, consolidation or purchase or sale of a significant amount of assets not in the ordinary course of our business.

Disclosure Adjustments for Reverse Stock Split

On January 19, 2015, our board of directors consented to effect a reverse stock split of our issued and outstanding shares of common stock on a basis of 20 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FINRA effective February 25, 2015. Our authorized capital was not affected by the reverse stock split.

On July 13, 2015, our board of directors consented to effect a reverse stock split of our issued and outstanding shares of common stock on a basis of 200 old shares of common stock for 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FINRA effective September 30, 2015. Our authorized capital was not affected by the reverse stock split.

In this Quarterly Report and in the accompanying financial statements and notes, the above described reverse splits are reflected retrospectively in the descriptions of shares and warrants, and their corresponding issuance and exercise prices, except where otherwise indicated.

43

Our Current Business

We are corporation engaged principally in the acquisition, exploration, and development of resource properties. Through our subsidiary Alta Disposal Morinville Ltd., we also operate in the waste water disposal industry.

Assignment Agreement with Lithium Exploration VIII Ltd.

On December 16, 2010, we entered into an assignment agreement with Lithium Exploration VIII Ltd. (not related to our company) to acquire an undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada. Lithium Exploration VIII and Golden Virtue Resources Inc. (formerly First Lithium Resources Inc.) (not related to our company) had entered into an underlying option agreement dated October 6, 2010, which option agreement and interest were assigned to our company.

On December 31, 2012, our company entered into an amending agreement to amend an original payment requirement of the assignment agreement of CAD$100,000 due on January 1, 2013 to the following payments:

• CAD$20,000 (USD$20,000) cash payment due on January 1, 2013; and
• CAD$80,000 (USD$80,000) by a 15% one year promissory note starting January 1, 2013.

The note was interest free until March 31, 2013. After March 31, 2013, interest accrued on the principal balance then in arrears at the rate of 15% per annum. Payments were due and payable by December 31, 2013. Further, at any time, Lithium Exploration VIII and Golden Virtue could elect to convert the remaining balance of the note and accrued interest into common shares of our company at 75% of the closing market price of our company’s common shares on the election day.

On July 3, 2013, Lithium Exploration VIII and Golden Virtue elected to convert the note and accrued interest in the combined aggregate amount of CAD$83,057.53 (USD$78,743) into common shares of our company. Pursuant to this election, we issued an aggregate of 239 shares (on a pre-reverse split basis) of our common stock at the price of USD$330 per share.

Glottech

On November 8, 2011, we entered into a letter agreement with Glottech-USA. Pursuant to the terms of the agreement, we were granted an exclusive license to use and distribute the technology within the Swan Hills region of Alberta as well as a non-exclusive right to distribute the technology within Canada.

We previously made the following payments in association with the production of a working unit of Glottech-USA’s technology:

• $25,000 on March 21, 2011 in consideration for entering into the letter agreement dated March 17, 2011;
• $75,000 on May 27, 2011 in consideration for continuance of the March 17, 2011 agreement; and
• $700,000 on May 27, 2011 in consideration for a licensing and technology payment.

As part of the November 8, 2011 agreement, our officer and director, Alexander Walsh, agreed to provide Glottech-USA with the option, for a period of 12 months from delivery of the first unit, to acquire 500 shares (of our common stock currently held by him , for a total price of $4,000 ($1 pre-reverse splits). Additionally, if, for any reason, Mr. Walsh failed to deliver the 500shares of our common stock to Glottech-USA, we agreed to issue the shares from treasury.

On June 12, 2012, we filed a complaint against Glottech-USA in the Court of Common Pleas of Chester County, Pennsylvania, alleging that Glottech-USA misused our funds and was in breach of our agreements that called for Glottech-USA to deliver one initial unit of the mechanical ultrasound technology. We further alleged that Glottech-USA was financially insolvent and unable to fulfill its promises to us.On June 12, 2012, we filed a complaint with the Court of Common Pleas of Chester County, Pennsylvania against Glottech-USA, LLC, Eldredge, Inc., and the Eldredge Companies, Inc. Pursuant to an unopposed motion, the Eldredge parties were dismissed in October of 2012. The complaint initially sought an order of the Court granting possession of the initial unit.

Effective August 14, 2012, we entered into an option agreement with GD Glottech International to protect our license and distribution rights in the event that Glottech-USA became unable to perform and honor its obligations to us.

Pursuant to the terms of the option agreement, we were required to provide an initial amount of $150,000 to be held in escrow for the option to obtain a license on the patent rights, as set forth in the option agreement. On September 1, 2012, Glottech-USA’s license to the technology expired and also on September 1, 2012, we exercised this option agreement and released the funds to GD Glottech International.

44

On October 1, 2012, we entered into a license agreement and a sales agency agreement with GD Glottech, regarding GD Glottech International’s proprietary and patented mechanical ultrasound technology for use in water purification in the process of separation of salt and other minerals from lithium bearing brine produced from oil and gas operations. The license agreement and sales agency agreement expands and replaces all prior agreements among our company, GD Glottech International and Glottech-USA, LLC regarding our rights to use and sell the mechanical ultrasound technology, included in our letter of intent dated November 18, 2011, and our option agreement dated August 14, 2012.

Pursuant to the sales agency agreement we were appointed as sales agent for the patented mechanical ultrasound technology within Canada. Our appointment is exclusive within the field of non petrochemical mining and non-exclusive in all other fields of use. In consideration of the sales agency rights, we agreed to issue to GD Glottech International 500 common shares of our capital stock which obligation has been satisfied through the transfer to GD Glottech International of 500 shares held by our officer and director, Alexander Walsh. It was the explicit intention of the parties that this share transfer fulfills the prior obligations of Alexander Walsh and our company with respect to the option contemplated in the March and November 2011 agreements with Glottech-USA.

We will receive a royalty in respect of sales of the technology secured by us. The term of the initial agreement will be for 5 years with the possibility of extension if sales targets are achieved.

Pursuant to the license agreement, we obtained the exclusive right to use the mechanical ultrasound technology within the field of non-petrochemical mining within the territory of Canada. We may also sublicense our rights under the license in respect of one or more units of the technology to any entity operating within the field of use in which we own or beneficially own at least a 20% equity interest. GD Glottech International agreed to supply us with up to 5 technology units per 12-month period from the effective date of the license term, which will start from the month of delivery of the unit of the technology. The first unit of the technology provided under the license to be provided at no additional cost to us and subsequent units shall be subject to a fee based on the then current retail price of the units. If we sublicense any of our rights, the term of the applicable license will be for 5 years from the date the applicable unit is delivered. Pursuant to the license agreement, GD Glottech International shall provide ongoing technical assistance and training in respect of our use of the technology at our cost.

In consideration of the license, we will pay to GD Glottech International a royalty based on the tonnage of water produced by our use of the technology in accordance with the agreement. A minimum annual royalty will be applicable. The term of the license agreement shall be for an initial period of 5 years and shall be renewable for additional terms of 5 years provided that we satisfy the minimum royalty requirements during each period.

GD Glottech International’s technology is designed to separate suspended solids from water (brine), which is one step in the process that we are taking to produce commercially viable minerals. The technology produces extremely high temperatures, which destroy organic substances such as bacteria and other toxic agents. We believe that GD Glottech International’s technology can provide lower costs of operation as well as reduced time for site clean-up than traditional methods of water treatment. We anticipate using this application to extract dissolved solids like lithium, potassium, and magnesium from oil field brine. The disposal of produced water (brine) from oil and gas production in Alberta is a significant environmental issue for the province and presents a considerable economic issue for producers. We intend to use the technology on our Valleyview Property in Alberta, in cooperation with oil and gas producers, to treat and dispose of their produced water while monetizing the minerals that are contained within that produced water stream that is being brought to the surface during the oil and gas production process. As we own the MAIM (Metals and Industrial Minerals) claims to the minerals on the Valleyview Property, the minerals contained in their produced water stream fall under our rights. While we have had discussions with oil and gas consultants and oil operators regarding their difficulties in treating the brine at some of their fields, we have no formal agreements in place.

The technical process is based on the use of mechanical ultrasound generated through the production of a series of cavitations. Mechanical ultrasound is a machine-produced sound of a frequency above the upper limit of the normal range of human hearing. Cavitations are the rapid formation and collapse of bubbles in liquids, caused by the movement of something such as a propeller or by waves of high-frequency sound. The production of mechanical ultrasound allows GD Glottech International’s technology to distill the fluid stock. Using mechanical ultrasound for distillation has been attempted before, but the external energy requirement needed to produce the mechanical ultrasound was far too expensive to make it commercially viable. GD Glottech International’s technology uses the energy released during the cavitations in order to make it commercially viable from an economic perspective. During these cavitations, a millisecond of energy is released. During this release, temperatures can reach 5,000 degrees centigrade.

On August 27, 2012, we filed a motion to amend our complaint to include claims of breach of trust and fiduciary duty, breach of good faith and fair dealing, breach of contract, conversion of funds, fraud, and the imposition of a constructive trust. We believe that this action was necessary to protect our interests against possible misuse of funds by Glottech-USA, LLC and its principals. On October 19, 2012, GD Glottech International moved to intervene as an interested party in the litigation pending against Glottech-USA. GD Glottech International cited its role as owner of the patents as a basis for intervening in the litigation against Glottech-USA. We believe GD Glottech International’s entry into the litigation against Glottech-USA is favorable to our cause in the litigation.

45

On October 22, 2012, the Court of Common Pleas in Chester County, Pennsylvania, granted our motion to amend our complaint against Glottech-USA to add claims for fraud and damages reflective of the malfeasance which we allege against Glottech-USA and its officers.

On December 12, 2012, GD Glottech International removed the management of Glottech-USA and appointed itself as the manager of Glottech-USA. On the same day, Larry Nesbit, Mark Siegel and Ron Fender filed a motion to dissolve Glottech-USA in Mississippi on the basis that Glottech-USA was unable to meet its financial obligations and could not finish or deliver the unit to us.

On December 19, 2012, an attorney purportedly acting on behalf of Glottech-USA filed a motion in the lawsuit pending in Chester County, Pennsylvania, seeking possession of the unit. In addition, Glottech-USA filed a counterclaim seeking possession of the unit.

GD Glottech International immediately filed a motion to quash Glottech-USA’s motion and for sanctions against the law firm that filed the motion. We also filed a motion, seeking disqualification of the law firm that purported to represent Glottech-USA on the basis that the new management for Glottech-USA had fired the law firm and, as such, the law firm no longer had authority to represent Glottech-USA.

On April 25, 2013, we attended a hearing on the motions pending in the lawsuit filed in Chester County, Pennsylvania. The Court did not rule on any of the motions and, instead, stayed the case as to Glottech-USA until December of 2013 pending the outcome of the lawsuit seeking dissolution of Glottech-USA. The matter in Pennsylvania is no longer stayed. An attorney purporting to represent Glottech-USA and the receiver appointed in Mississippi has filed motions and other documents that may move the matter forward. We have pending preliminary objections to the counterclaim, including a request for a determination of which group is in control of Glottech-USA.

Certain members of Glottech-USA continued to pursue dissolution of the company in Mississippi. The members of Glottech-USA who seek dissolution have stated in court filings that it is not practicable for Glottech-USA to continue as an ongoing business. In addition, Sulzer filed suit against Glottech-USA Texas for unfulfilled obligations.

We do not believe that Glottech-USA has sufficient capital to continue as an ongoing business. We have provided full consideration to Glottech-USA and complied with all other agreed upon terms. We believe any assertions against us to lack merit.

Given pending litigation against Glottech-USA, and the uncertainties naturally inherent of any litigation (particularly as to outcome and timing thereof), we have moved to assure continuity of our licensing rights through entering into, and exercising, the option to contract directly with the technology inventor and patents owner, GD Glottech International. Thus, regardless of the outcome of the litigation, or indeed any action or inaction of Glottech-USA, our interest in the technology is assured.

On December 18, 2015 we withdrew our complaint against Glottech-USA, LLC filed in the Court of Common Pleas in Chester County, Pennsylvania. Concurrently, we released Glottech –USA, LLC and its former principals, Mark Seigel, Larry Nesbit and Ron Fender, from any and all claims related to the complaint.

Alta Disposal Morinville Ltd. Acquisition

On June 11, 2013, we entered into a letter of intent with Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Inc.) pursuant to which we agreed to acquire not less than 51% of the outstanding securities of Alta Disposal Morinville in consideration of an aggregate investment of $450,000 in Alta Disposal Morinville’s waste water disposal facility located in Morinville, Alberta. The closing of the transaction was subject to a number of conditions precedent, including but not limited to completion of due diligence and the negotiation of a definitive long form agreement.

On July 29, 2013, in anticipation of the completion of a formal agreement with Alta Disposal Morinville embodying the terms of the letter of intent, we entered into a convertible debenture agreement with Alta Disposal Morinville pursuant to which we agreed to deliver to Alta Disposal Morinville up to CAD$300,000 (approximately USD$291,000) payable in two installments of CAD$150,000 deliverable respectively upon execution of the convertible debenture, and within 5 business days following receipt of regulatory approval for the re-activation of Alta Disposal Morinville’s waste water disposal facility. Delivery of the first and second installments totaling CAD$300,000 have been satisfied and the acquisition was finalized as of October 18, 2013. The funds advanced are secured against all present and future assets and undertakings of Alta Disposal Morinville and are convertible at our option into a number of common shares of Alta Disposal Morinville equal to 51% of its issued and outstanding voting stock.

46

Effective August 1, 2013, we entered into a joint venture agreement with Alta Disposal Morinville pursuant to which our company and Alta Disposal Morinville will operate certain lands and facilities including a disposal well in the Morinville area of Alberta.

On October 18, 2013, we completed the acquisition of 51% of the outstanding securities of Alta Disposal Morinville, pursuant to a letter of intent with Alta Disposal Morinville dated June 11, 2013. As a result of the share acquisition, Alta Disposal Morinville is now a partially owned subsidiary of our company through our wholly owned subsidiary, Alta Disposal Ltd.

In accordance with the letter of intent, we acquired, through our wholly owned subsidiary, Alta Disposal Ltd., 51% of the outstanding securities of Alta Disposal Morinville (being 510,000 common shares) in consideration of an aggregate investment of CDN$466,547 (approximately USD$453,204) in Alta Disposal Morinville’s waste water disposal facility located in Morinville, Alberta, where Alta Disposal Morinville holds a 100% working interest in 17 freehold mineral leases. There are currently two standing natural gas wells and one disposal well located on the leases, including water disposal facilities, tanks and equipment. Payment of an initial CDN$300,000 (USD$291,000) of the CDN$466,547 aggregate investment was made pursuant to a secured convertible debenture which has been fully converted into common shares of Alta Disposal Morinville. The Alta Disposal Morinville leases are subject to a 3% gross overriding royalty held by Mr. Vincent Murphy pursuant to a gross overriding royalty agreement dated June 30, 2013. The royalty is payable on all fluids separated, treated, or otherwise enhanced for sale on the lease property.

The acquisition of Alta Disposal Morinville was completed through our wholly owned subsidiary, Alta Disposal Ltd., which was formed in the Province of Alberta for the primary purpose of the transaction with Alta Disposal Morinville. Concurrent with the closing of the acquisition, Alta Disposal entered into a unanimous shareholders and management agreement (the “Shareholders Agreement”) dated October 18, 2013 with Excel Petroleum Ltd. (which holds 49% of Alta Disposal Morinville) and Alta Disposal Morinville itself.

Pursuant to the Shareholders Agreement, Alta Disposal may continue to fund the current capital requirements of Alta Disposal Morinville up to an aggregate of $420,000 in consideration of additional shares of Alta Disposal Morinville at the rate of 163,250 shares (equivalent to approximately 5% of Alta Disposal Morinville’s common shares on a diluted basis) for each $105,000 funded until Alta Disposal holds an aggregate of 70% of Alta Disposal Morinville’s outstanding common shares. If Alta Disposal elects to fund the on-going capital requirements of Alta Disposal Morinville beyond the aggregate of $870,000, any such funds advanced by Alta Disposal will be deemed to be funds loaned by Alta Disposal to Alta Disposal Morinville on a non-interest bearing, unsecured bridge loan basis.

Any such funds provided to Alta Disposal Morinville will be repayable from cash flow generated by Alta Disposal Morinville. Funds loaned prior to June 30, 2014 will not be due and payable until June 30, 2014 and thereafter will not be due and payable until at least 6 months following the date of any such loan.

Other terms of the Shareholders Agreement include:

• the board of directors of Alta Disposal Morinville will consist of 3 directors including 2 nominees of Alta Disposal and 1 nominee of Excel.
• Alexander Walsh will serve as chairman of the board of directors, president and chief executive officer of Alta Disposal Morinville.
• Approval of the shareholders holding not less than 60% of Alta Disposal Morinville shares will be required to remove or appoint officers of Alta Disposal Morinville.
• Unanimous approval of the shareholders will be required in order to (i) effect capital alterations; (ii) declare dividends except following the completion of a fiscal year end and on a pro-rata basis to all shareholders; or (iii) wind-up; dissolve; or reorganize the corporation or sell or lease substantially all of its assets.
• Alta Disposal will otherwise have sole discretion and authority in respect of any and all management and operational decisions relating to the corporation.
• Each shareholder of Alta Disposal Morinville will have a right of first refusal to purchase all shares sought to be sold by the other shareholder.
• Customary restrictions on the encumbrance and disposition of shares.

The Shareholders Agreement additionally provides for the engagement of Valeura Energy Inc. as the operator of Alta Disposal Morinville’s lands, wells, the facilities, pipelines and disposal wells pursuant to an operating agreement between Alta Disposal Morinville and Valeura dated July 9, 2013. Valeura was to retain a 10% working interest in Alta Disposal Morinville’s lands until completion of the initial work on the disposal well project and will re-convey that interest to Alta Disposal Morinville provided that Alta Disposal Morinville has paid Valeura a cash payment of $2,500 per month for acting as operator of the disposal well and the lands and upon payment of an amount of $10,000 to Valeura upon completion of the project. The disposal well work program must be mutually approved by Alta Disposal Morinville and Valeura. Alta Disposal Morinville will be responsible for all costs and expenses relating to the work program. Effective September 4, 2015, our company entered into an Asset Purchase Agreement with Cancen Oil Canada whereby we sold all right, title and interest of Alta Disposal Morinville Ltd. assets for total purchase price of CAD$10,000 (approximately USD$7,531.25) .

47

Tero Oilfield Services Ltd. Acquisition (and Disposition)

On August 20, 2013, we entered into a letter of intent with Tero Oilfield Services Ltd., a private company, pursuant to which Tero agreed to sell up to 75% of the issued and outstanding common shares of Tero to our company in exchange for payment in the amount of $1,500,000.

On March 1, 2014, Alta Disposal Ltd., our wholly-owned subsidiary, entered into a share purchase agreement with Tero and Garry Hofmann, the sole shareholder of Tero. Pursuant to the agreement, Mr. Hofmann agreed to sell and we agreed to purchase 50% of the issued and outstanding common shares of Tero (the “Tero Shares”) in exchange for an aggregate of CAD$1,000,000. As part of the share purchase by Alta Disposal, on February 22, 2014, Tero declared a dividend in the amount of $307,104, payable to Mr. Hofmann by way of a promissory note.

Additionally, Alta Disposal, Tero and Mr. Hofmann entered into an option agreement entitling Alta Disposal to purchase up to an additional 25% of the issued and outstanding common shares of Tero from Mr. Hofmann exercisable at a price of $500,000 for a period of one year.

Lastly, Alta Disposal, Tero and Mr. Hofmann entered into a shareholders’ agreement concerning any potential financing by the shareholders of Tero for the benefit of Tero’s operations. This agreement provides that the shareholders of Tero, Alta Disposal and Mr. Hofmann, may by unanimous resolution advance to Tero, upon demand by Tero, such funds as may be determined specified by unanimous resolution, subject to the agreement.

Tero was a family owned waste disposal company. The waste disposal facility had been under the same ownership since it began operations in 1997. In 2002, Tero successfully reclassified the original Class II well to a Class IB disposal well and expanded the capabilities of the facility to handle solid waste disposal. The facility is located near Wardlow, Alberta and is right in the heart of the area’s oil and gas producers. The nearest competing commercial disposal companies are 75 kilometers away which presents Tero’s facility with a large geographical advantage.

On May 1, 2015, our former subsidiary Alta Disposal entered into a share purchase agreement with Natel Hofmann and Tero Oilfield Services Ltd. for the sale of the Tero Shares by Alta Disposal to Ms. Hofmann in consideration of an aggregate of $300,000. As at April 29, 2015, the purchase price was paid in full.

Loans of Our Company

Since March 2014, our company has received various loans from unrelated third party that are listed below. These loans are convertible into shares of our company pursuant to the terms of the loan agreements. In the descriptions below of the loans, the issuance of common shares pursuant to the conversion of debt pursuant to convertible promissory notes, and the issuance of common shares pursuant to the exercise of warrants, transactions are a on a post reverse stock split basis. These adjustments include our first reverse share split approved on January 19, 2015 (20 old shares of common stock for one (1) new share of common stock), and our second reverse stock split approved by our board of directors on July 13, 2015 (200 old shares of common stock for one (1) new share of common stock). All the loans, convertible promissory notes, and warrants include terms that make them subject to the share splits.

Loan Agreements with JDF Capital Inc.

$500,000 Loan

On March 15, 2014, we entered into a securities purchase agreement with JDF, pursuant to which JDF provided us with an aggregate investment of $500,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued JDF a 10% original issue discount convertible promissory note of $550,000 due September 15, 2015 and convertible into common shares on a cashless basis at a price per share of 35% of the lower of lowest closing bid price of our common shares during the prior 20 trading days prior to 1) the date of the purchase agreement or 2) the day of the notice for conversion. The note bears interest, in arrears, at a rate per annum equal to fifteen percent (15%) accruing on a semi-annual basis commencing March 15, 2014 in cash or restricted shares of our company’s common stock, par value $0.001 per share at the option of the holder. During the six months ended December 31, 2015, an interest expense of $8,362 (June 30, 2015 - $6,279) was accrued.

In addition on March 15, 2014, we issued an aggregate of 4,583 warrants to JDF in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $240.00 and expire after a term of three years. In the case that after six months there is no registration statement available for the resale of our common shares from exercising of these warrants, the warrants may be exercised on a cashless basis at a price as set out in the warrant.

Pursuant to a partial sale and assignment agreement dated February 27, 2015 among our company, JDF Capital Inc. and River North Equity, LLC, JDF Capital assigned $100,000 portion of the March 15, 2014 note to River North Equity.

48

On March 30, 2015, our directors approved an amendment to the note. We amended and restated a $50,000 portion of the $550,000 note, into a new promissory note to LG Capital Funding LLC, in the amount of $50,000 to provide conversion features equal to 50% of the lowest closing price of the last 20 trading days prior to conversion, as well as 10% per annum interest and become due and payable one year after the issuance date.

To date, we have converted $400,000 portion of the March 15, 2014 convertible promissory note held by JDF Capital.

To date, we have issued the following securities in conversion of the $100,000 portion of the March 15, 2014 convertible promissory note held by River North Equity:

• On April 23, 2015, we issued 32,360 common shares at a deemed price of $0.24 per share for promissory note and interest conversion of $7,766.
• On April 28, 2015, we issued issued 39,303 common shares at a deemed price of $0.20 per share for promissory note and interest conversion of $7,860.
• On April 30, 2015, we issued 48,584 common shares at a deemed price of $0.15 per share for promissory note and interest conversion of $7,288.
• On May 5, 2015, we issued 73,637 common shares at a deemed price of $0.13 per share for promissory note and interest conversion of $9,573.
• On May 8, 2015, we issued 78,892 common shares at a deemed price of $0.08 per share for promissory note and interest conversion of $6,311.
• On May 13, 2015, we issued 111,138 common shares at a deemed price of $0.08 per share for promissory note and interest conversion of $8,891.
• On May 15, 2015, we issued 160,565 common shares at a deemed price of $0.07 per share for promissory note and interest conversion of $11,239.
• On May 22, 2015, we issued 166,802 common shares at a deemed price of $0.07 per share for promissory note and interest conversion of $11,676.
• On September 11, 2015, we issued 434,084 common shares at a deemed price of $0.03 per share for promissory note conversion of $13,022.
• On September 18, 2015, we issued 486,623 common shares at a deemed price of $0.02 per share for promissory note conversion of $9,732.

On November 11, 2015 the balance note of $6,639 along with interest of $5,681 totaling to $12,320 was assigned to VES Trust whereas all of the accompanying warrants remain unconverted and outstanding.

On March 3, 2015, JDF Capital, LG Capital Funding, LLC and our company agreed to assign an aggregate of $50,000 from the note of JDF Capital to LG Capital and to amend the conversion price to equal to 50% of the lowest closing price of the our common stock for the last 20 trading days prior to conversion, as well as 10% per annum interest. The terms of this note were not amended in the assignment. As at the date of this report, we have made the following issuances of common stock in conversion of this convertible note:

• On April 20, 2015, we issued 25,922 common shares at a deemed price of $0.39 per share for promissory note and interest conversion of $10,109.
• On May 27, 2015, we issued 102,839 common shares at a deemed price of $0.07 per share for promissory note and interest conversion of $7,198.
• On June 3, 2015, we issued issued 222,506 common shares at a deemed price of $0.04 per share for promissory note and interest conversion of $8,900.
• On June 15, 2015, we issued 218,089 common shares at a deemed price of $0.04 per share for promissory note and interest conversion of 8,723.
• On May 1, 2015, we issued 53,741 common shares at a deemed price of $0.15 per share for promissory note and interest conversion of $8,061.
• On July 10, 2015, we issued 201,465 common shares at a deemed price of $0.04 per share for promissory note and interest conversion of $7,800.

As at the date of this report, there remains no balance payable pursuant to the note.

49

Loan Agreements with JDF Capital Inc.

$600,000 Loan

On August 6, 2014, we entered into a securities purchase agreement with JDF dated July 22, 2014 pursuant to which we issued to JDF a convertible promissory note in the aggregate principal amount of $708,000, which amount includes the purchase price of $600,000 plus 18 months prepaid interest at the rate of 12% per annum. The convertible note has a maturity date of January 22, 2016 and is convertible in whole or in part into shares of our common stock at price per share equal to 65% of the lowest reported sale price of our common shares during the 20 trading days prior to July 22, 2014 ($160.00) or prior to the applicable conversion date. Our company will have the option to prepay the note within 60 days subject to a 10% penalty, within the subsequent 60 days subject to a 20% penalty, or anytime thereafter prior to maturity subject to a 30% penalty. The purchase price of the promissory note is payable in six installments beginning upon the effective date of the agreement (which amount has been paid) and monthly thereafter beginning on August 22, 2014. The promissory note is secured in first position against all assets of our subsidiary, Alta Disposal Ltd., pursuant to a general security agreement between Alta Disposal and JDF. On May 19, 2016 JDF Capital Inc. signed an extension of the maturity of the note due January 22, 2016. The note now matures on January 22, 2017 with the same terms and conditions.

As additional consideration for the proceeds of the convertible note, we issued to JDF Capital warrants exercisable for 5 years to purchase up to 4,200 shares of our common stock at an exercise price of $160.00 per share, subject to cashless exercise provisions.

To date, we have issued the following securities in conversion of the August 6, 2014 convertible promissory note:

• On June 2, 2015, we issued 144,231 common shares at a deemed price of $0.05 per share for promissory note and interest conversion $7,500.
• On June 5, 2015, we issued 220,000 common shares at a deemed price of $0.05 per share for promissory note and interest conversion $10,010.
• On June 10, 2015, we issued 275,000 common shares at a deemed price of $0.05 per share for promissory note and interest conversion $12,512.
• On July 8, 2015, we issued 125,000 common shares at a deemed price of $0.04 per share for promissory note conversion of $4,875.
• On July 21, 2015, we issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion of $9,750.
• On July 29, 2015, we issued 298,269 common shares at a deemed price of $0.04 per share for promissory note conversion of $11,633.
• On September 18, 2015, we issued 475,000 common shares at a deemed price of $0.03 per share for promissory note conversion of $12,350.
• On March 30, 2016, we issued 450,000 common shares at a deemed price of $0.14365 per share for promissory note conversion of $6,464.25
• On April 4, 2016 the Company issued 650,000 common shares at a deemed price of $0.026 per share for promissory note conversion and interest conversion of $16,900.00.
• On April 13, 2016 the Company issued 775,000 common shares at a deemed price of $0.00975 per share for promissory note conversion and interest conversion of $7556.25.
• On April 19, 2016 the Company issued 850,000 common shares at a deemed price of $0.00975 per share for promissory note conversion $8,287.50.
• On April 22, 2016 the Company issued 1,100,000 common shares at a deemed price of $0.00975 per share for promissory note conversion $10,725.00.
• On April 28, 2016 the Company issued 1,500,000 common shares at a deemed price of $0.0065 per share for promissory note conversion $9,750.00.
• On April 29, 2016 the Company issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion $11,000.00.
• On May 9, 2016 the Company issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion $4,062.50.
• On May 11, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion $3,412.50.

As at the date of this report, $353,212 remains unconverted and outstanding.

50

On March 9, 2015, JDF Capital and Blue Citi PR, LLC agreed to assign an aggregate of $100,000 from the convertible promissory note of JDF Capital (that was issued by our company) to Blue Citi PR LLC. On June 22, 2016, Blue Citi, LLC signed an extension of the maturity of the note due January 22, 2016. The note now matures on January 22, 2017 with the same terms and conditions. As at the date of this report, we have issued the following securities in conversion of the promissory note:

• On April 22, 2015, we issued 14,793 common shares at a deemed price of $0.34 per share for promissory note and interest conversion $5,000.
• On April 30, 2015, we issued 45,000 common shares at a deemed price of $0.17 per share for promissory note and interest conversion $7.605.
• On May 7, 2015, we issued 75,000 common shares at a deemed price of $0.09 per share for promissory note and interest conversion $6,825.
• On May 12, 2015, we issued 89,011 common shares at a deemed price of $0.09 per share for promissory note and interest conversion $8,100.
• On May 13, 2015, we issued 125,000 common shares at a deemed price of $0.08 per share for promissory note and interest conversion $9,750.
• On April 22, 2016 the Company issued 256,410 common shares at a deemed price of $0.00975 per share for promissory note conversion $2,500.00.
• On April 28, 2016 the Company issued 1,214,575 common shares at a deemed price of $0.0076 per share for promissory note conversion $6,000.00.On April 29, 2016, the Company issued 769,231 common shares at a deemed price of $0.0065 per share for promissory note conversion $5,000.00.

As at the March 31, 2016, there remains a balance of $62,720 unconverted and payable pursuant to the note. On March 25, 2016 Blue Citi, LLC agreed to assign an aggregate of $39,000 from the convertible promissory note of Blue Citi, LLC (that was assigned by JDF Capital) to APG Capital Holdings. As at the date of this report, we have issued the following securities in conversion of the promissory note:

On April 4, 2016, the Company issued 160,043 common shares at a deemed price of $0.0126 per share for promissory note conversion and interest conversion of $2,016.54.

On April 5, 2016, the Company issued 227,770 common shares at a deemed price of $0.011 per share for promissory note conversion and interest conversion of $2,505.47.

On April 7, 2016, the Company issued 267,396 common shares at a deemed price of $0.0075 per share for promissory note conversion and interest conversion of $2,005.47.

On April 13, 2016, the Company issued 669,222 common shares at a deemed price of $0.0075 per share for promissory note conversion and interest conversion of $5,019.17.

On April 14, 2016, the Company issued 803,725 common shares at a deemed price of $0.0075 per share for promissory note conversion and interest conversion of $6,027.94.

On April 19, 2016, the Company issued 1,041,960 common shares at a deemed price of $0.0075 per share for promissory note conversion $7,744.70.

On April 22, 2016, the Company issued 1,140,474 common shares at a deemed price of $0.0075 per share for promissory note conversion $8,553.56.

On May 2, 2016, the Company issued 1,514,380 common shares at a deemed price of $0.002 per share for promissory note conversion $3,028.76.

As at the March 31, 2016, there remains a balance of $62,720 unconverted and payable pursuant to the note.

On April 19, 2016, JDF Capital agreed to assign an aggregate of $50,000 from the convertible promissory note of JDF Capital (that was issued by our company) to Toledo Advisors LLC. As at the date of this report, we have issued the following securities in conversion of the promissory note:

• On April 20, 2016 the Company issued 750,000 common shares at a deemed price of $0.0075 per share for promissory note conversion $5,625.00.

51

• On May 2, 2016 the Company issued 1,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion $2,000.00.
• On May 3, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion $4,000.00.
• On May 4, 2016 the Company issued 2,302,321 common shares at a deemed price of $0.00145 per share for promissory note conversion $3,338.37.
• On May 5, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00125 per share for promissory note conversion $4,375.00.
• On May 9, 2016 the Company issued 5,500,000 common shares at a deemed price of $0.00115 per share for promissory note conversion $6,325.00.
• On May 9, 2016 the Company issued 6,100,000 common shares at a deemed price of $0.00075 per share for promissory note conversion $4,575.00
• On May 10, 2016 the Company issued 6,600,000 common shares at a deemed price of $0.00075 per share for promissory note conversion $4,950.00.
• On May 11, 2016 the Company issued 6,000,000 common shares at a deemed price of $0.00075 per share for promissory note conversion $4,500.00.
• On May 12, 2016 the Company issued 7,900,000 common shares at a deemed price of $0.0065 per share for promissory note conversion $5,135.00.
• On May 13, 2016 the Company issued 9,717,385 common shares at a deemed price of $0.00055 per share for promissory note conversion $5,109.30.

As at the March 31, 2016, there remains a balance of $4,652.33 unconverted and payable pursuant to the note.

Loan Agreement with JMJ Financial

On February 13, 2013, we entered into a securities purchase agreement with JMJ Financial. Pursuant to the terms of the agreement, our company will also enter into a convertible promissory note in the principal amount of $1,100,000 (for consideration of up to $1,000,000), of which $100,000 shall be paid to our company upon closing of the convertible promissory note and a common stock purchase warrant for the purchase of up to 135 shares of our common stock at an exercise price of $740 for a period of five years. The convertible promissory note shall have a maturity date of February 13, 2016. The remainder of the convertible debenture can be drawn down on by mutual agreement from JMJ Financial and our company. On July 13, 2016, JMJ Financial signed an extension of the maturity of the note due February 13, 2016. The note now matures on October 13, 2016 with the same terms and conditions.

As at the date of this report, we have made the following issuances of common stock in conversion of the February 13, 2013 note:

• On August 13, 2013, we issued 396 common shares at a deemed price of $294.00 per share for promissory note and interest conversion of $116,550.
• On November 11, 2013, we issued 347 common shares at a deemed price of $168.00 per share for promissory note and interest conversion of $58,275.
• On December 4, 2013, we issued 359 common shares at a deemed price of $162.40 per share for promissory note and interest conversion of $58,275.
• On January 6, 2014, we issued 638 common shares at a deemed price of $91.28 per share for promissory note conversion of $58,275.
• On February 14, 2014, we issued 500 common shares at a deemed price of $89.60 per share for promissory note conversion of $44,800.
• On March 3, 2014, we issued 475 common shares at a deemed price of $89.60 per share for promissory note conversion of $42,613.
• On June 10, 2014, we issued 400 common shares at a deemed price of $85.20 per share for promissory note conversion of $34,000.
• On June 27, 2014, we issued 425 common shares at a deemed price of $74.00 per share for promissory note conversion of $31,450.
• On July 16, 2014, we issued 450 common shares at a deemed price of $74.00 per share for promissory note and interest conversion of $33,300.
• On August 1, 2014, we issued 266 common shares at a deemed price of $67.00 per share for promissory note and interest conversion of $17,800.
• On September 3, 2014, we issued 750 common shares at a deemed price of $40.00 per share for promissory note and interest conversion of $30,000.
• On September 11, 2014, we issued 1,400 common shares at a deemed price of $20.20 per share for promissory note and interest conversion of $28,275.

52

• On October 22, 2014, we issued 4,750 common shares at a deemed price of $5.80 per share for promissory note and interest conversion of $27,550.
• On November 6, 2014, we issued 4,975 common shares at a deemed price of $4.20 per share for promissory note and interest conversion of $20,895.
• On November 19, 2014, we issued 8,500 common shares at a deemed price of $3.20 per share for promissory note and interest conversion of $27,200.
• On December 10, 2014, we issued 12,075 common shares at a deemed price of $1.20 per share for promissory note and interest conversion of $14,490.
• On December 17, 2014, we issued 15,425 common shares at a deemed price of $1.20 per share for promissory note and interest conversion of $18,510.
• On April 22, 2015, we issued 31,000 common shares at a deemed price of $0.26 per share for promissory note and interest conversion of $8,060.
• On April 24, 2015, we issued 41,500 common shares at a deemed price of $0.21 per share for promissory note and interest conversion of $8,715.
• On May 8, 2015, we issued 92,500 common shares at a deemed price of $0.07 per share for promissory note and interest conversion of $6,475.
• On May 14, 2015, we issued 132,000 common shares at a deemed price of $0.06 per share for promissory note and interest conversion $7,920
• On May 27, 2015, we issued 194,500 common shares at a deemed price of $0.05 per share for promissory note and interest conversion of $9,725.
• On June 3, 2015, we issued 225,000 common shares at a deemed price of $0.04 per share for promissory note and interest conversion $9,000
• On June 11, 2015, we issued 284,000 common shares at a deemed price of $0.03 per share for promissory note and interest conversion of $8,520.
• On June 16, 2015, we issued 249,500 common shares at a deemed price of $0.03 per share for promissory note and interest conversion of $7,485.
• On September 15, 2015, we issued 438,000 common shares at a deemed price of $0.03 per share for promissory note conversion of $13,140.
• On October 28, 2015 we issued 554,000 common shares at a deemed price of $0.01 per share for promissory note conversion of $5,540.
• On March 28, 2016 we issued 600,000 common shares at a deemed price of $ $0.025 per share for promissory note conversion of $15,000.
• On April 14, 2016 the Company issued 790,000 common shares at a deemed price of $0.007500 per share for promissory note conversion and interest conversion of $5925.00.
• On May 5, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion $4,000.00.
• On May 10, 2016 the Company issued 3,200,000 common shares at a deemed price of $0.000750 per share for promissory note conversion $2,400.00.

As at March 31, 2016, there remains a balance of approximately $34,233 unconverted and payable pursuant to the note.

Together with the promissory note issued on February 13, 2013, we issued the following warrants:

• warrants to purchase up to 135 of our common shares at an exercise price of $740.00 per share expiring February 13, 2018 (exercised);
• warrants to purchase up to 66 of our common shares at an exercise price of $760.00 expiring April 24, 2018 (exercised),
• warrants to purchase up to 74 of our common shares at an exercise price of $672.00 expiring June 4, 2018 (exercised),
• warrants to purchase up to 100 of our common shares at an exercise price of $500.00 expiring June 27, 2018 (exercised),
• warrants to purchase up to 84 of our common shares at an exercise price of $896.00 expiring August 14, 2018 (exercised),
• warrants to purchase up to 417 of our common shares at an exercise price of $240.00 expiring December 10, 2018 (exercised),
• warrants to purchase up to 179 shares of our common shares at an exercise price of $280.00 expiring February 20, 2019 (not exercised);
• warrants to purchase up to 952 of our common shares at an exercise price of $210.00 expiring April 16, 2019 (not exercised).
• On April 21, 2016 the Company issued 1,048,416 common shares at a deemed price of $0.007500 per share pursuant to warrant exercises.
• On April 29, 2016 the Company issued 1,529,480 common shares at a deemed price of $0.007500 per share pursuant to warrant exercises.

53

Loan Agreement with JSJ Investments Inc.

On February 23, 2014, we entered into a securities purchase agreement with JSJ Investments Inc., pursuant to which JSJ Investments provided our company with an aggregate investment of $100,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued JSJ Investments a convertible promissory note with 12% interest due August 27, 2014 and convertible into common shares on a cashless basis at a price of the lower of 50% of the average of the three lowest bids on the 20 trading days before February 27, 2014 or of a notice to convert during the twenty trading days preceding the delivery of any related conversion notice. On August 28, 2014, we issued 2,598 common shares at a deemed price of $40.80 per share in full conversion of the promissory note and interest at face value of $105,983.

In addition, we issued warrants to purchase an aggregate of 278 common shares of our company to JSJ Investments in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of approximately $360.00 and expire after a term of five years. In the case that after six months there is no registration statement available for the resale of our common shares from exercising of these warrants, the warrants may be exercised on a cashless basis at a price as set out in the warrant.

Loan Agreement with Centaurian Fund

On February 28, 2014, we entered into a securities purchase agreement with Centaurian Fund, pursuant to which Centaurian provided our company with an aggregate investment of $50,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued Centaurian a convertible promissory note with 15% interest due August 28, 2014 and convertible into common shares on a cashless basis at a price of the lower of 50% of the average of the three lowest bids on the 20 trading days before February 28, 2014 or of a notice to convert during the 20 trading days preceding the delivery of any related conversion notice. In addition, we issued warrants to purchase an aggregate of 1,289 common shares of our company to Centaurian in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $240.00 and expire after a term of six months. In the case that our common share closing price is greater than $240.00 per share for two days, the warrants may be exercised on a cashless basis at a price pursuant to the warrant. The warrants expired unexercised.

On September 4, 2014, JSJ, Centaurian Fund and our company agreed to assign the note from Centaurian Fund to JSJ Investments and increase the principal interest of the note to $74,750 with 12% interest.

• On September 10, 2014, we issued 1,684 common shares at a deemed price of $22.20 per share for promissory note and interest conversion of $37,375.
• On September 16, 2014, we issued 953 common shares at a deemed price of $21.33 per share for promissory note and interest conversion of $20,322.

On April 8, 2015, we issued 21,838 common shares at a market price of $0.85 per share for promissory note and interest conversion of $18,475. As at the date of this report, there remains no balance payable pursuant to the note.

Loan Agreements with LG Capital Funding, LLC

On February 27, 2014, we entered into another securities purchase agreement with LG Capital Funding, LLC. Pursuant to which LG Capital provided our company with an aggregate investment of $75,000 in consideration of a promissory note carrying interest at the rate of 10% per annum and due March 3, 2016. The promissory note is convertible into common shares of our company at the investor’s option at any time after 180 days at a price equal to 50% of the lowest bids price for the 20 days prior to conversion date subject to various prescribed conditions. During the year ended June 30, 2015, the full face value of the note including interest (being $80,145 (June 30, 2014 - $Nil) in the aggregate) was fully converted to 28,087 common shares pursuant to the following issuances of common stock:

• On September 29, 2014, we issued 1,512 common shares at a deemed price of $12.60 per share for promissory note and interest conversion of $19,050.
• On October 27, 2014, we issued 5,502 common shares at a deemed price of $6.20 per share for promissory note and interest conversion of $34,113.
• On December 11, 2014, we issued 8,473 common shares at a deemed price of $1.40 per share for promissory note and interest conversion of $11,862.
• On December 17, 2014, we issued 12,600 common shares at a deemed price of $1.20 per share for promissory note and interest conversion of $15,120.

54

On March 3, 2015, we entered into a securities purchase agreement with LG Capital Funding, LLC, pursuant to which LG Capital provided our company with an aggregate investment of $29,000 in consideration of our issuance of convertible promissory notes. We issued LG Capital a convertible promissory note with 10% interest due March 3, 2016 and convertible into common shares on a cashless basis at a price of 65% of the lowest closing bid price of our common shares during the prior 20 trading days including the delivery of any related conversion notice. On July 7, 2016, we signed an extension of the maturity of the note due March 3, 2016. The note now matures on May 3, 2016 with the same terms and conditions.

• On April 6, 2016 the Company issued 490,027 common shares at a deemed price of $0.01807 per share for promissory note conversion and interest conversion of $8854.79.
• On April 11, 2016 the Company issued 575,327 common shares at a deemed price of $0.010985 per share for promissory note conversion and interest conversion of $6319.97.
• On April 18, 2016 the Company issued 819,493 common shares at a deemed price of $0.010595 per share for promissory note conversion $8,682.53.
• On April 21, 2016 the Company issued 469,119 common shares at a deemed price of $0.010595 per share for promissory note conversion $4,970.32.
• On April 28, 2016 the Company issued 1,007,941 common shares at a deemed price of $0.0065 per share for promissory note conversion $5,661.62.

On September 11, 2015, the Company issued 80,801 common shares at a deemed price of $0.04 per share for partial conversion of the March 3, 2015 promissory note. During the year ended June 30, 2015, an interest expense of $967 was accrued in respect of the note. As at the date of this report, there remains a balance of approximately $26,000 unconverted and payable pursuant to the note.

On September 30, 2015, we entered into a securities purchase agreement with LG Capital Funding, LLC. Pursuant to the terms of the agreement, JDF Capital acquired a convertible redeemable promissory note with an aggregate principal amount $27,000 due on September 30, 2016 which amount includes an issuance discount of 10% and carries interest at the rate of 10% per annum after 12 months. The note is convertible at the lower of 65% discount of the lowest trading price for the 20 days prior to conversion date subject to various prescribed conditions.

Loan Agreement with St. George Investments LLC

On February 28, 2014, we entered into a securities purchase agreement with St. George Investments LLC, pursuant to which St. George Investments provided our company with an aggregate investment of $100,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued St. George Investments a convertible promissory note of $125,500 including 15% prepaid interest due August 28, 2015 and convertible into common shares on a cashless basis at a price of 50% of the lower of lowest closing bid price of our common shares during the prior 20 trading days prior to 1) the date of the purchase agreement or 2) the day of the notice for conversion. As at the date of this report we have made the following issuances of common stock in conversion of the February 28, 2014 note:

• On September 10, 2014, we issued 385 common shares at a deemed price of $26.00 per share for promissory note and interest conversion of $10,000.
• On September 23, 2014, we issued 962 common shares at a deemed price of $13.00 per share for promissory note and interest conversion of $12,500.
• On October 9, 2014, we issued 1,667 common shares at a deemed price of $9.00 per share for promissory note and interest conversion of $15,000.
• On October 16, 2014, we issued 1,829 common shares at a deemed price of $8.20 per share for promissory note and interest conversion of $15,000.
• On October 24, 2014, we issued 2,206 common shares at a deemed price of $6.80 per share for promissory note and interest conversion of $15,000.
• On October 31, 2014, we issued 3,125 common shares at a deemed price of $4.60 per share for promissory note and interest conversion of $15,000.
• On November 17, 2014, we issued 3,947 common shares at a deemed price of $3.80 per share for promissory note and interest conversion of $15,000.
• On December 3, 2014, we issued 5,357 common shares at a deemed price of $2.80 per share for promissory note and interest conversion of $15,000.
• On December 16, 2014, we issued 9,286 common shares at a deemed price of $1.40per share for promissory note and interest conversion of $13,000.

55

As at the date of this report, there remains no balance unconverted and payable pursuant to the note.

In addition, we issued an aggregate of 370 warrants to St. George Investments in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $270.00 and expire after a term of five years. As at the date of this report we have made the following issuances of common stock in full exercise of the February 28, 2014 warrant:

• On March 16, 2015, 141 warrants were exercised for 36,175 of our common shares at a deemed price of $0.64 in accordance with the terms of the agreement. On April 16, 2015, we issued 42,417 common shares at a deemed price of $3.14 per share in the aggregate pursuant to the exercise of 230 warrants.

Loan Agreement with Vista Capital Investments, LLC

On February 28, 2014, we entered into a securities purchase agreement with Vista Capital Investments, LLC, pursuant to which Vista Capital provided our company with an aggregate investment of $100,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued Vista Capital a convertible promissory note of $110,000 with 12% interest due September 1, 2014 and convertible into common shares on a cashless basis at a price of the lesser of $300 or 50% of the lowest bid price of our common shares during the prior 25 consecutive trading days prior the delivery of any related conversion notice. As at the date of this report, we have made the following issuances of common stock in full conversion of the February 28, 2014 note:

• On September 23, 2014, we issued 2,500 common shares at a deemed price of $11.00 per share for promissory note and interest conversion of $27,520.
• On October 27, 2014, we issued 3,750 common shares at a deemed price of $5.80 per share for promissory note and interest conversion of $21,520.
• On November 3, 2014, we issued 3,750 common shares at a deemed price of $4.60 per share for promissory note and interest conversion of $17,250.
• On December 10, 2014, we issued 8,500 common shares at a deemed price of $1.20 per share for promissory note and interest conversion of $10,200.
• On April 1, 2015, we issued 15,000 common shares at a deemed price of $1.20 per share for promissory note and interest conversion of $18,000.
• On April 7, 2015, we issued 22,500 common shares at a deemed price of $1.02 per share for promissory note and interest conversion of $22,950.
• On April 14, 2015, we issued 25,000 common shares at a deemed price of $0.49 per share for promissory note and interest conversion of $12,250.
• On April 20, 2015, we issued 30,000 common shares at a deemed price of $0.26 per share for promissory note and interest conversion of $7,800.
• On April 24, 2015, we issued 37,500 common shares at a deemed price of $0.21 per share for promissory note and interest conversion of $7,875.
• On April 29, 2015, we issued 45,000 common shares at a deemed price of $0.14 per share for promissory note and interest conversion of $6,300.
• On May 5, 2015 we issued 75,000 common shares at a deemed price of $0.01 per share for promissory note and interest conversion of $7,500.
• On May 8, 2015, we issued 75,000 common shares at a deemed price of $0.09 per share for promissory note and interest conversion of $5,250.

On May 13, 2015, we issued 122,357 common shares at a deemed price of $ 0.07 for promissory note and interest conversion of $8,565. As at the date of this report, there remains no balance unconverted and payable pursuant to the note. In addition, we issued warrants to purchase an aggregate of 2,578 common shares of our company to Vista Capital in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $240.00 during the period beginning August 28, 2014 and ending August 28, 2019. In the case that our common share closing price is greater than $240.00 per share for two days, the warrants may be exercised on a cashless basis at a price pursuant to the warrant.

On August 20, 2014, we issued an aggregate of 4,528 common shares at a deemed price of $203.13 per share for the cashless conversion of warrants issued on February 28, 2014.

56

Loan Agreement with Union Capital, LLC

On March 3, 2014, we entered into a securities purchase agreement with Union Capital, LLC, pursuant to which Union provided our company with an aggregate investment of $50,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued Union a convertible promissory note of $50,000 with 10% interest due March 5, 2015 and convertible into common shares on a cashless basis at a price per share of 50% of the lowest closing bid price of our common shares during the prior 20 trading days including the delivery of any related conversion notice. As at the date of this report, we have made the following issuances of common stock in conversion of the March 3, 2014 note:

• On September 8, 2014, we issued 277 common shares at a deemed price of $38.00 per share for promissory note and interest conversion of $10,510.
• On September 11, 2014, we issued 652 common shares at a deemed price of $24.20 per share for promissory note and interest conversion of $15,777.
• On September 12, 2014, we issued 717 common shares at a deemed price of $22.00 per share for promissory note and interest conversion of $15,781.
• On September 15, 2014, we issued 479 common shares at a deemed price of $22.00 per share for promissory note and interest conversion of $10,529.

As at the date of this report, there remains no balance unconverted and payable pursuant to the note.

In addition, we issued warrants to purchase an aggregate of 235 common shares of our company to Union in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $212.00 and expire after a term of five years. In the case that after six months there is no registration statement available for the resale of our common shares from exercising of these warrants, the warrants may be exercised on a cashless basis at a price as set out in the warrant.

Loan Agreement with Iconic Holdings, LLC

On March 3, 2014, we entered into a securities purchase agreement with Iconic Holdings, LLC, pursuant to which Iconic provides our company with an aggregate investment of $100,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued Iconic a convertible promissory note of $100,000 with 12% interest due September 3, 2014 and convertible into common shares on a cashless basis at a price of 50% of the lower of lowest closing bid price of our common shares during the prior 20 trading days prior to 1) the date of the purchase agreement or 2) the day of the notice for conversion. As at the date of this report, we have made the following issuances of common stock in conversion of the March 3, 2014 note:

• On September 12, 2014, we issued 2,475 common shares at a deemed price of $20.20 per share for promissory note and interest conversion of $50,000.
• On October 23, 2014, we issued 1,471 common shares at a deemed price of $6.80 per share for promissory note and interest conversion of $10,000.
• On November 14, 2014, we issued 5,263 common shares at a deemed price of $3.80 per share for promissory note and interest conversion of $20,000.
• On November 18, 2014, we issued 7,193 common shares at a deemed price of $3.80 per share for promissory note and interest conversion of $27,335.

As at the date of this report, all interest and principal of the note has been fully converted.

In addition, we issued an aggregate of 500 warrants to Iconic in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $200 and expire after a term of three years. As at the date of this report, we have made the following issuances of common stock in cashless exercise of the March 3, 2014 warrants:

• On April 14, 2015, we issued 5,385 common shares at a deemed price of $23.74 per share in full exercise of the warrants.

Loan Agreement with Adar Bays, LLC

On March 3, 2014, we entered into a securities purchase agreement with Adar Bays, LLC, pursuant to which Adar provided our company with an aggregate investment of $50,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants. We issued Adar a convertible promissory note of $50,000 with 10% interest due March 4, 2015 and convertible into common shares on a cashless basis at a price per share of 50% of the lowest closing bid price of our common shares during the prior 20 trading days including the delivery of any related conversion notice. As at the date of this report, we have made the following issuances of common stock in conversion of the March 3, 2014 note:

57

• On September 4, 2014, we issued 227 common shares at a deemed price of $44.00 per share for promissory note and interest conversion of $10,000.
• On September 11, 2014, we issued 413 common shares at a deemed price of $24.20 per share for promissory note and interest conversion of $10,000.
• On September 17, 2014, we issued 354 common shares at a deemed price of $19.80 per share for promissory note and interest conversion of $7,000.
• On September 23, 2014, we issued 369 common shares at a deemed price of $12.60 per share for promissory note and interest conversion of $4,655.
• On September 29, 2014, we issued 1,250 common shares at a deemed price of $12.60 per share for promissory note and interest conversion of $15,750.
• On October 27, 2014, we issued 836 common shares at a deemed price of $6.40 per share for promissory note and interest conversion of $5,353.

As at the date of this report, there remains no balance unconverted and payable pursuant to the note.

In addition on March 4, 2014, we issued an aggregate of 235 warrants to Adar in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $212.00 and expire after a term of five years.

Loan Agreement with Black Mountain Equities, Inc.

On March 3, 2014, we entered into a securities purchase agreement with Black Mountain Equities, Inc., pursuant to which Black Mountain provided our company with an aggregate investment of $100,000 in consideration of our issuance of original issue discount convertible promissory notes and common share purchase warrants. We issued Black Mountain a convertible promissory note of $115,000 with 15% prepaid interest due April 1, 2015 and convertible into common shares on a cashless basis at the lesser price per share of $240.00 or 50% of the lowest trade price of our common shares during the prior 20 trading days immediately preceding the delivery of any related conversion notice.

As at the date of this report, we have made the following issuances of common stock in conversion of the March 3, 2014 note:

• On October 27, 2014, we issued 5,678 common shares at a deemed price of 5.80 per share for promissory note and interest conversion of $32,934.
• On December 12, 2014, we issued 18,612 common shares at a deemed price of $1.20 per share for promissory note and interest conversion of $22,334.
• On March 31, 2015, we issued 20,834 common shares at a deemed price of $1.20 per share for promissory note and interest conversion of $25,000.
• On May 1, 2015, we issued 105,315 common shares at a deemed price of $0.16 per share for promissory note and interest conversion of $16,850.
• On May 7, 2015, we issued 90,775 common shares at a deemed price of $0.07 per share for promissory note and interest conversion of $6,354.
• On May 12, 2015, we issued 90,775 common shares at a deemed price of $0.07 per share promissory note and interest conversion of $6,354.
• On June 4, 2015, we issued 222,791 common shares at a deemed price of $0.04 per share for promissory note and interest conversion of $8,911.
• On June 11, 2015, we issued 428,933 common shares at a deemed price of $0.03 per share for promissory note and interest conversion $12,868.

As at the date of this report, there remains no balance unconverted and payable pursuant to the note.

In addition on March 3, 2014, we issued an aggregate of 417 warrants to Black Mountain in consideration for purchasing the note. Subject to adjustments, each warrant is convertible into common shares at a price of $240.00 per share and expire after a term of five years. In the case that our common share closing price is greater than $240.00 per share for two days, the warrants may be exercised on a cashless basis at a price pursuant to the warrant. As at the date of this report, we have made the following issuances of common stock in full exercise of the March 3, 2014 warrants:

58

• On August 5, 2014, we issued 5,161 common shares pursuant to the exercise of warrants at a deemed price of $33.59 per share or $173,367 in the aggregate.
• On September 15, 2014, we issued 2,737 common shares pursuant to the exercise of warrants at a deemed price of $34.12 per share or $93,401 in the aggregate.

As at the date of this report, there remain no warrants remaining pursuant to the securities purchase agreement.

Loan Agreement with Blue Citi, LLC

Effective March 3, 2014, we entered into another securities purchase agreement with Blue Citi LLC. Pursuant to the terms of the agreement, Blue Citi acquired a convertible promissory note with an aggregate face value of $220,000, at an issuance discount of $20,000; resulting in $200,000 net proceeds to our company. The note was due on September 3, 2014 and carries an interest rate of 12% per annum over the term of the note, with an effective interest rate of 1220.64% . The note is convertible at a 50% discount of the lowest closing price for the 20 trading days immediately prior to (i) date of the purchase agreement, or (ii) the voluntary conversion of the note.

During the year ended June 30, 2015, $453,200 (June 30, 2014 - $Nil) in face value of the note including interest was fully converted to 49,640 (June 30, 2014 - Nil) common shares pursuant to the following issuances of common shares:

• On September 3, 2014, we issued 125 common shares at a deemed price of $40.00 per share for promissory note and interest conversion of $5,000.
• On September 15, 2014, we issued 1,396 common shares at a deemed price of $20.20 per share for promissory note and interest conversion of $28,200.
• On September 24, 2014, we issued 2,273 common shares at a deemed price of $11.00 per share for promissory note and interest conversion of $25,000.
• On October 2, 2014, we issued 1,136 common shares at a deemed price of $11.00 per share for promissory note and interest conversion of $12,500.
• On October 13, 2014, we issued 2,670 common shares at a deemed price of $8.80 per share for promissory note and interest conversion of $23,500.
• On October 20, 2014, we issued 2,778 common shares at a deemed price of $7.20 per share for promissory note and interest conversion of $20,000.
• On October 21, 2014, we issued 2,500 common shares at a deemed price of $6.00 per share for promissory note and interest conversion of $15,000.
• On October 27, 2014, we issued 5,000 common shares at a deemed price of $6.00 per share for promissory note and interest conversion of $30,000
• On November 4, 2014, we issued 4,348 common shares at a deemed price of $4.60 per share for promissory note and interest conversion of $20,000.
• On December 4, 2014, we issued 7,500 common shares at a deemed price of $2.40 per share for promissory note and interest conversion of $18,000.
• On December 5, 2014, we issued 6,818 common shares at a deemed price of $2.20 per share for promissory note and interest conversion of $15,000.
• On December 8, 2014, we issued 6,667 common shares at a deemed price of $1.80 per share for promissory note and interest conversion of $12,000.
• On December 9, 2014, we issued 6,429 common shares at a deemed price of $1.40 per share for promissory note and interest conversion of $9,000.

There is no outstanding balance payable in respect of the note as of the date of this report. Along with the promissory note entered on March 3, 2014, we issued warrants to acquire a total of 1,000 shares of the company for a period of three years at an exercise price of $200.00. On September 4, 2014, 25 warrants were exercised for 146 of our common shares at a deemed price of $456 in accordance with the terms of the agreement.

Loan Agreement with 514742 B.C. Ltd.

On March 3, 2014, we entered into a securities purchase agreement with Alta Disposal Ltd., our wholly-owned subsidiary, and 514742 B.C. Ltd., pursuant to which 514742 B.C. provided Alta Disposal with an aggregate investment of CAD$330,000 (US$298,518) in consideration of our issuance of secured promissory notes and common share purchase warrants.

59

On March 3, 2014, 514742 B.C. funded an aggregate investment of CAD$333,000 to Alta Disposal. Therefore, Alta Disposal issued 514742 B.C. a secured promissory note of Alta Disposal CAD$333,000 with 20% interest due June 1, 2014. The note is secured by all present and after acquired property of Alta Disposal. Effective April 14, 2014, the company paid a total of CAD$346,274 (US$316,355) in principle and interest to settle this debt.

In addition on March 3, 2014, we issued an aggregate 550 warrants to 514742 B.C. in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $200.00 and expire after a term of three years. In the case that after six months there is no registration statement available for the resale of our common shares from exercising of these warrants, the warrants may be exercised on a cashless basis at a price as set out in the warrant.

Loan Agreement with JDF Capital, Inc.

On March 3, 2014, we entered into a securities purchase agreement with JDF Capital, Inc., pursuant to which JDF Capital agreed to provide us with an aggregate investment of $220,000 in consideration of our issuance of convertible promissory notes and common share purchase warrants.

On March 3, 2014, JDF Capital funded an aggregate investment of $200,000 to us. Therefore, we issued JDF Capital an original issue discount 10% convertible promissory note of $220,000 due September 3, 2014 and convertible into common shares on a cashless basis at a price per share of 50% of the lower of lowest closing bid price of our common shares during the prior 20 trading days prior to 1) the date of the purchase agreement or 2) the day of the notice for conversion.

In addition on March 3, 2014, we issued an aggregate of 4,000,000 warrants to JDF Capital in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $0.05 and expire after a term of three years. In the case that after six months there is no registration statement available for the resale of our common shares from exercising of these warrants, the warrants may be exercised on a cashless basis at a price as set out in the warrant.

Loan Agreement with Cardinal Capital Group, Inc.

On October 31, 2014, we entered into a securities purchase agreement with Cardinal Capital Group, Inc., pursuant to which Cardinal Capital provided our company with an aggregate investment of $50,000 in consideration of our issuance of a convertible promissory note. We issued Cardinal Capital a convertible promissory note of $59,500 comprised of $6,000 in interest and $3,500 in legal fees and due in two years. The note is convertible into shares of our common stock at the lesser of $20.00 or 65% of the lowest trade price of our common stock during the 20 trading days immediately preceding a conversion date. As at the date of this report, we have made the following issuances of common stock in conversion of the October 31, 2014 note:

• On April 30, 2015, we issued 49,000 common shares at a deemed price of $0.20 per share for promissory note and interest conversion of $9,800.
• On May 1, 2015, we issued 49,000 common shares at a deemed price of $0.20 per share for promissory note and interest conversion $9,800.
• On May 7, 2015, we issued 49,000 common shares at a deemed price of $0.09 per share for promissory note and interest conversion $4,459.
• On May 11, 2015, we issued 110,000 common shares at a deemed price of $0.09 per share for promissory note and interest conversion $10,010.
• On May 14, 2015, we issued 110,000 common shares at a deemed price of $0.08 per share for promissory note and interest conversion $8,580.
• On May 27, 2015, we issued 150,000 common shares at a deemed price of $0.07 per share for promissory note and interest conversion $9,750.
• On June 2, 2015, we issued 150,000 common shares at a deemed price of $0.05 per share for promissory note and interest conversion $7,800.
• On June 15, 2015, we issued 165,154 common shares at a deemed price of $0.04 per share for promissory note and interest conversion $6,441.

As at the date of this report, there remains no balance unconverted and payable pursuant to the note.

Loan Agreement with InLight Capital Partners, LLC.

On August 22, 2014, we entered into a securities purchase agreement with InLight Capital Partners, LLC, pursuant to which InLight Capital provided our company with an aggregate investment of $100,000 in consideration of our issuance of a convertible promissory note and warrants to purchase common shares of our company with an aggregate exercise price of $120,500. The note was funded by InLight Capital in the amount of $100,000 and shall include $20,500 in respect of pre-paid interest calculated in advance at the rate of 12% per annum for 18 months plus expenses of the Purchaser. InLight Capital delivered to us funds in the amount of $50,000 on the effective date and $50,000 on September 19, 2014. On July 27, 2016, InLight Capital Partners, LLC signed an extension of the maturity of the note due February 23, 2016. The note now matures on February 23, 2017 with the same terms and conditions.

60

As at the date of this report, we have made the following issuances of common stock in conversion of the August 22, 2014 note:

• On April 13, 2015, we issued 26,250 common shares at a deemed price of $0.64 per share for promissory note and interest conversion of$16,721.
• On April 27, 2015, we issued 26,250 common shares at a deemed price of $0.22 per share for promissory note and interest conversion of $5,801.
• On April 30, 2015, we issued 54,200 common shares at a deemed price of $0.15 per share for promissory note and interest conversion of $9,160.
• On May 5, 2015, we issued 78,892 common shares at a deemed price of $0.12 per share for promissory note and interest conversion of $9,230.
• On May 11, 2015, we issued 92,741 common shares at a deemed price of $0.09 per share for promissory note and interest conversion of $8,439.
• On May 19, 2015, we issued 166,802 common shares at a deemed price of $0.08 per share for promissory note and interest conversion of $13,091.
• On June 9, 2015, we issued 255,000 common shares at a deemed price of $0.05 per share for promissory note and interest conversion of $13,260.
• On July 22, 2015, we issued 100,000 common shares at a deemed price of $0.05 per share for promissory note conversion of $5,200.
• On April 11, 2016, we issued 500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion and interest conversion of $4,875.
• On April 26, 2016, we issued 1,600,000 common shares at a deemed price of $0.00715 per share for promissory note conversion $11,400.

There remains a principal balance of $23,323 unconverted and payable pursuant to the note as at February 23, 2017. On July 27, 2016, we agreed with InLight Capital to amend the promissory note by extending the maturity until February 23, 2017 in exchange for $35,000 in consideration to be added to the note.

In addition on August 22, 2014 and September 19, 2014, we issued an aggregate of 538 warrants to InLight Capital Partners, LLC in consideration for purchasing the note. Subject to adjustments, these warrants are convertible into common shares at a price of $112.00 and expire after a term of five years. In the case that after six months there is no registration statement available for the resale of our common shares from exercising of these warrants, the warrants may be exercised on a cashless basis at a price as set out in the warrant.

Loan Agreement with Louis Feld

On February 6, 2015, Louis Feld provided our company with an aggregate investment of $88,500 in consideration of our issuance of $88,500 convertible promissory note and warrants to acquire 13,828 common shares with an aggregate exercise price of $88,500. We issued Mr. Feld a convertible promissory note with 12% interest due August 6, 2016 and convertible into common shares on a cashless basis at a price of 65% of the lowest closing bid price of our common shares during the prior 20 trading days. During the period ended March 31, 2016, an interest expense of $8,863 was accrued. As at the date of this report, we have made the following issuances of common stock in conversion of promissory note:

• On August 17, 2015, we issued 250,000 common shares at a deemed price of $0.04 per share for promissory note and interest conversion of $9,750.
• On September 18, 2015, we issued 394,231 common shares at a deemed price of $0.03 per share for promissory note conversion of $10,250.
• On March 29, 2015 the Company issued 450,748 common shares at a deemed price of $0.0221 per share for promissory note conversion of $6,475.
• On April 4, 2016 the Company issued 641,025 common shares at a deemed price of $0.0252 per share for promissory note conversion and interest conversion of $10,500.00.
• On April 8, 2016 the Company issued 769,230 common shares at a deemed price of $0.0126 per share for promissory note conversion and interest conversion of $7,500.00.
• On April 14, 2016 the Company issued 846,153 common shares at a deemed price of $0.00975 per share for promissory note conversion and interest conversion of $8,250.
• On April 17, 2016 the Company issued 1,128,205 common shares at a deemed price of $0.00975 per share for promissory note conversion $11,000.00. On May 3, 2016 the Company issued 1,586,538 common shares at a deemed price of $0.0026 per share for promissory note conversion $4,125.00.

61

Loan Agreement with River North Equity LLC

On February 24, 2015, River North provided our company with an aggregate investment of $100,000 in consideration of our issuance of a convertible promissory note with a face value of $118,000. The face value of the note includes minimum interest for 18 months at the rate of 12% per annum, calculated monthly. The promissory note, which is due August 24, 2016, is convertible into common shares on a cashless basis at a price of 65% of the lowest closing bid price of our common shares during the prior 25 trading days including the delivery of any related conversion notice.

Bridge Loan Agreement with JDF Capital Inc.

On April 15, 2015, JDF Capital provided our company with a $50,000 loan with 10% interest per annum due April 15, 2015. On or about May 22, 2015 we prepaid the aggregate of $50,493.15, in full repayment of the loan, and aggregate accrued interest of $493.15.

Promissory Notes with VES Investment Trust

On December 1, 2015, we entered into a securities purchase agreement with VES Investment Trust dated December 1, 2015 pursuant to which we issued to VES Investment Trust a convertible promissory note in the aggregate principal amount of $18,000, which amount includes the purchase price of $15,000, 10% pre-paid interest (per annum, for 12 months) of $1,500, and $1,500 in respect of legal fees incurred by VES Investment Trust. The convertible note has a maturity date of December 1, 2016 and is convertible in whole or in part into shares of our common stock at price per share equal to 65% of the lowest reported sale price of our common shares during the 20 trading days prior to December 1, 2015 or prior to the applicable conversion date.

On January 27, 2016, we entered into a securities purchase agreement with VES Investment Trust. Pursuant to the terms of the agreement, VES Investment acquired a 10% convertible note with an aggregate face value of $5,500, with an issuance discount of $500 and maturity of one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

As at the date of this report, we have made the following issuances of common stock in conversion of promissory note:

• On April 8, 2016 the Company issued 591,620 common shares at a deemed price of $0.009329 per share for promissory note conversion and interest conversion of $5,519.
• On April 13, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion and interest conversion of $7,000.
• On April 19, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion $7,000.
• On April 26, 2016 the Company issued 923,077 common shares at a deemed price of $0.0065 per share for promissory note conversion $6,000.
• On May 12, 2016 the Company issued 4,000,000 common shares at a deemed price of $0.000845 per share for promissory note conversion $3,380.

Recent Loan Agreements

On August 3, 2015, we entered into a securities purchase agreement with JDF Capital Inc. Pursuant to the terms of the agreement, JDF Capital acquired a convertible promissory note with an aggregate face value of $36,000 due on February 3, 2016, which amount includes an issuance discount of 10% and carries interest at the rate of 10% per annum after 12 months. The note is convertible at a 35% discount to the lowest sale price for the 20 days trading days immediately prior to (i) the date of the purchase agreement, or (ii) the voluntary conversion date, subject to various prescribed conditions. On May 19, 2016, JDF Capital Inc. signed an extension of the maturity of the note due February 3, 2016. The note now matures on February 3, 2017 with the same terms and conditions.

On September 9, 2015, we entered into a securities purchase agreement with JDF Capital Inc. Pursuant to the terms of the agreement, JDF Capital acquired a convertible promissory note with an aggregate face value of $30,000 due on September 9, 2016, which amount includes an issuance discount of 10% and carries interest at the rate of 10% per annum after 12 months. The note is convertible at a 35% discount to the lowest sale price for the 20 days trading days immediately prior to (i) the date of the purchase agreement, or (ii) the voluntary conversion date, subject to various prescribed conditions.

62

On September 30, 2015, we entered into a securities purchase agreement with LG Capital Funding, LLC. Pursuant to the terms of the agreement, JDF Capital acquired a convertible redeemable promissory note with an aggregate principal amount $27,000 due on September 30, 2016 which amount includes an issuance discount of 10% and carries interest at the rate of 10% per annum after 12 months. The note is convertible at the lower of 65% discount of the lowest trading price for the 20 days prior to conversion date subject to various prescribed conditions.

On November 6, 2015, we entered into another securities purchase agreement with JDF Capital Inc. Pursuant to the terms of the agreement, JDF Capital acquired a convertible promissory note with an aggregate face value of $12,000 due on November 6, 2016, which amount includes an issuance discount of 10% and carries interest at the rate of 10% per annum after 12 months. The note is convertible at a 35% discount to the lowest sale price for the 20 days trading days immediately prior to (i) the date of the purchase agreement, or (ii) the voluntary conversion date, subject to various prescribed conditions.

On December 1, 2015, we entered into a securities purchase agreement with JDF Capital Inc. dated December 1, 2015 pursuant to which we issued to JDF a convertible promissory note in the aggregate principal amount of $18,000, which amount includes the purchase price of $15,000, 10% pre-paid interest (per annum, for 12 months) of $1,500, and $1,500 in respect of legal fees incurred by JDF. The convertible note has a maturity date of December 1, 2016 and is convertible in whole or in part into shares of our common stock at price per share equal to 65% of the lowest reported sale price of our common shares during the 20 trading days prior to December 1, 2015 or prior to the applicable conversion date.

On December 3, 2015, we entered into a securities purchase agreement with LG Capital Funding pursuant to which we issued to LG Capital a convertible redeemable note with an aggregate face value of $17,000 due December 3, 2016 and bearing interest form issuance at the rate of 10% per annum payable on maturity. The holder of the note is entitled, at its option, before or after maturity, to convert all or a part of the principal or interest outstanding into shares of our common stock at a price equal to 65% of lowest trading price during the 20 trading days on the date the notice of conversion is delivered. In the event that we experience a DTC “Chill” on our shares, the conversion price shall be decreased to 55% instead of 65% while that “Chill” is in effect.

On January 27, 2016, we entered into a securities purchase agreement with JDF Capital Inc. Pursuant to the terms of the agreement, JDF Capital acquired a 10% convertible note with an aggregate face value of $24,750, with an issuance discount of $2,250 and legal fees of $2,500. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On March 1, 2016, we entered into a securities purchase agreement with JDF Capital Inc. Pursuant to the terms of the agreement, JDF Capital acquired a 10% convertible note with an aggregate face value of $13,200, with an issuance discount of $1,200 and $2,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On March 24, 2016, we entered into a securities purchase agreement with JDF Capital Inc. Pursuant to the terms of the agreement, JDF Capital acquired a 10% convertible note with an aggregate face value of $12,100, with an issuance discount of $ $1,100 and $1,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On March 28, 2016, we entered into a securities purchase agreement with APG Capital Holdings, LLC. Pursuant to the terns of the agreement, APG Capital Holdings, LLC acquired a 10% convertible note with an aggregate face value of $40,700, with an issuance discount of $ 3,700.00. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On April 4, 2016, we issued 160,043 common shares at a deemed price of $0.0126 per share for promissory note conversion and interest conversion of $2,016.54.

On April 5, 2016, we issued 227,770 common shares at a deemed price of $0.011 per share for promissory note conversion and interest conversion of $2,505.47.

On April 7, 2016, we issued 267,396 common shares at a deemed price of $0.0075 per share for promissory note conversion and interest conversion of $2,005.47.

On April 13, 2016, we issued 669,222 common shares at a deemed price of $0.0075 per share for promissory note conversion and interest conversion of $5,019.17.

63

On April 14, 2016, we issued 803,725 common shares at a deemed price of $0.0075 per share for promissory note conversion and interest conversion of $6,027.94.

On April 19, 2016, we issued 1,041,960 common shares at a deemed price of $0.0075 per share for promissory note conversion $7,744.70.

On April 22, 2016, we issued 1,140,474 common shares at a deemed price of $0.0075 per share for promissory note conversion $8,553.56.

On May 2, 2016, we issued 1,514,380 common shares at a deemed price of $0.002 per share for promissory note conversion $3,028.76.

On February 1, 2016, we entered into a securities purchase agreement with Vigere Capital LP, a Delaware limited partnership. Pursuant to the terms of the agreement, Vigere acquired all right, title and interest to an aggregate of $70,500 portion of the note issued pursuant to a securities purchase agreement between JDF Capital, Inc. and our company on July 22, 2014. The convertible note purchased by Vigere has a maturity date of January 22, 2016 and is convertible in whole or in part into shares of our common stock at price per share equal to 65% of the lowest reported sale price of our common shares during the 20 trading days prior to July 22, 2014 ($160.00) or prior to the applicable conversion date. On August 11, 2016, Vigere signed an extension of the maturity of the note to be due January 22, 2017.

On April 12, 2016, we issued 776,000 common shares at a deemed price of $0.0075 per share for promissory note conversion and interest conversion of $5,820.00.

On May 2, 2016, we issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion $8,398.00.

On May 10, 2016, we issued 3,100,000 common shares at a deemed price of $0.000975 per share for promissory note conversion $3,022.50.

On May 12, 2016, we issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion $4,062.50.

Agreements with Executive Officers, Directors and Consultants

Regardless of their date, the transactions described below are adjusted on a post reverse stock split basis. The adjustments included our first reverse share split approved by our board of directors on January 19, 2015 (on the basis of 20 old shares of common stock for one (1) new share of common stock), and our second reverse stock split, approved by our board of directors on July 13, 2015 (on the basis of 200 old shares of common stock for one (1) new share of common stock).

On October 24, 2012, we entered into a share exchange agreement dated October 18, 2012, with Alexander Walsh, our president and director. Pursuant to the agreement, on October 25, 2012 we issued to Mr. Walsh 5,000 Series A Convertible Preferred shares in our capital stock in consideration of the cancellation and return to treasury of 5,000 shares of our common stock held by Mr. Walsh. The Series A Convertible Preferred Shares have a par value of $0.001 per share and are convertible on a one for one basis into shares of our common stock after a one year hold period. There are no other preferential rights attached to the Series A Convertible Preferred Shares. Mr. Walsh established a series of a 10b5-1 Sales Plans in connection with an overall asset diversification strategy. Sales transactions occurring under Mr. Walsh’s 10b5-1 Plans were disclosed publicly through Form 4 filings with the SEC and are subject to the restrictions and filing requirements of Rule 144.

On July 25, 2013, we entered into a consulting agreement with Advanced Capital Trading, LLC, pursuant to which Advanced Capital performed financial consulting services for our company for a period of three months with an extension of an additional three months based on performance, such services commenced effective August 1, 2013. Compensation payable to Advanced Capital of $10,000 was paid upon execution of the consulting agreement.

Effective January 1, 2014, we entered into a consulting agreement for a term of 12 months with International Compass, LLC for the services of Bryan Kleinlein as chief financial officer of our company. As compensation, we agreed to pay to International Compass $12,000 per month during the term of the agreement payable in cash and/or common shares of our company that were previously registered on Form S-8 at our sole discretion. The value of the shares of our company issued as compensation, if any, shall be based on the volume weighted average trading closing price of the shares of our company in the five (5) trading days immediately preceeding the date(s) which the shares are due. Mr. Kleinlein was first appointed as our chief financial officer on May 15, 2012. Effective October 22, 2014, we entered into an amending agreement with International Compass. Pursuant to this amending agreement, the term of the agreement dated January 1, 2014 with International Compass was reduced from 12 months to 10 months. As consideration to International Compass for agreeing to enter into the amending agreement, we agreed to pay Mr. Kleinlein an aggregate of $30,000, payable in our S-8 shares with a deemed price per share equal to the volume weighted average trading close price of the shares in the five trading days immediately preceding the amending agreement. As a result, we issued Mr. Kleinlein an aggregate of 1,908 S-8 shares on October 22, 2014 Mr. Kleinlein resigned as our chief financial officer as of November 1, 2014.

64

Effective January 12, 2014, we entered into an employment agreement with Alexander Walsh for provision of services as our president and chief executive officer. The employment agreement will terminate on January 12, 2016. Pursuant to the terms of the employment agreement, Mr. Walsh will receive an annual salary of $120,000 payable in monthly cash installments or, in the event cash is unavailable, in shares of our company’s common stock. The employment agreement also provides for liability insurance and any travel and out-of-pocket expenses incurred and approved by our company.

On April 28, 2014, we entered into a consulting agreement, with our director, Brandon Colker, to provide services on behalf of our company. Pursuant to the terms of the consulting agreement, Mr. Colker was to receivem my May 15, 2014, compensation of $12,000 payable in unregistered restricted common shares of our company's common stock at a deemed value of $200 per share (Subsequent to the agreement, on February 12, 2015, Mr. Colker resigned as a director and consultant of the company and, accordingly, the common shares were not issued.

Effective May 30, 2014, we entered into a consulting agreement with Robert Gomer. Pursuant to this agreement, Mr. Gomer is to assist us with the current business of testing ultrasonic generator technology and performing services customary expected of a consultant for a term of six months. In exchange for these services that are to be provided to us, we agreed to issue an aggregate of $10,000 per month, payable in two sums of $30,000 and in our S-8 shares with a deemed price per share equal to the volume weighted average trading close price of the shares in the five trading days immediately preceding the amending agreement. As a result, we issued Mr. Gomer an aggregate of 292 S-8 shares on September 1, 2014. The agreement expired and was not subsequently renewed.

Effective August 1, 2014, we entered into a consultant agreement with TEN Associates LLC. Pursuant to this agreement, TEN Associates is to provide advice relative to corporate and business services and to perform other related activities as directed by us. In exchange for these services that are to be provided to us, we agreed to issue 500 common shares of our company to TEN Associates.

Our company was made aware that a shareholder, who is also a director and officer of our company, had sold an aggregate amount of shares that would cause the shareholder to be required to pay our company with respect to a short swing profit. Our company informed the shareholder that the shareholder was liable to our company for an aggregate short swing profit of $80,523.58 under Section 16(b) of the Securities Exchange Act of 1934, as amended, for the profit realized from transactions in our company’s common stock. Our company and the shareholder entered into a settlement agreement dated December 31, 2014 wherein, in exchange for the forbearance of legal action by our company pursuant to Section 16(b) of the Act, the shareholder agreed to disgorge the short swing profit to our company as of the effective date of the short swing settlement agreement. Payment of the short swing profit from the shareholder was received by our company on December 31, 2014.

On December 15, 2010, Alexander Walsh, a director and officer of our company, entered into an assignment of debt agreement with Nanuk Warman, which was also acknowledged by our company, whereby the debt of $47,537 advanced by Mr. Warman to our company and outstanding as of December 6, 2010, was assigned to Mr. Walsh.

On December 23, 2014, Mr. Walsh made demand for repayment of the debt by our company. In connection with the assignment of debt agreement and the demand, Mr. Walsh and our company entered into a settlement agreement dated December 23, 2014 wherein our company is to repay the debt to Mr. Walsh in full. Our company also agreed to pay an aggregate of $150,000 to Mr. Walsh as a performance bonus for the services provided by Mr. Walsh for the period from August 2013 to March 2014 as related to the acquisition of Tero Oilfield Services Ltd. due on the following terms:

1.	an aggregate of $50,000 due immediately; and
2.	an aggregate of $100,000 bearing no interest and due on the earlier of:
	a.	at the sole discretion of our company; or
	b.	the date of the sale, merger, amalgamation or other business combination or reorganization of our company.

Notes entered into subsequent to March 31, 2016

On April 19, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

65

On April 19, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On April 19, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,000, with an issuance discount of $2,500 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On May 16, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,250, with an issuance discount of $2,750 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On August 12, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $42,500, with an issuance discount of $4,250 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On September 1, 2016, our company entered into letter agreements with five separate investors with the intent to buyout their notes and warrants. Pursuant to the terms of the agreement, the investors have agreed to a standstill period until September 16, 2016. The buyout will take place over a six month period of time and will result in an aggregate of $252,856 in debt being retired, an aggregate of $195,500 in warrants being retired and an aggregate buyout amount of $460,000 will be paid over the period Additionally the Company will also issue an aggregate of $232,500 in new convertible debt. Conversion Price for note will be 65% of the lowest trading price of the Common Stock as reported on the OTC Markets electronic quotation service or such marketplace. Note will have no prepayment penalties and can be purchased from the holder at face value.

On September 2, 2016 our company entered into a bridge loan in the amount of $50,000 with 10% interest per annum due November 2, 2016.

Results of Operations

We have generated minimal revenues since inception and have incurred $63,979 and $378,393, respectively, in operating expenses for the three and nine month periods ended March 31, 2016.

The following provides selected financial data about our company for the three and nine month periods ended March 31, 2016 and 2015.

Three months ended March 31, 2016 and 2015.

		Three months			Three months
		ended			ended
		March 31, 2016			March 31, 2015
Revenue	$	Nil		$	Nil
Operating expenses	$	63,979		$	999,877
Other income (expenses):
Interest expense	$	(97,758	)	$	(297,288	)
Gain (loss) on change in fair value of derivative liability	$	112,247		$	(1,835,099	)
Amortization of debt discount	$	(78,688	)	$	101,726
Gain (loss) on disposal of business operations	$	(97	)	$	Nil
Equity in income (loss) of unconsolidated affiliate	$	Nil		$	(6,469	)
Other income	$	Nil		$	80,524
Net loss	$	(128,274	)	$	(2,956,483	)

Operating expenses for the three months ended March 31, 2016 decreased as a result of decreases in selling and general and administrative expenses, change in fair value of derivative liability, decrease in interest expenses, impairment loss, other income.

Nine months ended March 31, 2016 and 2015.

66

		Nine months			Nine months
		ended			ended
		March 31, 2016			March 31, 2015
Revenue	$	Nil		$	Nil
Operating expenses	$	378,393		$	1,600,605
Other income (expenses):
Interest expense	$	(699,718	)	$	(1,333,192	)
Gain (loss) on change in fair value of derivative liability	$	576,533		$	1,083,198
Amortization of debt discount	$	(399,010	)	$	(1,483,168	)
Bad-debt write off	$	(20,000	)	$	Nil
Gain (loss) on disposal of business operations	$	7,468		$	Nil
Equity in income (loss) of unconsolidated affiliate	$	Nil		$	(324	)
Other income	$	Nil		$	80,524
Loss from discontinued operations	$	(78,860	)	$	(305,966	)
Net loss	$	(991,981	)	$	(3,559,534	)

Operating expenses for the nine months ended March 31, 2016 decreased as a primary result of decreases in selling and general and administrative expenses and mining costs.

Liquidity and Capital Resources

The following table provides selected financial data about our company as of March 31, 2016, and June 30, 2015, respectively.

Working Capital

		As at			As at
		March 31, 2016			June 30, 2015
Total current assets	$	33,440		$	115,020
Total current liabilities	$	2,976,229		$	2,571,497
Working capital (deficit)	$	(2,942,789	)	$	(2,456,477	)

Cash Flows

		Nine Months			Nine Months
		ended			ended
		March 31, 2016			March 31, 2015
Net cash used in operating activities	$	(286,851	)	$	(907,052	)
Net cash used in investing activities	$	Nil		$	Nil
Net cash provided by financing activities	$	238,000		$	908,668
Effect of foreign exchange on cash	$	(7,947	)	$	(21,831	)
Increase (Decrease) in cash	$	(56,798	)	$	(20,215	)

We had cash and cash equivalents of $7,301 as of March 31, 2016 compared to cash and cash equivalents of $64,098 as of June 30, 2015. We had a working capital deficit of $2,942,789 as of March 31, 2016 compared to a working capital deficit of $2,456,477 as of June 30, 2015.During the nine months ended March 31, 2016, we spent $286,851 on operating activities, whereas $907,052 was spent on operating activities for the nine month period ended March 31, 2015. The decrease in cash used in operating activities was due to a decrease in operating activities from continued operations.

67

During the nine months ended March 31, 2016, we had received $Nil in investing activities, whereas we used nil in investing activities during the three months ended March 31, 2015.

During the nine months ended March 31, 2016, we received $238,000 from financing activities, which consisted of $238,000 in proceeds from issuance of convertible notes, whereas we received $908,668 from financing activities, which consisted of $954,000 from issuance of convertible notes offset by a $45,332 in repayments from related parties during the nine months ended March 31, 2015.

The report of our auditors on our audited consolidated financial statements for the fiscal year ended June 30, 2015, contains a going concern qualification as we have suffered losses since our inception. We have minimal assets and have achieved no operating revenues since our inception. We have depended on loans and sales of equity securities to conduct operations. Unless and until we commence material operations and achieve material revenues, we will remain dependent on financings to continue our operations.

Anticipated Cash Requirements

We estimate that our expenses over the next 12 months will be approximately $1,550,000 as described in the table below. These estimates may change significantly depending on the nature of our future business activities and our ability to raise capital from shareholders or other sources.

Description	Estimated		Estimated
	Completion		Expenses
	Date		($)
General and administrative	12 months	$	300,000
Mining expenses (mainly technology related)	12 months	$	150,000
Tero acquisition expenses	12 months	$	500,000
Morinville expansion	12 months	$	400,000
Legal and accounting	12 months	$	200,000
Total		$	1,550,000

We intend to meet our cash requirements for the next 12 months through the use of the cash we have on hand and through equity financing, debt financing, or other sources, which may result in further dilution in the equity ownership of our shares. We currently do not have any other arrangements in place to complete any private placement financings and there is no assurance that we will be successful in completing any such financings on terms that will be acceptable to us.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Inflation

The amounts presented in our financial statements do not provide for the effect of inflation on our operations or financial position. The net operating losses shown would be greater than reported if the effects of inflation were reflected either by charging operations with amounts that represent replacement costs or by using other inflation adjustments.

Critical Accounting Policies

Principal of Consolidation

The consolidated financial statements include the accounts of our company, our wholly-owned subsidiary Alta Disposal Ltd. and our 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework.

68

Use of Estimates

The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of our company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments.

Cash and Cash Equivalents

Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. Our company had $7,301 and $64,098 in cash and cash equivalents at March 31, 2016 and June 30, 2015, respectively.

Concentration of Risk

Our company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of March 31, 2016 and June 30, 2015, we had no deposits in excess of federally insured limits in its US bank. We have not experienced any losses with regard to our bank accounts and believe we are not exposed to any risk of loss on our cash in bank accounts.

Prepaid expenses

Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period.

Start-Up Costs

In accordance with FASC 720-15-20 “Start-Up Costs,” our company expenses all costs incurred in connection with the start-up and organization of our company.

Mineral Acquisition and Exploration Costs

We have been in the exploration stage since our formation on May 31, 2006. Our company is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves.

Concentrations of Credit Risk

Our company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. We place our cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. Our management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

Net Income or (Loss) per Share of Common Stock

Our company has adopted FASC Topic No. 260, “Earnings Per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.

Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive.

69

Foreign Currency Translations

Our company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ equity (deficit) as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized.

Translation of Foreign Operations

The financial results and position of foreign operations whose functional currency is different from our company’s presentation currency are translated as follows:

-      assets and liabilities are translated at period-end exchange rates prevailing at that reporting date; and
-      income and expenses are translated at average exchange rates for the period.

Exchange differences arising on translation of foreign operations are transferred directly to our company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations.

The relevant translation rates are as follows: For the period ending March 31, 2016 closing rate at 0.771 CDN$: US$, average rate at 0.7468 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$.

Comprehensive Income (Loss)

FASC Topic No. 220, “Comprehensive Income,” establishes standards for reporting and display of comprehensive income and its components in a full set of general-purpose financial statements. As at March 31, 2016 and June 30, 2015, our company had no material items of other comprehensive income except for the foreign currency translation adjustment.

Risks and Uncertainties

Our company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure.

Environmental Expenditures

The operations of our company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon our company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures.

Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.

Warrants

Our company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the condensed consolidated statements of operations and comprehensive Income (Loss).

70

Convertible Instruments

Our company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Our company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption

Fair Value of Financial Instruments

ASC 820, “Fair Value Measurements and Disclosures” requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities;

Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and

Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

The carrying amounts of our company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments.

Our company’s Level 3 financial liabilities consist of the liability of our company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Our company used a fair value model which incorporates transaction details such as company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

Revenue Recognition

Our company has generated little revenues to date. It is our company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Our company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that our company and the customer jointly determine that the product/service has been delivered or no refund will be required.

Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of our company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. Our company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured.

Income Taxes

Our company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.

71

Receivables

Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. Our company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. Our company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts.

Recently Issued Accounting Pronouncements

In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. Our company does not anticipate a material impact to our company’s financial statements as a result of the amendments.

In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. Our company does not anticipate a material impact to our company’s financial statements as a result of the amendments.

FASB Statements:

In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented.

Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to our company or their effect on the financial statements would not have been significant.

Item 3.           Quantitative and Qualitative Disclosures About Market Risk

As a “smaller reporting company”, we are not required to provide the information required by this Item.

Item 4.           Controls and Procedures

Management’s Report on Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our president (our principal executive officer, principal financial officer and principal accounting officer) to allow for timely decisions regarding required disclosure.

72

As of the end of the quarter covered by this report, we carried out an evaluation, under the supervision and with the participation of our president (our principal executive officer, principal financial officer and principal accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our president (our principal executive officer, principal financial officer and principal accounting officer) concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report. Our company is in the process of adopting specific internal control mechanisms with our board and officers’ collaboration to ensure effectiveness as we grow. We have engaged an outside consultant to assist in adopting new measures to improve upon our internal controls. Future controls, among other things, will include more checks and balances and communication strategies between the management and the board to ensure efficient and effective oversight over company activities as well as more stringent accounting policies to track and update our financial reporting.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarterly period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1.           Legal Proceedings

Other than as set out below, we know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our company.

On June 12, 2012, we filed a complaint against Glottech-USA in the Court of Common Pleas of Chester County, Pennsylvania, alleging that Glottech-USA misused our funds and was in breach of our agreements that called for Glottech-USA to deliver one initial unit of the mechanical ultrasound technology. We further alleged that Glottech-USA was financially insolvent and unable to fulfill its promises to us.

On June 12, 2012, we filed a complaint with the Court of Common Pleas of Chester County, Pennsylvania against Glottech-USA, LLC, Eldredge, Inc., and the Eldredge Companies, Inc. Pursuant to an unopposed motion, the complaint against the Eldredge parties was dismissed in October of 2012. The complaint initially sought an order of the Court granting possession of the initial unit.

Effective August 14, 2012, we entered into an option agreement with GD Glottech International to protect our license and distribution rights in the event that Glottech-USA became unable to perform and honor its obligations to us.

Pursuant to the terms of the option agreement, we were required to provide an initial amount of $150,000 to be held in escrow for the option to obtain a license on the patent rights, as set forth in the option agreement. On September 1, 2012, Glottech-USA’s license to the technology expired and also on September 1, 2012, we exercised this option agreement and released the funds to GD Glottech International.

On October 1, 2012, we entered into a license agreement and a sales agency agreement with GD Glottech, regarding GD Glottech International’s proprietary and patented mechanical ultrasound technology for use in water purification in the process of separation of salt and other minerals from lithium bearing brine produced from oil and gas operations. The license agreement and sales agency agreement expands and replaces all prior agreements among our company, GD Glottech International and Glottech-USA, LLC regarding our rights to use and sell the mechanical ultrasound technology, included in our letter of intent dated November 18, 2011, and our option agreement dated August 14, 2012.

Pursuant to the sales agency agreement we were appointed as sales agent for the patented mechanical ultrasound technology within Canada. Our appointment is exclusive within the field of non petrochemical mining and non-exclusive in all other fields of use. In consideration of the sales agency rights, we agreed to issue to GD Glottech International 500 (adjusted for subsequent reverse stock splits) common shares of our capital stock, which obligation has been satisfied through the transfer to GD Glottech International of 500 (adjusted for subsequent reverse stock splits) shares held by our officer and director, Alexander Walsh. It was the explicit intention of the parties that this share transfer fulfills the prior obligations of Alexander Walsh and our company with respect to the option contemplated in the March and November 2011 agreements with Glottech-USA. We will receive a royalty in respect of sales of the technology secured by us. The term of the initial agreement will be for 5 years with the possibility of extension if sales targets are achieved.

73

Pursuant to the license agreement, we obtained the exclusive right to use the mechanical ultrasound technology within the field of non-petro-chemical mining within the territory of Canada. We may also sublicense our rights under the license in respect of one or more units of the technology to any entity operating within the field of use in which we own or beneficially own at least a 20% equity interest. GD Glottech International agreed to supply us with up to 5 technology units per 12-month period from the effective date of the license term, which will start from the month of delivery of the unit of the technology. The first unit of the technology provided under the license to be provided at no additional cost to us and subsequent units shall be subject to a fee based on the then current retail price of the units. If we sublicense any of our rights, the term of the applicable license will be for 5 years from the date the applicable unit is delivered. Pursuant to the license agreement, GD Glottech International shall provide ongoing technical assistance and training in respect of our use of the technology at our cost.

In consideration of the license, we will pay to GD Glottech International a royalty based on the tonnage of water produced by our use of the technology in accordance with the agreement. A minimum annual royalty will be applicable. The term of the license agreement shall be for an initial period of 5 years and shall be renewable for additional terms of 5 years provided that we satisfy the minimum royalty requirements during each period.

GD Glottech International’s technology is designed to separate suspended solids from water (brine), which is one step in the process that we are taking to produce commercially viable minerals. The technology produces extremely high temperatures, which destroy organic substances such as bacteria and other toxic agents. We believe that GD Glottech International's technology can provide lower costs of operation as well as reduced time for site clean-up than traditional methods of water treatment. We anticipate using this application to extract dissolved solids like lithium, potassium, and magnesium from oil field brine. The disposal of produced water (brine) from oil and gas production in Alberta is a significant environmental issue for the province and presents a considerable economic issue for producers. We intend to use the technology on our Valleyview Property in Alberta, in cooperation with oil and gas producers, to treat and dispose of their produced water while monetizing the minerals that are contained within that produced water stream that is being brought to the surface during the oil and gas production process. As we own the MAIM (Metals and Industrial Minerals) claims to the minerals on the Valleyview Property, the minerals contained in their produced water stream fall under our rights. While we have had discussions with oil and gas consultants and oil operators regarding their difficulties in treating the brine at some of their fields, we have no formal agreements in place.

The technical process is based on the use of mechanical ultrasound generated through the production of a series of cavitations. Mechanical ultrasound is a machine-produced sound of a frequency above the upper limit of the normal range of human hearing. Cavitations are the rapid formation and collapse of bubbles in liquids, caused by the movement of something such as a propeller or by waves of high-frequency sound. The production of mechanical ultrasound allows GD Glottech International’s technology to distill the fluid stock. Using mechanical ultrasound for distillation has been attempted before, but the external energy requirement needed to produce the mechanical ultrasound was far too expensive to make it commercially viable. GD Glottech International’s technology uses the energy released during the cavitations in order to make it commercially viable from an economic perspective. During these cavitations, a millisecond of energy is released. During this release, temperatures can reach 5,000 degrees centigrade.

On August 27, 2012, we filed a motion to amend our complaint to include claims of breach of trust and fiduciary duty, breach of good faith and fair dealing, breach of contract, conversion of funds, fraud, and the imposition of a constructive trust. We believe that this action was necessary to protect our interests against possible misuse of funds by Glottech-USA, LLC and its principals. We will also seek damages as appropriate.

On October 19, 2012, GD Glottech International moved to intervene as an interested party in the litigation pending against Glottech-USA. GD Glottech International cited its role as owner of the patents as a basis for intervening in the litigation against Glottech-USA. We believe GD Glottech International’s entry into the litigation against Glottech-USA is favorable to our cause in the litigation.

On October 22, 2012, the Court of Common Pleas in Chester County, Pennsylvania, granted our motion to amend our complaint against Glottech-USA to add claims for fraud and damages reflective of the malfeasance which we allege against Glottech-USA and its officers.

On December 12, 2012, GD Glottech International removed the management of Glottech-USA and appointed itself as the manager of Glottech-USA. On the same day, Larry Nesbit, Mark Siegel and Ron Fender filed a motion to dissolve Glottech-USA in Mississippi on the basis that Glottech-USA was unable to meet its financial obligations and could not finish or deliver the unit to us.

On December 19, 2012, an attorney purportedly acting on behalf of Glottech-USA filed a motion in the lawsuit pending in Chester County, Pennsylvania, seeking possession of the unit. In addition, Glottech-USA filed a counterclaim seeking possession of the unit.

74

GD Glottech International immediately filed a motion to quash Glottech-USA’s motion and for sanctions against the law firm that filed the motion. We also filed a motion, seeking disqualification of the law firm that purported to represent Glottech-USA on the basis that the new management for Glottech-USA had fired the law firm and, as such, the law firm no longer had authority to represent Glottech-USA.

On April 25, 2013, we attended a hearing on the motions pending in the lawsuit filed in Chester County, Pennsylvania. The Court did not rule on any of the motions and, instead, stayed the case as to Glottech-USA until December of 2013 pending the outcome of the lawsuit seeking dissolution of Glottech-USA. The matter in Pennsylvania is no longer stayed. An attorney purporting to represent Glottech-USA and the receiver appointed in Mississippi has filed motions and other documents that may move the matter forward. We have pending preliminary objections to the counterclaim, including a request for a determination of which group is in control of Glottech-USA.

Certain members of Glottech-USA continued to pursue dissolution of the company in Mississippi. The members of Glottech-USA who seek dissolution have stated in court filings that it is not practicable for Glottech-USA to continue as an ongoing business. In addition, Sulzer filed suit against Glottech-USA Texas for unfulfilled obligations.

We do not believe that Glottech-USA has sufficient capital to continue as an ongoing business. We have provided full consideration to Glottech-USA and complied with all other agreed upon terms. We believe any assertions against us to lack merit.

Given pending litigation against Glottech-USA, and the uncertainties naturally inherent of any litigation (particularly as to outcome and timing thereof), we have moved to assure continuity of our licensing rights through entering into, and exercising, the option to contract directly with the technology inventor and patents owner, GD Glottech International. Thus, regardless of the outcome of the litigation, or indeed any action or inaction of Glottech-USA, our interest in the technology is assured.

On December 18, 2015 we withdrew our complaint against Glottech-USA, LLC filed in Court of Common Pleas in Chester County, Pennsylvania. Concurrently, we released Glottech –USA, LLC and its former principals, Mark Seigel, Larry Nesbit and Ron Fender , from any and all claims related to the complaint.

Item 1A.        Risk Factors

As a “smaller reporting company”, we are not required to provide the information required by this Item.

Item 2.           Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.           Defaults Upon Senior Securities

None.

Item 4.           Mine Safety Disclosures

Not Applicable.

Item 5.           Other Information

Subsequent to the issuance of June 30, 2015 financial statements, management determined that the warrants issued were incorrectly valued and derivative liability on the conversion option embedded in convertible notes was not recognized and during the nine months period ending March 31, 2016, these warrants were revalued and a derivative liability on the conversion option was calculated. As a result of revaluation of the warrants, the consolidated balance sheet for the year ending June 30, 2015, the consolidated statements of operations and comprehensive income (loss) and consolidated statement of cash flows for the nine months period ending March 31, 2015 and consolidated statements of changes in stockholders’ deficit for the period ending June 30, 2014 and June 30, 2015 were restated.

75

Item 6.           Exhibits

Exhibit
Number	Description
(3)	(i) Articles of Incorporation; and (ii) Bylaws
3.1	Articles of Incorporations (incorporated by reference to our Registration Statement on Form SB-2 filed on September 20, 2006)
3.2	Bylaws (incorporated by reference to our Registration Statement on Form SB-2 filed on September 20, 2006)
3.3	Articles of Amendment dated May 31, 2006 (incorporated by reference to our Current Report on Form 8-K filed on April 21, 2009)
3.4	Certificate of Amendment dated April 8, 2009 (incorporated by reference to our Current Report on Form 8- K/A filed on April 23, 2009)
3.5	Articles of Merger dated November 17, 2010 (incorporated by reference to our Current Report on Form 8-K filed on December 7, 2010)
3.6	Certificate of Amendment dated October 17, 2014 (incorporated by reference to our Quarterly Report on Form 10-Q/A filed on December 2, 2014)
3.7	Articles of Incorporation of Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Inc.) (incorporated by reference to our Current Report on Form 8-K filed on October 24, 2013)
3.8	Certificate of Amendment of Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Inc.) (incorporated by reference to our Current Report on Form 8-K filed on October 24, 2013)
3.9	Bylaws of Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Inc.) (incorporated by reference to our Current Report on Form 8-K filed on October 24, 2013)
3.10	Certificate of Incorporation of 1617437 Alberta Ltd. (incorporated by reference to our Current Report on Form 8-K filed on October 24, 2013)
3.11	Articles of Amendment of Alta Disposal Ltd. (incorporated by reference to our Current Report on Form 8-K filed on October 24, 2013)
3.12	Bylaws of Alta Disposal Ltd. (incorporated by reference to our Current Report on Form 8-K filed on October 24, 2013)
3.13	Certificate of Amendment filed September 9, 2015 (incorporated by reference to exhibit 4.1 of our Current Report on Form 8-K filed on September 15, 2015)
(4)	Instruments Defining the Rights of Security Holders, Including Indentures
4.1	Certificate of Designation of Series B Preferred Stock (incorporated by reference to our Current Report on Form 8-K filed on January 9, 2014)
4.2	Certificate of Designation of Series A Preferred Stock (incorporated by reference to exhibit 4.1 of our Current Report on Form 8-K filed July 15, 2015
(10)	Material Contracts
10.1	Securities Purchase Agreement between our company and JMJ Financial dated February 13, 2013 (incorporated by reference to our Current Report on Form 8-K filed on February 15, 2013)
10.2	Amendment and Settlement Agreement dated January 3, 2014 between our company and JDF Capital Inc. (incorporated by reference to our Current Report on Form 8-K filed on January 9, 2014)
10.3	Form of Common Stock Purchase Warrant between our company and Centaurian Fund (incorporated by reference to our Current Report on Form 8-K filed on April 3, 2014)
10.4	Form of Common Stock Purchase Warrant between our company and Union Capital, LLC (incorporated by reference to our Current Report on Form 8-K filed on April 3, 2014)
10.5	Form of Common Stock Purchase Warrant between our company and Adar Bays, LLC (incorporated by reference to our Current Report on Form 8-K filed on April 3, 2014)

76

Exhibit
Number	Description
10.6	Form of Common Stock Purchase Warrant between our company and 514742 B.C. Ltd. (incorporated by reference to our Current Report on Form 8-K filed on April 3, 2014)
10.7	Securities Purchase Agreement dated as of March 3, 2014 between our company and JDF Capital Inc. (incorporated by reference to our Current Report on Form 8-K filed on April 3, 2014)
10.8	Form of Convertible Promissory Note between our company and JDF Capital Inc. (incorporated by reference to our Current Report on Form 8-K filed on April 3, 2014)
10.9	Form of Common Stock Purchase Warrant between our company and JDF Capital Inc. (incorporated by reference to our Current Report on Form 8-K filed on April 3, 2014)
10.10	Employment Agreement with Alexander Walsh dated January 12, 2014 (incorporated by reference to our Current Report on Form 8-K filed on April 4, 2014)
10.11	2014 Stock Option Plan (incorporated by reference to our Current Report on Form 8-K filed on August 6, 2014)
10.12	Form of Stock Option Agreement (incorporated by reference to our Current Report on Form 8- K filed on August 6, 2014)
10.13	Form of Stock Grant Agreement (incorporated by reference to our Current Report on Form 8-K filed on August 6, 2014)
10.14	Securities Purchase Agreement dated July 22, 2014 between our company and JDF Capital Inc. Agreement (incorporated by reference to our Current Report on Form 8-K filed on August 7, 2014)
10.15	Convertible Promissory Note dated July 22, 2014 between our company and JDF Capital Inc. (incorporated by reference to our Current Report on Form 8-K filed on August 7, 2014)
10.16	Common Stock Purchase Warrant dated July 22, 2014 between our company and JDF Capital Inc. (incorporated by reference to our Current Report on Form 8-K filed on August 7, 2014)
10.17	Securities Purchase Agreement dated as of February 24, 2015 between our company and River North Equity LLC Debt Settlement Agreement with Alexander R. Walsh dated December 23, 2014 (incorporated by reference to our Quarterly Report on Form 10-Q filed on February 23, 2015)
10.18	Form of Convertible Promissory Note between our company and River North Equity LLC (incorporated by reference to our Quarterly Report on Form 10-Q filed on February 23, 2015)
10.19	Loan Agreement dated April 15, 2015 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)
10.20	Purchase Agreement dated November 6, 2015 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)
10.21	Convertible Promissory Note dated November 6, 2015 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)
10.22	Securities Purchase Agreement dated December 1, 2015 with VES Investment Trust (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016).
10.23	Convertible Promissory Note dated December 1, 2015 with VES Investment Trust. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)
10.24	Securities Purchase Agreement dated December 1, 2015 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)
10.25	Convertible Promissory Note dated December 1, 2015 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)
10.26	Securities Purchase Agreement dated December 3, 2015 with LG Capital Funding, LLC. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)
10.27	Convertible Promissory Note dated December 3, 2015 with LG Capital Funding, LLC. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 4, 2016)

77

Exhibit
Number	Description
10.28	Securities Purchase Agreement dated January 27, 2016 with VES Investment Trust. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 22, 2016)
10.29	Convertible Promissory Note dated January 27, 2016 with VES Investment Trust. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 22, 2016)
10.30	Securities Purchase Agreement dated January 27, 2016 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 22, 2016)
10.31	Convertible Promissory Note dated January 27, 2016 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 22, 2016)
10.32	Securities Purchase Agreement dated March 1, 2016 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 22, 2016)
10.33	Convertible Promissory Note dated March 1, 2016 with JDF Capital Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed on March 22, 2016)
10.34*	Partial replacement note issued to APG Capital Holdings, LLC, originally issued on July 22, 2014 in the amount of $672,000
10.35*	Convertible Promissory Note dated April 19, 2016 with Toledo Advisors LLC
10.36*	Convertible Promissory Note dated February 1, 2016 with Vigere Capital LP
(14)	Code of Ethics
14.1	Code of Ethics (Incorporated by reference to our Annual Report on Form 10-KSB on September 28, 2007)
(21)	Subsidiaries of the Registrant
21.1	Alta Disposal Ltd., an Alberta, Canada corporation (wholly-owned)
(31)	Rule 13a-14(a)/15d-14(a) Certification
31.1	Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
(32)	Section 1350 Certification
32.1	Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
101	Interactive Data Files
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

*Filed herewith

78

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	LITHIUM EXPLORATION GROUP, INC.
	(Registrant)
Dated: September 6, 2016	/s/ Alexander Walsh
	Alexander Walsh
	President, Secretary, Treasurer and Director
	(Principal Executive Officer, Principal Financial
	Officer and Principal Accounting Officer)

79

EX-10.34

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT”)

US $39,000.00

PARTIAL REPLACEMENT NOTE- ORIGINALLY ISSUED ON JULY 22, 2014 IN THE AMOUNT OF $672,000

LITHIUM EXPLORATION GROUP, INC
10% CONVERTIBLE REDEEMABLE NOTE
DUE MARCH 28, 2017

       FOR VALUE RECEIVED, Lithium Exploration Group, Inc. (the “Company”) promises to pay to the order of APG CAPITAL HOLDINGS, LLC and its authorized successors and Permitted Assigns, defined below, ("Holder"), the aggregate principal face amount of Thirty Nine Thousand Dollars exactly (U.S. $39,000.00) on March 28, 2017 ("Maturity Date") and to pay interest on the principal amount outstanding hereunder at the rate of 10% per annum commencing on March 28, 2016. The interest will be paid to the Holder in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note. The principal of, and interest on, this Note are payable at 300 Cadman Plaza West, 12th Floor, Brooklyn, NY 11201, initially, and if changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to paragraph 4(b) herein. Permitted Assigns means any Holder assignment, transfer or sale of all or a portion of this Note accompanied by an Opinion of Counsel

as provided for in Section 2(f) of the Securities Purchase Agreement.

                    This Note is subject to the following additional provisions:

                    1.          This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be made for such registration or transfer or exchange, except that Holder shall pay any tax or other governmental charges payable in connection therewith. To the extent that Holder subsequently transfers, assigns, sells or exchanges any of the multiple lesser denomination notes, Holder acknowledges that it will provide the Company with Opinions of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

                    2.          The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.

                    3.          This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended ("Act"), applicable state securities laws and Sections 2(f) of the Securities Purchase Agreement. Any attempted transfer to a non-qualifying party shall be treated by the Company as void. Prior to due presentment for transfer of this Note, the Company and any agent of the Company may treat the person in whose name this Note is duly registered on the Company's records as the owner hereof for all other purposes, whether or not this Note be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any Holder of this Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the requirements set forth in Section 4(a), and any prequalified prospective transferee of this Note, also is required to give the Company written confirmation that this Note is being converted ("Notice of Conversion") in the form annexed hereto as Exhibit A. The date of receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion Date. All notices of conversion will be accompanied by an Opinion of Counsel.

                    4.          (a)        The Holder of this Note is entitled, at its option, at any time, to convert all or any amount of the principal face amount of this Note then outstanding into shares of the Company's common stock (the "Common Stock") at a price ("Conversion Price") for each share of Common Stock equal to 50% of the lowest trading price of the Common Stock as reported on the National Quotations Bureau OTC Markets exchange which the Company’s shares are traded or any exchange upon which the Common Stock may be traded in the future ("Exchange"), for the twenty prior trading days including the day upon which a Notice of Conversion is received by the Company (provided such Notice of Conversion is delivered together with an Opinion of Counsel, by fax or other electronic method of communication to the Company after 4 P.M. Eastern Standard or Daylight Savings Time if the Holder wishes to include the same day closing price). If the shares have not been delivered within 3 business days, the Notice of Conversion may be rescinded. Such conversion shall be effectuated by the Company delivering the shares of Common Stock to the Holder within 3 business days of receipt by the Company of the Notice of Conversion. Accrued, but unpaid interest shall be subject to conversion. No fractional shares or scrip representing fractions of shares will be issued on conversion, but the number of shares issuable shall be rounded to the nearest whole share. To the extent the Conversion Price of the Company’s Common Stock closes below the par value per share, the Company will take all steps necessary to solicit the consent of the stockholders to reduce the par value to the lowest value possible under law. The Company agrees to honor all conversions submitted pending this increase. In the event the Company experiences a DTC “Chill” on its shares, the conversion price shall be decreased to 40% instead of 50% while that “Chill” is in effect. In no event shall the Holder be allowed to effect a conversion if such conversion, along with all other shares of Company Common Stock beneficially owned by the Holder and its affiliates would exceed 9.9% of the outstanding shares of the Common Stock of the Company.

2

                    (b)        Interest on any unpaid principal balance of this Note shall be paid at the rate of 10% per annum. Interest shall be paid by the Company in Common Stock ("Interest Shares"). Holder may, at any time, send in a Notice of Conversion to the Company for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.

                    (c)        The Note may not be prepaid.

                    (d)        Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series of related transactions, (ii) a reclassification, capital reorganization (excluding an increase in authorized capital) or other change or exchange of outstanding shares of the Common Stock, other than a forward or reverse stock split or stock dividend, or (iii) any consolidation or merger of the Company with or into another person or entity in which the Company is not the surviving entity (other than a merger which is effected solely to change the jurisdiction of incorporation of the Company and results in a reclassification, conversion or exchange of outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and (iii) being referred to as a "Sale Event"), then, in each case, the Company shall, upon request of the Holder, redeem this Note in cash for 150% of the principal amount, plus accrued but unpaid interest through the date of redemption, or at the election of the Holder, such Holder may convert the unpaid principal amount of this Note (together with the amount of accrued but unpaid interest) into shares of Common Stock immediately prior to such Sale Event at the Conversion Price.

                    (e)        In case of any Sale Event (not to include a sale of all or substantially all of the Company’s assets) in connection with which this Note is not redeemed or converted, the Company shall cause effective provision to be made so that the Holder of this Note shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number of shares of stock or other securities or property (including cash) receivable upon such reclassification, capital reorganization or other change, consolidation or merger by a holder of the number of shares of Common Stock that could have been purchased upon exercise of the Note and at the same Conversion Price, as defined in this Note, immediately prior to such Sale Event. The foregoing provisions shall similarly apply to successive Sale Events. If the consideration received by the holders of Common Stock is other than cash, the value shall be as determined by the Board of Directors of the Company or successor person or entity acting in good faith.

3

                    5.          No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.

                    6.          The Company hereby expressly waives demand and presentment for payment, notice of non-payment, protest, notice of protest, notice of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

                    7.          The Company agrees to pay all costs and expenses, including reasonable attorneys' fees and expenses, which may be incurred by the Holder in collecting any amount due under this Note.

                    8.          If one or more of the following described "Events of Default" shall occur:

                    (a)        The Company shall default in the payment of principal or interest on this Note or any other note issued to the Holder by the Company; or

                    (b)        Any of the representations or warranties made by the Company herein or in any certificate or financial or other written statements heretofore or hereafter furnished by or on behalf of the Company in connection with the execution and delivery of this Note, or the Securities Purchase Agreement under which this note was issued shall be false or misleading in any respect; or

                    (c)        The Company shall fail to perform or observe, in any respect, any covenant, term, provision, condition, agreement or obligation of the Company under this Note or any other note issued to the Holder; or

                    (d)        The Company shall (1) become insolvent (which does not include a “going concern opinion); (2) admit in writing its inability to pay its debts generally as they mature; (3) make an assignment for the benefit of creditors or commence proceedings for its dissolution; (4) apply for or consent to the appointment of a trustee, liquidator or receiver for its or for a substantial part of its property or business; (5) file a petition for bankruptcy relief, consent to the filing of such petition or have filed against it an involuntary petition for bankruptcy relief, all under federal or state laws as applicable; or

                    (e)        A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without its consent and shall not be discharged within sixty (60) days after such appointment; or

                    (f)        Any governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody or control of the whole or any substantial portion of the properties or assets of the Company; or

4

                    (g)        One or more money judgments, writs or warrants of attachment, or similar process, in excess of fifty thousand dollars ($50,000) in the aggregate, shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid, unvacated, unbonded or unstayed for a period of fifteen (15) days or in any event later than five (5) days prior to the date of any proposed sale thereunder; or

                    (h)        Defaulted on or breached any term of any other note of similar debt instrument into which the Company has entered and failed to cure such default within the appropriate grace period; or

                    (i)        The Company shall have its Common Stock delisted from an exchange (including the OTC Markets exchange) or, if the Common Stock trades on an exchange, then trading in the Common Stock shall be suspended for more than 10 consecutive days or ceases to file its 1934 act reports with the SEC;

                    (j)        If a majority of the members of the Board of Directors of the Company on the date hereof are no longer serving as members of the Board;

                    (k)        The Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4 herein without restrictive legend within 3 business days of its receipt of a Notice of Conversion which includes an Opinion of Counsel expressing an opinion which supports the removal of a restrictive legend; or

                    (l)        The Company shall not replenish the reserve set forth in Section 12, within 3 business days of the request of the Holder.

                    (m)        The Company shall be delinquent in its periodic report filings with the Securities and Exchange Commission; or

                    (n)        The Company shall cause to lose the “bid” price for its stock in a market (including the OTC marketplace or other exchange).

Then, or at any time thereafter, unless cured within 5 days, and in each and every such case, unless such Event of Default shall have been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option of the Holder and in the Holder's sole discretion, the Holder may consider this Note immediately due and payable, without presentment, demand, protest or (further) notice of any kind (other than notice of acceleration), all of which are hereby expressly waived, anything herein or in any note or other instruments contained to the contrary notwithstanding, and the Holder may immediately, and without expiration of any period of grace, enforce any and all of the Holder's rights and remedies provided herein or any other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default interest rate of 24% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event of a breach of Section 8(k) the penalty shall be $250 per day the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty shall increase to $500 per day beginning on the 10^th day. The penalty for a breach of Section 8(n) shall be an increase of the outstanding principal amounts by 20%. In case of a breach of Section 8(i), the outstanding principal due under this Note shall increase by 50%. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%. Further, if a breach of Section 8(m) occurs or is continuing after the 6 month anniversary of the Note, then the Holder shall be entitled to use the lowest closing bid price during the delinquency period as a base price for the conversion. For example, if the lowest closing bid price during the delinquency period is $0.01 per share and the conversion discount is 50% the Holder may elect to convert future conversions at $0.005 per share. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%.

5

If the Holder shall commence an action or proceeding to enforce any provisions of this Note, including, without limitation, engaging an attorney, then if the Holder prevails in such action, the Holder shall be reimbursed by the Company for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

                                 Make-Whole for Failure to Deliver Loss. At the Holder’s election, if the Company fails for any reason to deliver to the Holder the conversion shares by the by the 3rd business day following the delivery of a Notice of Conversion to the Company and if the Holder incurs a Failure to Deliver Loss, then at any time the Holder may provide the Company written notice indicating the amounts payable to the Holder in respect of the Failure to Deliver Loss and the Company must make the Holder whole as follows: Failure to Deliver Loss = [(High trade price at any time on or after the day of exercise) x (Number of conversion shares)]

The Company must pay the Failure to Deliver Loss by cash payment, and any such cash payment must be made by the third business day from the time of the Holder’s written notice to the Company.

                    9.          In case any provision of this Note is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected or impaired thereby.

                    10.        Neither this Note nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the Company and the Holder. This Note may not be assigned without the prior written consent of the Company.

                    11.        The Company represents that it is not a “shell” issuer and that if it previously has been a “shell” issuer that at least 12 months have passed since the Company has reported Form 10 type information indicating it is no longer a “shell issuer.

6

                    12.        The Company shall issue irrevocable transfer agent instructions reserving 10,000,000 shares of its Common Stock for conversions under this Note and another note in the amount of $40,700 of even date herein (the “Share Reserve”). Upon full conversion of this Note, any shares remaining in the Share Reserve shall be cancelled. The Company shall pay all transfer agent costs associated with issuing and delivering the share certificates to Holder. If such amounts are to be paid by the Holder, it may deduct such amounts from the Conversion Price. The company should at all times reserve a minimum of four times the amount of shares required if the note would be fully converted. The Holder may reasonably request increases from time to time to reserve such amounts. The Company will instruct its transfer agent to provide the outstanding share information to the Holder in connection with its conversions.

                    13.        The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits, recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

                    14.        This Note shall be governed by and construed in accordance with the laws of New York applicable to contracts made and wholly to be performed within the State of New York and shall be binding upon the successors and assigns of each party hereto. The Holder and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts, and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original.

7

                    IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by an officer thereunto duly authorized.

Dated: 03/28/2016

8

EXHIBIT A

NOTICE OF CONVERSION

(To be Executed by the Registered Holder in order to Convert the Note)

                    The undersigned hereby irrevocably elects to convert $___________ of the above Note into _________ Shares of Common Stock of Lithium Exploration Group, Inc. (“Shares”) according to the conditions set forth in such Note, as of the date written below.

                    If Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes and charges payable with respect thereto.

Date of Conversion: ____________________________________________________________________________
Applicable Conversion Price: _____________________________________________________________________
Signature: ___________________________________________________________________________________
                                                    [Print Name of Holder and Title of Signer]

Address: ____________________________________________________________________________________
                 ____________________________________________________________________________________

SSN or EIN: ___________________________________
Shares are to be registered in the following name: __________________________________________________________

Name: ______________________________________________________________________________________
Address: ____________________________________________________________________________________
Tel: _________________________________________
Fax: _________________________________________
SSN or EIN: ___________________________________

Shares are to be sent or delivered to the following account:

Account Name: _______________________________________________________________________________
Address: ____________________________________________________________________________________

9

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT”)

US $40,700.00

LITHIUM EXPLORATION GROUP, INC
10% CONVERTIBLE REDEEMABLE NOTE
DUE MARCH 28, 2017

       FOR VALUE RECEIVED, Lithium Exploration Group, Inc. (the “Company”) promises to pay to the order of APG CAPITAL HOLDINGS, LLC and its authorized successors and Permitted Assigns, defined below, ("Holder"), the aggregate principal face amount of Forty Thousand Seven Hundred Dollars exactly (U.S. $40,700.00) on March 28, 2017 ("Maturity Date") and to pay interest on the principal amount outstanding hereunder at the rate of 10% per annum commencing on March 28, 2016. The Company acknowledges this Note was issued with a 10% original issue discount (OID) and as such the purchase price was $37,000. The interest will be paid to the Holder in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note. The principal of, and interest on, this Note are payable at 300 Cadman Plaza West, 12th Floor, Brooklyn, NY 11201, initially, and if changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to paragraph 4(b) herein. Permitted Assigns means any Holder assignment, transfer or sale of all or a portion of this Note accompanied by an Opinion of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

                    This Note is subject to the following additional provisions:

                    1.          This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be made for such registration or transfer or exchange, except that Holder shall pay any tax or other governmental charges payable in connection therewith. To the extent that Holder subsequently transfers, assigns, sells or exchanges any of the multiple lesser denomination notes, Holder acknowledges that it will provide the Company with Opinions of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

                    2.          The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.

                    3.          This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended ("Act"), applicable state securities laws and Sections 2(f) of the Securities Purchase Agreement. Any attempted transfer to a non-qualifying party shall be treated by the Company as void. Prior to due presentment for transfer of this Note, the Company and any agent of the Company may treat the person in whose name this Note is duly registered on the Company's records as the owner hereof for all other purposes, whether or not this Note be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any Holder of this Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the requirements set forth in Section 4(a), and any prequalified prospective transferee of this Note, also is required to give the Company written confirmation that this Note is being converted ("Notice of Conversion") in the form annexed hereto as Exhibit A. The date of receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion Date. All notices of conversion will be accompanied by an Opinion of Counsel.

                    4.          (a)        The Holder of this Note is entitled, at its option, at any time, to convert all or any amount of the principal face amount of this Note then outstanding into shares of the Company's common stock (the "Common Stock") at a price ("Conversion Price") for each share of Common Stock equal to 65% of the lowest trading price of the Common Stock as reported on the National Quotations Bureau OTC Markets exchange which the Company’s shares are traded or any exchange upon which the Common Stock may be traded in the future ("Exchange"), for the twenty prior trading days including the day upon which a Notice of Conversion is received by the Company (provided such Notice of Conversion is delivered together with an Opinion of Counsel, by fax or other electronic method of communication to the Company after 4 P.M. Eastern Standard or Daylight Savings Time if the Holder wishes to include the same day closing price). If the shares have not been delivered within 3 business days, the Notice of Conversion may be rescinded. Such conversion shall be effectuated by the Company delivering the shares of Common Stock to the Holder within 3 business days of receipt by the Company of the Notice of Conversion. Accrued, but unpaid interest shall be subject to conversion. No fractional shares or scrip representing fractions of shares will be issued on conversion, but the number of shares issuable shall be rounded to the nearest whole share. To the extent the Conversion Price of the Company’s Common Stock closes below the par value per share, the Company will take all steps necessary to solicit the consent of the stockholders to reduce the par value to the lowest value possible under law. The Company agrees to honor all conversions submitted pending this increase. In the event the Company experiences a DTC “Chill” on its shares, the conversion price shall be decreased to 55% instead of 65% while that “Chill” is in effect. In no event shall the Holder be allowed to effect a conversion if such conversion, along with all other shares of Company Common Stock beneficially owned by the Holder and its affiliates would exceed 9.9% of the outstanding shares of the Common Stock of the Company.

2

                    (b)        Interest on any unpaid principal balance of this Note shall be paid at the rate of 10% per annum. Interest shall be paid by the Company in Common Stock ("Interest Shares"). Holder may, at any time, send in a Notice of Conversion to the Company for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.

                    (c)        The Notes may be prepaid with the following penalties:

PREPAY DATE	PREPAY AMOUNT
≤ 30 days	120% of principal plus accrued interest
31-60 days	126% of principal plus accrued interest
61- 90 days	132% of principal plus accrued interest
91-120 days	138% of principal plus accrued interest
121-150 days	144% of principal plus accrued interest
151-180 days	150% of principal plus accrued interest

This Note may not be prepaid after the 180^th day. Such redemption must be closed and funded within 3 days of giving notice of redemption of the right to redeem shall be null and void.

                    (d)        Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series of related transactions, (ii) a reclassification, capital reorganization (excluding an increase in authorized capital) or other change or exchange of outstanding shares of the Common Stock, other than a forward or reverse stock split or stock dividend, or (iii) any consolidation or merger of the Company with or into another person or entity in which the Company is not the surviving entity (other than a merger which is effected solely to change the jurisdiction of incorporation of the Company and results in a reclassification, conversion or exchange of outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and (iii) being referred to as a "Sale Event"), then, in each case, the Company shall, upon request of the Holder, redeem this Note in cash for 150% of the principal amount, plus accrued but unpaid interest through the date of redemption, or at the election of the Holder, such Holder may convert the unpaid principal amount of this Note (together with the amount of accrued but unpaid interest) into shares of Common Stock immediately prior to such Sale Event at the Conversion Price.

                    (e)        In case of any Sale Event (not to include a sale of all or substantially all of the Company’s assets) in connection with which this Note is not redeemed or converted, the Company shall cause effective provision to be made so that the Holder of this Note shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number of shares of stock or other securities or property (including cash) receivable upon such reclassification, capital reorganization or other change, consolidation or merger by a holder of the number of shares of Common Stock that could have been purchased upon exercise of the Note and at the same Conversion Price, as defined in this Note, immediately prior to such Sale Event. The foregoing provisions shall similarly apply to successive Sale Events. If the consideration received by the holders of Common Stock is other than cash, the value shall be as determined by the Board of Directors of the Company or successor person or entity acting in good faith.

3

                    5.          No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.

                    6.          The Company hereby expressly waives demand and presentment for payment, notice of non-payment, protest, notice of protest, notice of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

                    7.          The Company agrees to pay all costs and expenses, including reasonable attorneys' fees and expenses, which may be incurred by the Holder in collecting any amount due under this Note.

                    8.          If one or more of the following described "Events of Default" shall occur:

                    (a)        The Company shall default in the payment of principal or interest on this Note or any other note issued to the Holder by the Company; or

                    (b)        Any of the representations or warranties made by the Company herein or in any certificate or financial or other written statements heretofore or hereafter furnished by or on behalf of the Company in connection with the execution and delivery of this Note, or the Securities Purchase Agreement under which this note was issued shall be false or misleading in any respect; or

                    (c)        The Company shall fail to perform or observe, in any respect, any covenant, term, provision, condition, agreement or obligation of the Company under this Note or any other note issued to the Holder; or

                    (d)        The Company shall (1) become insolvent (which does not include a “going concern opinion); (2) admit in writing its inability to pay its debts generally as they mature; (3) make an assignment for the benefit of creditors or commence proceedings for its dissolution; (4) apply for or consent to the appointment of a trustee, liquidator or receiver for its or for a substantial part of its property or business; (5) file a petition for bankruptcy relief, consent to the filing of such petition or have filed against it an involuntary petition for bankruptcy relief, all under federal or state laws as applicable; or

                    (e)        A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without its consent and shall not be discharged within sixty (60) days after such appointment; or

4

                    (f)        Any governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody or control of the whole or any substantial portion of the properties or assets of the Company; or

                    (g)        One or more money judgments, writs or warrants of attachment, or similar process, in excess of fifty thousand dollars ($50,000) in the aggregate, shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid, unvacated, unbonded or unstayed for a period of fifteen (15) days or in any event later than five (5) days prior to the date of any proposed sale thereunder; or

                    (h)        Defaulted on or breached any term of any other note of similar debt instrument into which the Company has entered and failed to cure such default within the appropriate grace period; or

                    (i)        The Company shall have its Common Stock delisted from an exchange (including the OTC Markets exchange) or, if the Common Stock trades on an exchange, then trading in the Common Stock shall be suspended for more than 10 consecutive days or ceases to file its 1934 act reports with the SEC;

                    (j)        If a majority of the members of the Board of Directors of the Company on the date hereof are no longer serving as members of the Board;

                    (k)        The Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4 herein without restrictive legend within 3 business days of its receipt of a Notice of Conversion which includes an Opinion of Counsel expressing an opinion which supports the removal of a restrictive legend; or

                    (l)        The Company shall not replenish the reserve set forth in Section 12, within 3 business days of the request of the Holder.

                    (m)        The Company shall be delinquent in its periodic report filings with the Securities and Exchange Commission; or

                    (n)        The Company shall cause to lose the “bid” price for its stock in a market (including the OTC marketplace or other exchange).

Then, or at any time thereafter, unless cured within 5 days, and in each and every such case, unless such Event of Default shall have been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option of the Holder and in the Holder's sole discretion, the Holder may consider this Note immediately due and payable, without presentment, demand, protest or (further) notice of any kind (other than notice of acceleration), all of which are hereby expressly waived, anything herein or in any note or other instruments contained to the contrary notwithstanding, and the Holder may immediately, and without expiration of any period of grace, enforce any and all of the Holder's rights and remedies provided herein or any other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default interest rate of 24% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event of a breach of Section 8(k) the penalty shall be $250 per day the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty shall increase to $500 per day beginning on the 10^th day. The penalty for a breach of Section 8(n) shall be an increase of the outstanding principal amounts by 20%. In case of a breach of Section 8(i), the outstanding principal due under this Note shall increase by 50%. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%. Further, if a breach of Section 8(m) occurs or is continuing after the 6 month anniversary of the Note, then the Holder shall be entitled to use the lowest closing bid price during the delinquency period as a base price for the conversion. For example, if the lowest closing bid price during the delinquency period is $0.01 per share and the conversion discount is 50% the Holder may elect to convert future conversions at $0.005 per share. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%.

5

If the Holder shall commence an action or proceeding to enforce any provisions of this Note, including, without limitation, engaging an attorney, then if the Holder prevails in such action, the

Holder shall be reimbursed by the Company for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

                    Make-Whole for Failure to Deliver Loss. At the Holder’s election, if the Company fails for any reason to deliver to the Holder the conversion shares by the by the 3rd business day following the delivery of a Notice of Conversion to the Company and if the Holder incurs a Failure to Deliver Loss, then at any time the Holder may provide the Company written notice indicating the amounts payable to the Holder in respect of the Failure to Deliver Loss and the Company must make the Holder whole as follows: Failure to Deliver Loss = [(High trade price at any time on or after the day of exercise) x (Number of conversion shares)]

The Company must pay the Failure to Deliver Loss by cash payment, and any such cash payment must be made by the third business day from the time of the Holder’s written notice to the Company.

                    9.          In case any provision of this Note is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected or impaired thereby.

                    10.        Neither this Note nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the Company and the Holder. This Note may not be assigned without the prior written consent of the Company.

6

                    11.        The Company represents that it is not a “shell” issuer and that if it previously has been a “shell” issuer that at least 12 months have passed since the Company has reported Form 10 type information indicating it is no longer a “shell issuer.

                    12.        The Company shall issue irrevocable transfer agent instructions reserving 10,000,000 shares of its Common Stock for conversions under this Note and another note in the amount of $39,000 of even date herein (the “Share Reserve”). Upon full conversion of this Note, any shares remaining in the Share Reserve shall be cancelled. The Company shall pay all transfer agent costs associated with issuing and delivering the share certificates to Holder. If such amounts are to be paid by the Holder, it may deduct such amounts from the Conversion Price. The company should at all times reserve a minimum of four times the amount of shares required if the note would be fully converted. The Holder may reasonably request increases from time to time to reserve such amounts. The Company will instruct its transfer agent to provide the outstanding share information to the Holder in connection with its conversions.

                    13.        The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits, recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

                    14.        This Note shall be governed by and construed in accordance with the laws of New York applicable to contracts made and wholly to be performed within the State of New York and shall be binding upon the successors and assigns of each party hereto. The Holder and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts, and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original.

7

                    IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by an officer thereunto duly authorized.

Dated:                   03/28/16                                       

8

EXHIBIT A

NOTICE OF CONVERSION

  The undersigned hereby irrevocably elects to convert $___________ of the above Note into _________ Shares of Common Stock of Lithium Exploration Group, Inc. (“Shares”) according to the conditions set forth in such Note, as of the date written below.

                    If Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes and charges payable with respect thereto.

Date of Conversion: ____________________________________________________________________________
Applicable Conversion Price: _____________________________________________________________________
Signature: ___________________________________________________________________________________
                                                    [Print Name of Holder and Title of Signer]

Address: ____________________________________________________________________________________
                 ____________________________________________________________________________________

SSN or EIN: ___________________________________
Shares are to be registered in the following name: __________________________________________________________

Name: ______________________________________________________________________________________
Address: ____________________________________________________________________________________
Tel: _________________________________________
Fax: _________________________________________
SSN or EIN: ___________________________________

Shares are to be sent or delivered to the following account:

Account Name: _______________________________________________________________________________
Address: ____________________________________________________________________________________

9

EX-10.35

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT”)

US $50,000.00

PARTIAL REPLACEMENT NOTE- ORIGINALLY ISSUED ON JULY 22, 2014 IN THE AMOUNT OF $672,000

LITHIUM EXPLORATION GROUP, INC
10% CONVERTIBLE REDEEMABLE NOTE
DUE APRIL 19, 2017

       FOR VALUE RECEIVED, Lithium Exploration Group, Inc. (the “Company”) promises to pay to the order of TOLEDO ADVISORS, LLC and its authorized successors and Permitted Assigns, defined below, ("Holder"), the aggregate principal face amount of Fifty Thousand Dollars exactly (U.S. $50,000.00) on April 19, 2017 ("Maturity Date") and to pay interest on the principal amount outstanding hereunder at the rate of 10% per annum commencing on April 19, 2016. The interest will be paid to the Holder in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note. The principal of, and interest on, this Note are payable at 641 5^th Street, Lakewood, NJ 08701, initially, and if changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to paragraph 4(b) herein. Permitted Assigns means any Holder assignment, transfer or sale of all or a portion of this Note accompanied by an Opinion of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

                    This Note is subject to the following additional provisions:

                    1.          This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be made for such registration or transfer or exchange, except that Holder shall pay any tax or other governmental charges payable in connection therewith. To the extent that Holder subsequently transfers, assigns, sells or exchanges any of the multiple lesser denomination notes, Holder acknowledges that it will provide the Company with Opinions of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

                    2.          The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.

                    3.          This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended ("Act"), applicable state securities laws and Sections 2(f) of the Securities Purchase Agreement. Any attempted transfer to a non-qualifying party shall be treated by the Company as void. Prior to due presentment for transfer of this Note, the Company and any agent of the Company may treat the person in whose name this Note is duly registered on the Company's records as the owner hereof for all other purposes, whether or not this Note be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any Holder of this Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the requirements set forth in Section 4(a), and any prequalified prospective transferee of this Note, also is required to give the Company written confirmation that this Note is being converted ("Notice of Conversion") in the form annexed hereto as Exhibit A. The date of receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion Date. All notices of conversion will be accompanied by an Opinion of Counsel.

                    4.          (a)        The Holder of this Note is entitled, at its option, at any time, to convert all or any amount of the principal face amount of this Note then outstanding into shares of the Company's common stock (the "Common Stock") at a price ("Conversion Price") for each share of Common Stock equal to 50% of the lowest trading price of the Common Stock as reported on the National Quotations Bureau OTC Markets exchange which the Company’s shares are traded or any exchange upon which the Common Stock may be traded in the future ("Exchange"), for the twenty prior trading days including the day upon which a Notice of Conversion is received by the Company (provided such Notice of Conversion is delivered together with an Opinion of Counsel, by fax or other electronic method of communication to the Company after 4 P.M. Eastern Standard or Daylight Savings Time if the Holder wishes to include the same day closing price). If the shares have not been delivered within 3 business days, the Notice of Conversion may be rescinded. Such conversion shall be effectuated by the Company delivering the shares of Common Stock to the Holder within 3 business days of receipt by the Company of the Notice of Conversion. Accrued, but unpaid interest shall be subject to conversion. No fractional shares or scrip representing fractions of shares will be issued on conversion, but the number of shares issuable shall be rounded to the nearest whole share. To the extent the Conversion Price of the Company’s Common Stock closes below the par value per share, the Company will take all steps necessary to solicit the consent of the stockholders to reduce the par value to the lowest value possible under law. The Company agrees to honor all conversions submitted pending this increase. In the event the Company experiences a DTC “Chill” on its shares, the conversion price shall be decreased to 40% instead of 50% while that “Chill” is in effect. In no event shall the Holder be allowed to effect a conversion if such conversion, along with all other shares of Company Common Stock beneficially owned by the Holder and its affiliates would exceed 9.9% of the outstanding shares of the Common Stock of the Company. All the terms set forth herein, including but not limited to interest rate, prepayment terms, conversion discount or lookback period will be adjusted downward (i.e. for the benefit of the Holder) if the Company offers a more favorable conversion discount (whether via interest, rate OID or otherwise) or lookback period to another party or otherwise grants any more favorable terms to any third party than those contained herein while this note is in effect.

2

                    (b)        Interest on any unpaid principal balance of this Note shall be paid at the rate of 10% per annum. Interest shall be paid by the Company in Common Stock ("Interest Shares"). Holder may, at any time, send in a Notice of Conversion to the Company for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.

                    (c)        The Note may not be prepaid.

                    (d)        Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series of related transactions, (ii) a reclassification, capital reorganization (excluding an increase in authorized capital) or other change or exchange of outstanding shares of the Common Stock, other than a forward or reverse stock split or stock dividend, or (iii) any consolidation or merger of the Company with or into another person or entity in which the Company is not the surviving entity (other than a merger which is effected solely to change the jurisdiction of incorporation of the Company and results in a reclassification, conversion or exchange of outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and (iii) being referred to as a "Sale Event"), then, in each case, the Company shall, upon request of the Holder, redeem this Note in cash for 150% of the principal amount, plus accrued but unpaid interest through the date of redemption, or at the election of the Holder, such Holder may convert the unpaid principal amount of this Note (together with the amount of accrued but unpaid interest) into shares of Common Stock immediately prior to such Sale Event at the Conversion Price.

                    (e)        In case of any Sale Event (not to include a sale of all or substantially all of the Company’s assets) in connection with which this Note is not redeemed or converted, the Company shall cause effective provision to be made so that the Holder of this Note shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number of shares of stock or other securities or property (including cash) receivable upon such reclassification, capital reorganization or other change, consolidation or merger by a holder of the number of shares of Common Stock that could have been purchased upon exercise of the Note and at the same Conversion Price, as defined in this Note, immediately prior to such Sale Event. The foregoing provisions shall similarly apply to successive Sale Events. If the consideration received by the holders of Common Stock is other than cash, the value shall be as determined by the Board of Directors of the Company or successor person or entity acting in good faith.

3

                    5.          No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.

                    6.          The Company hereby expressly waives demand and presentment for payment, notice of non-payment, protest, notice of protest, notice of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

                    7.          The Company agrees to pay all costs and expenses, including reasonable attorneys' fees and expenses, which may be incurred by the Holder in collecting any amount due under this Note.

                    8.          If one or more of the following described "Events of Default" shall occur:

                    (a)        The Company shall default in the payment of principal or interest on this Note or any other note issued to the Holder by the Company; or

                    (b)        Any of the representations or warranties made by the Company herein or in any certificate or financial or other written statements heretofore or hereafter furnished by or on behalf of the Company in connection with the execution and delivery of this Note, or the Securities Purchase Agreement under which this note was issued shall be false or misleading in any respect; or

                    (c)        The Company shall fail to perform or observe, in any respect, any covenant, term, provision, condition, agreement or obligation of the Company under this Note or any other note issued to the Holder; or

                    (d)        The Company shall (1) become insolvent (which does not include a “going concern opinion); (2) admit in writing its inability to pay its debts generally as they mature; (3) make an assignment for the benefit of creditors or commence proceedings for its dissolution; (4) apply for or consent to the appointment of a trustee, liquidator or receiver for its or for a substantial part of its property or business; (5) file a petition for bankruptcy relief, consent to the filing of such petition or have filed against it an involuntary petition for bankruptcy relief, all under federal or state laws as applicable; or

                    (e)        A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without its consent and shall not be discharged within sixty (60) days after such appointment; or

                    (f)        Any governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody or control of the whole or any substantial portion of the properties or assets of the Company; or

4

                    (g)        One or more money judgments, writs or warrants of attachment, or similar process, in excess of fifty thousand dollars ($50,000) in the aggregate, shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid, unvacated, unbonded or unstayed for a period of fifteen (15) days or in any event later than five (5) days prior to the date of any proposed sale thereunder; or

                    (h)        Defaulted on or breached any term of any other note of similar debt instrument into which the Company has entered and failed to cure such default within the appropriate grace period; or

                    (i)        The Company shall have its Common Stock delisted from an exchange (including the OTC Markets exchange) or, if the Common Stock trades on an exchange, then trading in the Common Stock shall be suspended for more than 10 consecutive days or ceases to file its 1934 act reports with the SEC;

                    (j)        If a majority of the members of the Board of Directors of the Company on the date hereof are no longer serving as members of the Board;

                    (k)        The Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4 herein without restrictive legend within 3 business days of its receipt of a Notice of Conversion which includes an Opinion of Counsel expressing an opinion which supports the removal of a restrictive legend; or

                    (l)        The Company shall not replenish the reserve set forth in Section 12, within 3 business days of the request of the Holder.

                    (m)        The Company shall be delinquent in its periodic report filings with the Securities and Exchange Commission; or

                    (n)        The Company shall cause to lose the “bid” price for its stock in a market (including the OTC marketplace or other exchange).

Then, or at any time thereafter, unless cured within 5 days, and in each and every such case, unless such Event of Default shall have been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option of the Holder and in the Holder's sole discretion, the Holder may consider this Note immediately due and payable, without presentment, demand, protest or (further) notice of any kind (other than notice of acceleration), all of which are hereby expressly waived, anything herein or in any note or other instruments contained to the contrary notwithstanding, and the Holder may immediately, and without expiration of any period of grace, enforce any and all of the Holder's rights and remedies provided herein or any other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default interest rate of 24% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event of a breach of Section 8(k) the penalty shall be $250 per day the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty shall increase to $500 per day beginning on the 10^th day. The penalty for a breach of Section 8(n) shall be an increase of the outstanding principal amounts by 20%. In case of a breach of Section 8(i), the outstanding principal due under this Note shall increase by 50%. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%. Further, if a breach of Section 8(m) occurs or is continuing after the 6 month anniversary of the Note, then the Holder shall be entitled to use the lowest closing bid price during the delinquency period as a base price for the conversion. For example, if the lowest closing bid price during the delinquency period is $0.01 per share and the conversion discount is 50% the Holder may elect to convert future conversions at $0.005 per share. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%.

5

If the Holder shall commence an action or proceeding to enforce any provisions of this Note, including, without limitation, engaging an attorney, then if the Holder prevails in such action, the Holder shall be reimbursed by the Company for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

                    Make-Whole for Failure to Deliver Loss. At the Holder’s election, if the Company fails for any reason to deliver to the Holder the conversion shares by the by the 3rd business day following the delivery of a Notice of Conversion to the Company and if the Holder incurs a Failure to Deliver Loss, then at any time the Holder may provide the Company written notice indicating the amounts payable to the Holder in respect of the Failure to Deliver Loss and the Company must make the Holder whole as follows: Failure to Deliver Loss = [(High trade price at any time on or after the day of exercise) x (Number of conversion shares)]

The Company must pay the Failure to Deliver Loss by cash payment, and any such cash payment must be made by the third business day from the time of the Holder’s written notice to the Company.

                    9.          In case any provision of this Note is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected or impaired thereby.

                    10.        Neither this Note nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the Company and the Holder. This Note may not be assigned without the prior written consent of the Company.

                    11.        The Company represents that it is not a “shell” issuer and that if it previously has been a “shell” issuer that at least 12 months have passed since the Company has reported Form 10 type information indicating it is no longer a “shell issuer.

                    12.        The Company shall issue irrevocable transfer agent instructions reserving 25,128,000 shares of its Common Stock for conversions under this Note and another note in the amount of $57,500 of even date herein (the “Share Reserve”). Upon full conversion of this Note, any shares remaining in the Share Reserve shall be cancelled. The Company shall pay all transfer agent costs associated with issuing and delivering the share certificates to Holder. If such amounts are to be paid by the Holder, it may deduct such amounts from the Conversion Price. The company should at all times reserve a minimum of three times the amount of shares required if the note would be fully converted. The Holder may reasonably request increases from time to time to reserve such amounts. The Company will instruct its transfer agent to provide the outstanding share information to the Holder in connection with its conversions.

6

                    13.        The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits, recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

                    14.        This Note shall be governed by and construed in accordance with the laws of Nevada applicable to contracts made and wholly to be performed within the State of Nevada and shall be binding upon the successors and assigns of each party hereto. The Holder and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts, and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original.

7

                    IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by an officer thereunto duly authorized.

Dated: April 19, 2016

8

EXHIBIT A

NOTICE OF CONVERSION

(To be Executed by the Registered Holder in order to Convert the Note)

                    The undersigned hereby irrevocably elects to convert $___________ of the above Note into _________ Shares of Common Stock of Lithium Exploration Group, Inc. (“Shares”) according to the conditions set forth in such Note, as of the date written below.

                    If Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes and charges payable with respect thereto.

Date of Conversion: ____________________________________________________________________________
Applicable Conversion Price: _____________________________________________________________________
Signature: ___________________________________________________________________________________
                                                    [Print Name of Holder and Title of Signer]

Address: ____________________________________________________________________________________
                 ____________________________________________________________________________________

SSN or EIN: ___________________________________
Shares are to be registered in the following name: __________________________________________________________

Name: ______________________________________________________________________________________
Address: ____________________________________________________________________________________
Tel: _________________________________________
Fax: _________________________________________
SSN or EIN: ___________________________________

Shares are to be sent or delivered to the following account:

Account Name: _______________________________________________________________________________
Address: ____________________________________________________________________________________

9

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT”)

US $57,500.00

LITHIUM EXPLORATION GROUP, INC
10% CONVERTIBLE REDEEMABLE NOTE
DUE APRIL 19, 2017

       FOR VALUE RECEIVED, Lithium Exploration Group, Inc. (the “Company”) promises to pay to the order of TOLEDO ADVISORS, LLC and its authorized successors and Permitted Assigns, defined below, ("Holder"), the aggregate principal face amount of Fifty Seven Thousand Five Hundred Dollars exactly (U.S. $57,500.00) on April 19, 2017 ("Maturity Date") and to pay interest on the principal amount outstanding hereunder at the rate of 10% per annum commencing on April 19, 2016. The Company acknowledges this Note was issued with a $7,500 original issue discount (OID) and as such the purchase price was $50,000. The interest will be paid to the Holder in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note. The principal of, and interest on, this Note are payable at 641 5^th Street, Lakewood, NJ 08701, initially, and if changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to paragraph 4(b) herein. Permitted Assigns means any Holder assignment, transfer or sale of all or a portion of this Note accompanied by an Opinion of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

                    This Note is subject to the following additional provisions:

                    1.         This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be made for such registration or transfer or exchange, except that Holder shall pay any tax or other governmental charges payable in connection therewith. To the extent that Holder subsequently transfers, assigns, sells or exchanges any of the multiple lesser denomination notes, Holder acknowledges that it will provide the Company with Opinions of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

                    2.          The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.

                    3.          This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended ("Act"), applicable state securities laws and Sections 2(f) of the Securities Purchase Agreement. Any attempted transfer to a non-qualifying party shall be treated by the Company as void. Prior to due presentment for transfer of this Note, the Company and any agent of the Company may treat the person in whose name this Note is duly registered on the Company's records as the owner hereof for all other purposes, whether or not this Note be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any Holder of this Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the requirements set forth in Section 4(a), and any prequalified prospective transferee of this Note, also is required to give the Company written confirmation that this Note is being converted ("Notice of Conversion") in the form annexed hereto as Exhibit A. The date of receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion Date. All notices of conversion will be accompanied by an Opinion of Counsel.

                    4.          (a)        The Holder of this Note is entitled, at its option, at any time, to convert all or any amount of the principal face amount of this Note then outstanding into shares of the Company's common stock (the "Common Stock") at a price ("Conversion Price") for each share of Common Stock equal to 65% of the lowest trading price of the Common Stock as reported on the National Quotations Bureau OTC Markets exchange which the Company’s shares are traded or any exchange upon which the Common Stock may be traded in the future ("Exchange"), for the twenty prior trading days including the day upon which a Notice of Conversion is received by the Company (provided such Notice of Conversion is delivered together with an Opinion of Counsel, by fax or other electronic method of communication to the Company after 4 P.M. Eastern Standard or Daylight Savings Time if the Holder wishes to include the same day closing price). If the shares have not been delivered within 3 business days, the Notice of Conversion may be rescinded. Such conversion shall be effectuated by the Company delivering the shares of Common Stock to the Holder within 3 business days of receipt by the Company of the Notice of Conversion. Accrued, but unpaid interest shall be subject to conversion. No fractional shares or scrip representing fractions of shares will be issued on conversion, but the number of shares issuable shall be rounded to the nearest whole share. To the extent the Conversion Price of the Company’s Common Stock closes below the par value per share, the Company will take all steps necessary to solicit the consent of the stockholders to reduce the par value to the lowest value possible under law. The Company agrees to honor all conversions submitted pending this increase. In the event the Company experiences a DTC “Chill” on its shares, the conversion price shall be decreased to 55% instead of 65% while that “Chill” is in effect. In no event shall the Holder be allowed to effect a conversion if such conversion, along with all other shares of Company Common Stock beneficially owned by the Holder and its affiliates would exceed 9.9% of the outstanding shares of the Common Stock of the Company. All the terms set forth herein, including but not limited to interest rate, prepayment terms, conversion discount or lookback period will be adjusted downward (i.e. for the benefit of the Holder) if the Company offers a more favorable conversion discount (whether via interest, rate OID or otherwise) or lookback period to another party or otherwise grants any more favorable terms to any third party than those contained herein while this note is in effect.

2

                    (b)        Interest on any unpaid principal balance of this Note shall be paid at the rate of 10% per annum. Interest shall be paid by the Company in Common Stock ("Interest Shares"). Holder may, at any time, send in a Notice of Conversion to the Company for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.

                    (c)        The Notes may be prepaid with the following penalties:

PREPAY DATE	PREPAY AMOUNT
≤ 30 days	120% of principal plus accrued interest
31-60 days	126% of principal plus accrued interest
61- 90 days	132% of principal plus accrued interest
91-120 days	138% of principal plus accrued interest
121-150 days	144% of principal plus accrued interest
151-180 days	150% of principal plus accrued interest

This Note may not be prepaid after the 180^th day. Such redemption must be closed and funded within 3 days of giving notice of redemption of the right to redeem shall be null and void.

                    (d)        Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series of related transactions, (ii) a reclassification, capital reorganization (excluding an increase in authorized capital) or other change or exchange of outstanding shares of the Common Stock, other than a forward or reverse stock split or stock dividend, or (iii) any consolidation or merger of the Company with or into another person or entity in which the Company is not the surviving entity (other than a merger which is effected solely to change the jurisdiction of incorporation of the Company and results in a reclassification, conversion or exchange of outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and (iii) being referred to as a "Sale Event"), then, in each case, the Company shall, upon request of the Holder, redeem this Note in cash for 150% of the principal amount, plus accrued but unpaid interest through the date of redemption, or at the election of the Holder, such Holder may convert the unpaid principal amount of this Note (together with the amount of accrued but unpaid interest) into shares of Common Stock immediately prior to such Sale Event at the Conversion Price.

                    (e)        In case of any Sale Event (not to include a sale of all or substantially all of the Company’s assets) in connection with which this Note is not redeemed or converted, the Company shall cause effective provision to be made so that the Holder of this Note shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number of shares of stock or other securities or property (including cash) receivable upon such reclassification, capital reorganization or other change, consolidation or merger by a holder of the number of shares of Common Stock that could have been purchased upon exercise of the Note and at the same Conversion Price, as defined in this Note, immediately prior to such Sale Event. The foregoing provisions shall similarly apply to successive Sale Events. If the consideration received by the holders of Common Stock is other than cash, the value shall be as determined by the Board of Directors of the Company or successor person or entity acting in good faith.

3

                    5.          No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.

                    6.          The Company hereby expressly waives demand and presentment for payment, notice of non-payment, protest, notice of protest, notice of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

                    7.          The Company agrees to pay all costs and expenses, including reasonable attorneys' fees and expenses, which may be incurred by the Holder in collecting any amount due under this Note.

                    8.          If one or more of the following described "Events of Default" shall occur:

                    (a)        The Company shall default in the payment of principal or interest on this Note or any other note issued to the Holder by the Company; or

                    (b)        Any of the representations or warranties made by the Company herein or in any certificate or financial or other written statements heretofore or hereafter furnished by or on behalf of the Company in connection with the execution and delivery of this Note, or the Securities Purchase Agreement under which this note was issued shall be false or misleading in any respect; or

                    (c)        The Company shall fail to perform or observe, in any respect, any covenant, term, provision, condition, agreement or obligation of the Company under this Note or any other note issued to the Holder; or

                    (d)        The Company shall (1) become insolvent (which does not include a “going concern opinion); (2) admit in writing its inability to pay its debts generally as they mature; (3) make an assignment for the benefit of creditors or commence proceedings for its dissolution; (4) apply for or consent to the appointment of a trustee, liquidator or receiver for its or for a substantial part of its property or business; (5) file a petition for bankruptcy relief, consent to the filing of such petition or have filed against it an involuntary petition for bankruptcy relief, all under federal or state laws as applicable; or

4

                    (e)        A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without its consent and shall not be discharged within sixty (60) days after such appointment; or

                    (f)        Any governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody or control of the whole or any substantial portion of the properties or assets of the Company; or

                    (g)        One or more money judgments, writs or warrants of attachment, or similar process, in excess of fifty thousand dollars ($50,000) in the aggregate, shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid, unvacated, unbonded or unstayed for a period of fifteen (15) days or in any event later than five (5) days prior to the date of any proposed sale thereunder; or

                    (h)        Defaulted on or breached any term of any other note of similar debt instrument into which the Company has entered and failed to cure such default within the appropriate grace period; or

                    (i)        The Company shall have its Common Stock delisted from an exchange (including the OTC Markets exchange) or, if the Common Stock trades on an exchange, then trading in the Common Stock shall be suspended for more than 10 consecutive days or ceases to file its 1934 act reports with the SEC;

                    (j)        If a majority of the members of the Board of Directors of the Company on the date hereof are no longer serving as members of the Board;

                    (k)        The Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4 herein without restrictive legend within 3 business days of its receipt of a Notice of Conversion which includes an Opinion of Counsel expressing an opinion which supports the removal of a restrictive legend; or

                    (l)        The Company shall not replenish the reserve set forth in Section 12, within 3 business days of the request of the Holder.

                    (m)        The Company shall be delinquent in its periodic report filings with the Securities and Exchange Commission; or

                    (n)        The Company shall cause to lose the “bid” price for its stock in a market (including the OTC marketplace or other exchange).

Then, or at any time thereafter, unless cured within 5 days, and in each and every such case, unless such Event of Default shall have been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option of the Holder and in the Holder's sole discretion, the Holder may consider this Note immediately due and payable, without presentment, demand, protest or (further) notice of any kind (other than notice of acceleration), all of which are hereby expressly waived, anything herein or in any note or other instruments contained to the contrary notwithstanding, and the Holder may immediately, and without expiration of any period of grace, enforce any and all of the Holder's rights and remedies provided herein or any other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default interest rate of 24% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event of a breach of Section 8(k) the penalty shall be $250 per day the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty shall increase to $500 per day beginning on the 10^th day. The penalty for a breach of Section 8(n) shall be an increase of the outstanding principal amounts by 20%. In case of a breach of Section 8(i), the outstanding principal due under this Note shall increase by 50%. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%. Further, if a breach of Section 8(m) occurs or is continuing after the 6 month anniversary of the Note, then the Holder shall be entitled to use the lowest closing bid price during the delinquency period as a base price for the conversion. For example, if the lowest closing bid price during the delinquency period is $0.01 per share and the conversion discount is 50% the Holder may elect to convert future conversions at $0.005 per share. If this Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%.

5

If the Holder shall commence an action or proceeding to enforce any provisions of this Note, including, without limitation, engaging an attorney, then if the Holder prevails in such action, the Holder shall be reimbursed by the Company for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

                    Make-Whole for Failure to Deliver Loss. At the Holder’s election, if the Company fails for any reason to deliver to the Holder the conversion shares by the by the 3rd business day following the delivery of a Notice of Conversion to the Company and if the Holder incurs a Failure to Deliver Loss, then at any time the Holder may provide the Company written notice indicating the amounts payable to the Holder in respect of the Failure to Deliver Loss and the Company must make the Holder whole as follows: Failure to Deliver Loss = [(High trade price at any time on or after the day of exercise) x (Number of conversion shares)]

The Company must pay the Failure to Deliver Loss by cash payment, and any such cash payment must be made by the third business day from the time of the Holder’s written notice to the Company.

                    9.          In case any provision of this Note is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected or impaired thereby.

6

                    10.        Neither this Note nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the Company and the Holder. This Note may not be assigned without the prior written consent of the Company.

                    11.        The Company represents that it is not a “shell” issuer and that if it previously has been a “shell” issuer that at least 12 months have passed since the Company has reported Form 10 type information indicating it is no longer a “shell issuer.

                    12.        The Company shall issue irrevocable transfer agent instructions reserving 25,128,000 shares of its Common Stock for conversions under this Note and another note in the amount of $50,000 of even date herein (the “Share Reserve”). Upon full conversion of this Note, any shares remaining in the Share Reserve shall be cancelled. The Company shall pay all transfer agent costs associated with issuing and delivering the share certificates to Holder. If such amounts are to be paid by the Holder, it may deduct such amounts from the Conversion Price. The company should at all times reserve a minimum of three times the amount of shares required if the note would be fully converted. The Holder may reasonably request increases from time to time to reserve such amounts. The Company will instruct its transfer agent to provide the outstanding share information to the Holder in connection with its conversions.

                    13.        The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits, recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

                    14.        This Note shall be governed by and construed in accordance with the laws of Nevada applicable to contracts made and wholly to be performed within the State of Nevada and shall be binding upon the successors and assigns of each party hereto. The Holder and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts, and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original.

7

                    IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by an officer thereunto duly authorized.

Dated: April 19, 2016

EXHIBIT A

NOTICE OF CONVERSION NOTICE OF CONVERSION

(To be Executed by the Registered Holder in order to Convert the Note)

                    The undersigned hereby irrevocably elects to convert $___________ of the above Note into _________ Shares of Common Stock of Lithium Exploration Group, Inc. (“Shares”) according to the conditions set forth in such Note, as of the date written below.

                    If Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes and charges payable with respect thereto.

Date of Conversion: ____________________________________________________________________________
Applicable Conversion Price: _____________________________________________________________________
Signature: ___________________________________________________________________________________
                                                    [Print Name of Holder and Title of Signer]

Address: ____________________________________________________________________________________
                 ____________________________________________________________________________________

SSN or EIN: ___________________________________
Shares are to be registered in the following name: __________________________________________________________

Name: ______________________________________________________________________________________
Address: ____________________________________________________________________________________
Tel: _________________________________________
Fax: _________________________________________
SSN or EIN: ___________________________________

8

____
Initials

Shares are to be sent or delivered to the following account:

Account Name: _______________________________________________________________________________
Address: ____________________________________________________________________________________

9

____
Initials

EX-10.36

 

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO
18 U.S.C. ss 1350, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Alexander Walsh, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Lithium Exploration Group, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: September 6, 2016

 

Alexander Walsh

President, Secretary, Treasurer and Director

(Principal Executive Officer, Principal Financial

Officer and Principal Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Alexander Walsh, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	the Quarterly Report on Form 10-Q of Lithium Exploration Group, Inc. for the period ended March 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Lithium Exploration Group, Inc.

Dated: September 6, 2016
	Alexander Walsh
	President, Secretary, Treasurer and Director
	(Principal Executive Officer, Principal Financial Officer and
	Principal Accounting Officer)
	Lithium Exploration Group, Inc.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Lithium Exploration Group, Inc. and will be retained by Lithium Exploration Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2016	Jul. 27, 2016
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Trading Symbol	lexg
Entity Registrant Name	Lithium Exploration Group, Inc.
Entity Central Index Key	0001375576
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		119,772,784
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3

XML

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2016	Jun. 30, 2015
Current
Cash and cash equivalents	$ 7,301	$ 64,098
Receivable	0	13,421
Loan receivable	0	20,000
Prepaid expenses	2,788	2,788
Current assets held for sale .	23,351	14,713
Total current assets	33,440	115,020
Total Assets	33,440	115,020
Current
Accounts payable and accrued liabilities	171,606	65,962
Derivative liability - convertible promissory notes	1,352,033	1,646,448
Derivative liability - warrants	395,536	143,375
Due to related party	115,000	115,000
Convertible promissory notes - net of unamortized discount	811,265	533,994
Accrued interest - convertible promissory notes	124,350	60,022
Current liabilities held for sale	6,439	6,696
Total Current Liabilities	2,976,229	2,571,497
DEFICIT Lithium Explorations Group, Inc. Stockholders' Deficit
Capital stock Authorized: 100,000,000 preferred shares, $0.001 par value Issued and outstanding: Nil preferred shares (June 30, 2015 - Nil)	0	0
Capital stock Authorized: 10,000,000,000 (June 30, 2015 - 2,000,000,000) common shares, $0.001 par value Issued and outstanding: 13,670,617 common shares (June 30, 2015 - 7,574,353)	13,663	7,575
Additional paid-in capital	47,890,759	47,383,232
Accumulated other comprehensive loss	(37,432)	(29,484)
Accumulated deficit	(50,457,687)	(49,504,350)
Total Lithium Exploration Group, Inc. Stockholders' Deficit	(2,590,697)	(2,143,027)
Non-controlling interest	(352,092)	(313,450)
Total Deficit	(2,942,789)	(2,456,477)
Total Liabilities and Deficit	$ 33,440	$ 115,020

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2016	Jun. 30, 2015
Preferred Stock, Shares Authorized	100,000,000	100,000,000
Preferred Stock, Par Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Shares Authorized	10,000,000,000	2,000,000,000
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	13,670,617	7,574,353
Common Stock, Shares, Outstanding	13,670,617	7,574,353

XML

Condensed Consolidated Statements of Operations And Comprehensive Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Revenue	$ 0	$ 0	$ 0	$ 0
Operating Expenses:
Mining	0	16,212	5,000	31,212
Selling, general and administrative	63,979	359,236	373,393	944,964
Impairment Loss	0	624,429	0	624,429
Total operating expenses	63,979	999,877	378,393	1,600,605
Loss from operations	(63,979)	(999,877)	(378,393)	(1,600,605)
Other income (expenses)
Interest expense	(97,758)	(297,288)	(699,719)	(1,333,193)
Gain (loss) on change in the fair value of derivative liability	112,247	(1,835,099)	576,533	1,083,198
Amortization of debt discount	(78,688)	101,726	(399,010)	(1,483,168)
Bad-debt write off	0	0	(20,000)	0
(Loss) gain on disposal of business operations	(96)	0	7,468	0
Equity in income (loss) of unconsolidated affiliate	0	(6,469)	0	(324)
Other Income	0	80,524	0	80,524
Loss before income taxes	(128,274)	(2,956,483)	(913,121)	(3,253,568)
Provision for Income Taxes	0	0	0	0
Net loss for the period	(128,274)	(2,956,483)	(913,121)	(3,253,568)
Loss from discontinued operations	(290)	(24,078)	(78,860)	(305,966)
Net loss	(128,564)	(2,980,561)	(991,981)	(3,559,534)
Less:Net loss attributable to the non-controlling interest	(142)	(11,798)	(38,642)	(149,923)
Net loss attributable to Lithium Exploration Group, Inc. Common shareholders	$ (128,422)	$ (2,968,763)	$ (953,339)	$ (3,409,611)
Basic and Diluted loss per Common Share	$ (0.01)	$ (7.43)	$ (0.09)	$ (15.28)
Basic and Diluted Weighted Average Number of Common Shares Outstanding	11,742,168	399,318	10,696,351	223,184
Comprehensive loss:
Net loss	$ (128,564)	$ (2,980,561)	$ (991,980)	$ (3,559,534)
Foreign currency translation adjustment	275	(13,997)	(7,947)	(21,831)
Comprehensive loss	(128,289)	(2,994,558)	(999,927)	(3,581,365)
Comprehensive loss attributable to non-controlling interest	(142)	(11,798)	(38,642)	(149,923)
Comprehensive loss attributable to Lithium Exploration Group, Inc.	$ (128,147)	$ (2,982,760)	$ (961,285)	$ (3,431,442)

XML

Condensed Consolidated Statements of Changes in Stockholders Deficit - 9 months ended Mar. 31, 2016 - USD ($)	Common Shares [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Non-controlling interest [Member]	Total
Beginning Balance at Jun. 30, 2015	$ 7,574	$ 47,383,232	$ (29,485)	$ (49,504,348)	$ (313,450)	$ (2,456,477)
Beginning Balance (Shares) at Jun. 30, 2015	7,574,353
Common shares issued for debt conversion	$ 6,088	145,078				151,166
Common shares issued for debt conversion (Shares)	6,088,220
Common shares issued for the reclassification of derivative liability on convertible notes		302,262				302,262
Common shares issued for fractional shares adjustment	$ 1					1
Common shares issued for fractional shares adjustment (Shares)	8,044
Disposal of business operations		60,187				60,187
Foreign exchange translation			(7,947)			(7,947)
Net loss for the period				(953,339)	(38,642)	(991,981)
Ending Balance at Mar. 31, 2016	$ 13,663	$ 47,890,759	$ (37,432)	$ (50,457,687)	$ (352,092)	$ (2,942,789)
Ending Balance (Shares) at Mar. 31, 2016	13,670,617

XML

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash Flows from Operating Activities
Net loss from continuing operations	$ (913,121)	$ (3,253,568)
Loss from discontinued operations	(78,860)	(305,966)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in income of investment held for sale	0	324
Common shares issued for consulting fees	0	118,991
Non-cash Interest expense	629,248	1,126,957
(Loss) gain on disposal of business operations	(7,468)	0
Impairment Loss	0	624,429
Bad debt written-off	20,000	0
Common shares issued for interest expenses	0	103,048
Gain on change in the fair value of derivative liability	(576,533)	(1,083,198)
Amortization of debt discount	399,010	1,483,168
Common shares issued for investor relations	0	5,000
Changes in operating assets and liabilities:
Receivable, net	13,421	0
Prepaid expenses	0	16,610
Due to related party	0	115,000
Accrued interest	70,471	103,187
Accounts payable and accrued liabilities	105,644	47,178
Net cash used in operating activities from continuing operations	(338,188)	(898,840)
Net cash provided by (used in) operating activities from discontinued operations	51,338	(8,212)
Net cash used in operating activities	(286,850)	(907,052)
Cash Flows from Financing Activities
Repayment to related party	0	(45,332)
Proceed from issuance of convertible promissory notes, net	238,000	954,000
Net cash provided by financing activities	238,000	908,668
Effect of foreign exchange	(7,947)	(21,831)
Decrease in cash and cash equivalents	(56,797)	(20,215)
Cash and cash equivalents - beginning of period	64,098	57,632
Cash and cash equivalents - end of period	7,301	37,417
Cash paid during the period for:
Interest	0	2,205
Income taxes	0	0
Non-cash investing and financing activities:
Common stock issued for debt conversion and interest	151,166	1,499,202
Common stock issued on cashless exercise of warrants	0	2,442,770
Derivative liability re-classed to additional paid in capital	302,262	2,312,157
Debt discount on issuance of convertible note and warrants	230,005	901,327
Initial derivative liability on note issuance and warrants	836,980	2,018,791
Interest reclassed to convertible note	5,680	0
Re-classification of discontinued assets and liabilities to additional paid in capital	$ 60,188	$ 0

XML

Organization

9 Months Ended

Mar. 31, 2016

Organization [Text Block]

1.    Organization

Lithium Exploration Group, Inc. (formerly Mariposa Resources, Ltd.) (the “Company”) was incorporated on May 31, 2006 in the State of Nevada, U.S.A. It is based in Phoenix, Arizona, USA. The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America, and the Company’s fiscal year end is June 30.

Effective November 30, 2010, the Company changed its name to “Lithium Exploration Group, Inc.,” by way of a merger with its wholly-owned subsidiary Lithium Exploration Group, Inc., which was formed solely for the change of name.

A wholly owned subsidiary, 1617437 Alberta Ltd. was incorporated in the province of Alberta, Canada on July 8, 2011. Effective October 2, 2013, the subsidiary changed its name to Alta Disposal Ltd.

On October 18, 2013, the Company acquired 51% interest in Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Ltd.). Effective September 4, 2015, the Company entered into an Asset Purchase Agreement with Cancen Oil Canada whereby the Company agrees to sell all right, title and interest of Alta Disposal Morinville Ltd. assets for total purchase price of CAD$10,000 approximately USD$7,466.

On March 1, 2014, the Company through its 100% subsidiary Alta Disposal Ltd. acquired 50% interest in Tero Oilfield Services Ltd. (the “Tero”) On May 1, 2015, the Company entered into a Share Purchase Agreement with an individual and disposed its 50% interest in Tero.

The Company is engaged principally in the acquisition, exploration, and development of resource properties. Prior to June 25, 2009, the Company had the right to conduct exploration work on 20 mineral mining claims in Esmeralda County, Nevada, U.S.A. On July 31, 2009, the Company acquired an option to enter into a joint venture for the management and ownership of the Jack Creek Project, a mining project located in Elko County, Nevada. On September 25, 2009, the joint venture was terminated and the Company entered into an agreement with Beeston Enterprises Ltd., under which the Company was granted an option to acquire an undivided 50% interest in eight mineral claims located in the Clinton Mining District of British Columbia, Canada. On December 16, 2010, the Company entered into an Assignment Agreement to acquire an undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada (see Note 5). On November 8, 2011, the Company entered into a letter agreement with Glottech-USA. Pursuant to the terms of the agreement, the Company was granted an exclusive license to use and distribute the technology within the Swan Hills region of Alberta as well as a non-exclusive right to distribute the technology within Canada.

XML

Significant Accounting Policies

9 Months Ended

Mar. 31, 2016

Significant Accounting Policies [Text Block]

2.   Significant Accounting Policies

Basis of presentation and consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

These interim financial statements as of and for the nine months ended March 31, 2016 and 2015 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the nine months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to March 31, 2016 and 2015 in these footnotes are unaudited.

These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015.

The condensed consolidated balance sheet as of June 30, 2015 was restated during the period ending September 30, 2015 and has been carried forward for the period ending March 31, 2016, and do not include all disclosures required by the accounting principles generally accepted in the United States of America.

Principal of Consolidation

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework.

Use of Estimates

The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments.

Cash and Cash Equivalents

Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $7,301 and $64,098 in cash and cash equivalents at March 31, 2016 and June 30, 2015, respectively.

Concentration of Risk

The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of March 31, 2016 and June 30, 2015, the Company had no deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts.

Prepaid expenses

Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period.

Start-Up Costs

In accordance with FASC 720-15-20 “ Start-Up Costs,” the Company expenses all costs incurred in connection with the start-up and organization of the Company.

Mineral Acquisition and Exploration Costs

The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves.

Concentrations of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

Net Income or (Loss) per Share of Common Stock

The Company has adopted FASC Topic No. 260, “ Earnings Per Share ,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.

Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive.

Foreign Currency Translations

The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ deficit as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized.

Translation of Foreign Operations

The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows:

-      assets and liabilities are translated at period-end exchange rates prevailing at that reporting date; and
-      income and expenses are translated at average exchange rates for the period.

Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations.

The relevant translation rates are as follows: For the period ending March 31, 2016 closing rate at 0.771 CDN$: US$, average rate at 0.7468 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$.

Comprehensive Income (Loss)

FASC Topic No. 220, “ Comprehensive Income,” establishes standards for reporting and display of comprehensive income and its components in a full set of general-purpose financial statements. As at March 31, 2016 and June 30, 2015, the Company had no material items of other comprehensive income except for the foreign currency translation adjustment.

Risks and Uncertainties

The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure.

Environmental Expenditures

The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures.

Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.

Warrants

The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the unaudited condensed consolidated statements of operations and comprehensive Income (Loss).

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption.

Fair Value of Financial Instruments

ASC 820, “Fair Value Measurements and Disclosures” requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities;

Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and

Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments.

The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

Revenue Recognition

The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required.

Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured.

Income Taxes

The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.

Receivables

Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts.

Recent Accounting Pronouncements

In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.

In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.

FASB Statements:

In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented.

Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.

XML

Capital Stock

9 Months Ended

Mar. 31, 2016

Capital Stock [Text Block]

3.   Capital Stock

On January 19, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 20 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective February 25, 2015.

On July 13, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 200 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective March 31, 2016. Upon effect of the reverse stock split the issued and outstanding shares pre-split as at March 31, 2016 were 2,734,123,494 and the post-split were 13,670,617. The Company’s authorized capital will not be affected by the reverse stock split. The split is reflected retrospectively in the accompanying financial statements.

Authorized Stock

At inception, the Company authorized 100,000,000 common shares and 100,000,000 preferred shares, both with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

On April 8, 2009, the Company increased the number of authorized shares to 600,000,000 shares, of which 500,000,000 shares are designated as common stock par value $0.001 per share, and 100,000,000 shares are designated as preferred stock, par value $0.001 per share.

On October 25, 2012, the Company designated 20,000,000 series A convertible preferred stock with a par value of $0.001 per share and stated value of $100 per share. The designated preferred stock is convertible at the option of the holder, at any time beginning one year from the date such shares are issued, into common stock of the Company with a par value of $0.001. All shares of common stock of the Company, shall be of junior rank to all series A preferred stock in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. All other shares of preferred stock shall be of junior rank to all series A preferred shares in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company.

On January 3, 2014, the Company designated 2,000,000 series B convertible preferred stock with a par value $0.001 per share, issuable only in consideration of the extinguishment of existing debt convertible in to the Company’s common stock with a par value of $0.001. The designated preferred stock shall be issued on the basis of 1 preferred stock for each $1 of convertible debt. The series B convertible preferred stock shall be subordinate to and rank junior to all indebtedness of the Company now or hereafter outstanding.

On October 17, 2014, the Company amended its Articles of Incorporation, which amendment was filed with the Nevada Secretary of State on October 17, 2014, to increase the authorized capital of its common shares from 500,000,000 common shares, par value $0.001 to 2,000,000,000 common shares, par value $0.001.

The Company's authorized capital consists of 2,000,000,000 common shares and 100,000,000 preferred shares, all with a par value of $0.001.

Effective June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of preferred stock as series A preferred stock. The series A preferred stock, par value $0.001, will rank senior to the Company’s common stock, carrying general voting rights with the common stock at the rate of 62 votes per share. The series A preferred stock will be deemed cancelled within 1 year of issuance and are not entitled to share in dividends or other distributions. So long as any shares of series A preferred stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of series A preferred stock will be required for any change to the Company’s Articles of Incorporation.

Effective September 9, 2015, the Company increase the authorized capital of its common shares from 2,000,000,000 common shares, par value $0.001 to 10,000,000,000 common shares, par value $0.001.

Share Issuances

Common Stock Issuance

For the period ended March 31, 2016:

On July 8, 2015, the Company issued 125,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On July 10, 2015, the Company issued 201,465 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On July 21, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On July 22, 2015, the Company issued 100,000 common shares at a deemed price of $0.05 per share for promissory note conversion (Note 6).

On July 29, 2015, the Company issued 298,269 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On August 17, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On September 11, 2015, the Company issued 80,801 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6).

On September 11, 2015, the Company issued 434,084 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On September 15, 2015, the Company issued 438,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On September 18, 2015, the Company issued 486,623 common shares at a deemed price of $0.02 per share for promissory note conversion (Note 6).

On September 18, 2015, the Company issued 475,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On September 18, 2015, the Company issued 394,231 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On October 8, 2015, the Company issued 8,044 common shares at a deemed price of $0.0001 per share to the depository trust as a result of the reverse stock split round-up.

On October 28, 2015 the Company issued 554,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

On March 24, 2016 the Company issued 500,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

On March 28, 2016 the Company issued 600,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6).

On March 29, 2016 the Company issued 450,748 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

On March 30, 2016 the Company issued 450,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6).

Issuances of Preferred Shares

On June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of Preferred Stock as Series “A” Preferred Stock. The Series “A’ Preferred Stock, par value $0.001, ranks senior to the common stock and carries general voting rights with the common stock at the rate of 62 votes per share. The Series “A” Preferred Stock will be deemed cancelled within 1 year of issuance and is not entitled to share in dividends or other distributions. So long as any shares of Series “A” Preferred Stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of Series “A” Preferred Stock will be required for any change to articles of incorporation.

On July 6, 2015, the Company issued 130,000 Series “A” preferred shares in consideration of the release and discharge of a first ranking general security interest over all current and future assets of Alta Disposal Ltd. that was granted to secure to the promissory note entered into on July 22, 2014. These shares were issued at par value of $0.001. These shares were subsequently cancelled on December 5, 2015 therefore the net impact on share capital is nil.

XML

Provision For Income Taxes

9 Months Ended

Mar. 31, 2016

Provision For Income Taxes [Text Block]

4.   Provision for Income Taxes

The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.

Exploration stage deferred tax assets arising as a result of net operating loss carryforwards have been offset completely by a valuation allowance due to the uncertainty of their utilization in future periods. Operating loss carryforwards generated during the period from May 31, 2006 (date of inception) through March 31, 2016 of approximately $13,287,598 will begin to expire in 2026. Accordingly, deferred tax assets were offset by the valuation allowance that increased by approximately $464,277 and $1,130,089 during the periods ended March 31, 2016 and June 30, 2015 respectively.

The Company follows the provisions of uncertain tax positions as addressed in FASC 740-10-65-1. The Company recognized approximately no increase in the liability for unrecognized tax benefits.

The Company has no tax position at March 31, 2016 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the periods presented. The Company had no accruals for interest and penalties at March 31, 2016. The Company’s utilization of any net operating loss carry forward may be unlikely as a result of its intended exploration stage activities. The tax years for June 30, 2015, June 30, 2014, June 30, 2013 and June 30, 2012 are still open for examination by the Internal Revenue Service (IRS).

		For the nine months ended March 31, 2016
		Amount			Tax Effect ( 35%)
Net loss	$	913,120		$	319,592
Shares issued for consulting fees, mining expenses, investor relation and director fees
Interest expense		(699,718	)		(244,901	)
Gain on derivative liability		576,533			201,787
Amortization of debt discount		(399,010	)		(139,654	)
Impairment		7,468			2,614
Total		398,393			139,438
Valuation allowance		(398,393	)		(139,438	)
Net deferred tax asset (liability)	$	-		$	-

		For the nine months ended March 31, 2015
		Amount			Tax Effect ( 35%)
Net loss	$	3,253,568		$	1,138,749
Shares issued for consulting fees, mining expenses, investor relation and director fees		(118,990	)		(41,647	)
Shares issued for interest expenses		(103,048	)		(36,067	)
Amortization of discount		(1,483,168	)		(519,109	)
Interest expense		(1,333,192	)		(466,617	)
Impairment Loss		(624,429	)		(218,550	)
Gain on derivative liability
		1,083,198			379,119
Total		673,938			235,878
Valuation allowance		(673,938	)		(235,878	)
Net deferred tax asset (liability)	$	-		$	-

XML

Mineral Property Costs

9 Months Ended

Mar. 31, 2016

Mineral Property Costs [Text Block]

5.   Mineral Property Costs

Mineral Permit (Assignment Agreement with Lithium Exploration VIII Ltd.)

On December 16, 2010, the Company entered into an Assignment Agreement to acquire the following:

a.)	An undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada.
b.)	All of the assignor’s right, title and interest in and to the Option Agreement.

In consideration for the Assignment, the Company agreed to pay US$90,000 by way of cash or stock of equal value (consisting of amounts previously paid by the Assignor pursuant to the Option Agreement). The full $90,000 (consisting of option payments ‘i’ and ‘v’ below) was expensed and included in the December 31, 2011 accounts payable balance. The Option shall be in good standing and exercisable by the Company by paying the following amounts on or before the dates specified in the following schedule:

i.)	CDN $40,000 (paid) upon execution of the agreement;
ii.)	CDN $60,000 (paid) on or before January 1, 2012;
iii )	CDN $100,000 on or before January 1, 2013 (amended and paid);
iv.)	CDN $300,000 on or before January 1, 2014 (not paid); and
v.)	Paying all such property payments as may be required to maintain the mineral permits in good standing.

The Optionee shall provide a refundable amount of CDN$50,000 (paid) to the Optionor by November 2, 2010, which shall be applied by the Optionor towards work assessment expenses acceptable to the Government of Alberta, with any unused portion to be applied against payments required to maintain the permits underlying the property in good standing.

On December 31, 2012, the Company entered into an agreement to amend the original payment requirement of CDN$100,000 due on January 1, 2013 to the following payments: CDN $20,000 (paid) cash payment due on January 1, 2013 and CDN $80,000 by a 15% one year promissory note starting January 1, 2013. The promissory note is interest free until March 31, 2013. After then, interest will accrue on the principal balance then in arrears at the rate of 15% per annum. No payments shall be payable until December 31, 2013. At any time, the Optionor may elect to convert the remaining balance of CDN $80,000 plus accrued interest into common shares of the Company at 75% of the closing market price of the Company’s common shares on the election day. The full CDN$100,000 (US$95,008) (consisting of cash payment of CDN$20,000 (US$19,164) and note payable of CDN$80,000 (US$75,844) was expensed. The note is subject to be measured at its fair value in accordance with ASC 480-10-25-14. The fair value at issuance was CDN$106,667 (US$101,125) as of June 30, 2013. An additional $26,667 was charged to mining expense during the year June 30, 2013. An interest expense of CDN$3,058 (US$2,899) was accrued as at June 30, 2013. On July 3, 2013, the Optionor elected to convert the promissory note of CDN $80,000 (US$75,844) plus accrued interest of CDN$3,058 (US$2,899) for the total amount of CDN $83,058 (US$78,743) into 239 common shares of the Company at a price of US$330 per share. The January 1, 2014 payment was not paid by the Company, and subsequent to the schedule payment date, the agreement was terminated.

Glottech Technology

On March 17, 2011 and subsequently amended on November 18, 2011, the Company entered into a letter agreement to acquire one initial unit of proprietary and patented mechanical ultrasound technology for use in water purification, inclusive of its process of separating from water, as the primary fluid stock, the salt and other minerals and by –products contained therein, with Glottech – USA.

To acquire the unit, the Company must make the following payments:

a)	US$25,000 upon execution of the agreement (paid);
b)	US$75,000 within 180 days of execution of the agreement (paid);
c)	US$700,000 within 10 days of receipt of invoice from Glottech –USA LLC if the payment in b) is made (paid).
d)	The Company also granted an option to acquire 500 shares for $1.00 to Glottech – USA upon receipt of the operational ultrasonic generator that they are building for Lithium Exploration Group. The 500 shares are to be paid from outstanding shares owned by Alex Walsh, company CEO. During the year ended June 30, 2011, the option resulting in additional mining expenses of $4,940,000 was valued using the fair market value of the shares to be issued. On October 1, 2012, Alex Walsh and GD International entered into an agreement to transfer 500 common shares owned by Alex Walsh to GD International. The shares were received by GD International on October 29, 2012.

Commencing as of the end of an initial sixty day testing and training period following satisfactory delivery and physical setup of the technology, and continuing thereafter for as long as the technology remains in the possession of the Company, the Company shall pay continuing monthly royalties in an amount equal to $2.00 per physical ton of water processed pursuant to the usage of the technology.

On June 12, 2012, the Company filed a complaint with the court of common pleas of Chester County, Pennsylvania against Glottech – USA, LLC, Eldredge, Inc., and the Eldredge Companies, Inc. The complaint seeks an order of the court granting possession of the unit, in its current state, to the Company.

Effective August 14, 2012, the Company entered into an option agreement with GD Glottech-International, Limited (“GD International”) to protect our license and distribution rights in the event that GD-Glottech-USA, LLC (“GD USA”) is unable to perform and honor the obligations contingent to a letter agreement dated November 8, 2011.

Pursuant to the terms of the option agreement, we are required to provide an initial deposit of $150,000 to be held in escrow for the option to obtain a license on the patent rights, as set forth in the option agreement. A further $15,000 was required for exercising the option agreement and it will be credited to future fees when patents rights are exercised. We exerised this option agreement on September 1, 2012 and released the funds to GD International.

On October 1, 2012, the Company entered into a sales agency agreement with GD International. The agreement shall replace all agreements entered previously. Pursuant to the agreement, the Company is appointed as GD International’s sales agent for the technology within the territory. As a consideration, 10,000 common shares of the Company shall be issued to GD International (issued: see d) above). GD International retains all right, title and interest in the technology. The term of this agreement will be an initial period of five years. The term shall be automatically renewable thereafter for successive five year periods provided that the Company has sold not less than 25 or more technology units during each applicable five year period.

On May 2, 2013, the Company entered into an agreement to retain the future use of the unit. Pursuant to the agreement, the Company must make the following payments:

a)	US$20,000 within three days of execution of the agreement (paid);
b)	US$30,000 within three days upon the testing of the unit has been successfully completed.

XML

Convertible Promissory Notes

9 Months Ended

Mar. 31, 2016

Convertible Promissory Notes [Text Block]

6.   Convertible Promissory Notes

Summary of convertible promissory note at March 31, 2016 and June 30, 2015 is as follows:

		June 30,			Principal		Interest		Total converted			Total		March 31, 2016
		2015			Issued		Converted to					repaid
							Principal
February 13, 2013	$	67,913		$	-	$	-	$	(33,680	)	$	-	$	34,233
March 15, 2014		29,394			-		5,681		(29,938	)		-		5,137
July 22, 2014		540,498			-		-		(52,872	)		-		487,626
August 22, 2014		37,242			-		-		(5,200	)		-		32,042
February 6, 2015		75,000			-		-		(26,475	)		-		48,525
February 24, 2015		100,000			-		-					-		100,000
March 3, 2015		29,000			-		-		(3,000	)		-		26,000
August 3, 2015		-			36,000		-		-			-		36,000
September 9, 2015		-			30,000		-		-			-		30,000
September 30, 2015		-			27,000		-		-			-		27,000
November 06,2015		-			12,000		-		-			-		12,000
December 01, 2015		-			18,000		-		-			-		18,000
December 01, 2015		-			18,000		-		-			-		18,000
December 03, 2015		-			17,000		-		-			-		17,000
January 27, 2016		-			24,750		-		-			-		24,750
January 27, 2016		-			5,000		-		-			-		5,000
March 01, 2016		-			13,200		-		-			-		13,200
March 24, 2016		-			12,100		-		-			-		12,100
March 28, 2016		-			40,700		-		-			-		40,700
	$	879,047		$	253,750	$	5,681	$	(151,165	)	$		$	987,313
Less: Unamortized debt discount	$	(345,053	)										$	(176,047	)
Total note payable, net of debt discount	$	533,994											$	811,265
Current portion	$	533,994											$	811,265
Long term portion	$	-											$	-

The Company during the period and subsequently has extended the maturity dates on few of the Convertible Promissory Notes.

On August 3, 2015 the Company issued an aggregate of $36,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $52,720 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	269.35%
Risk free rate:	0.17%

The initial fair values of the embedded debt derivative of $33,231 was allocated as a debt discount up to the proceeds of the note with the remainder $19,489 was charged to current period operations as interest expense.

The note matured during the period however, no repayment was made. An agreement was entered into by the investor and the Company and the maturity of the note has been extended by a year.

On September 9, 2015, the Company issued an aggregate of $30,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $54,495 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	275.84%
Risk free rate:	0.39%

The initial fair values of the embedded debt derivative $30,000 was allocated as a debt discount up to the proceeds of the note with the remainder $24,495 was charged to current period operations as interest expense.

On September 30, 2015, Company issued an aggregate of $27,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $306,808 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	375.79%
Risk free rate:	0.33%

The initial fair values of the embedded debt derivative $27,000 was allocated as a debt discount up to the proceeds of the note with the remainder $279,808 was charged to current period operations as interest expense.

On November 6, 2015, the Company issued an aggregate of $12,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $115,109 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	383.46%
Risk free rate:	0.47%

The initial fair values of the embedded debt derivative of $12,000 was allocated as a debt discount up to the proceeds of the note with the remainder $103,109 charged to operations as interest expense.

On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	392.28%
Risk free rate:	0.51%

The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense.

On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	392.28%
Risk free rate:	0.51%

The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense.

On December 3, 2015, the Company issued an aggregate of $17,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $27,706 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	394.55%
Risk free rate:	0.57%

The initial fair values of the embedded debt derivative of $17,000 was allocated as a debt discount up to the proceeds of the note with the remainder $10,706 charged to operations as interest expense.

On January 27, 2016, the Company issued an aggregate of $24,750 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $45,731 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	383.68%
Risk free rate:	0.47%

The initial fair values of the embedded debt derivative of $22,846 was allocated as a debt discount with the remainder $22,885 charged to operations as interest expense.

On January 27, 2016, the Company issued an aggregate of $5,500 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $9,239 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	383.68%
Risk free rate:	0.47%

The initial fair values of the embedded debt derivative of $4,615 was allocated as a debt discount with the remainder $4,623 charged to operations as interest expense.

On March 01, 2016, the Company issued an aggregate of $13,200 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $29,217 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.68%

The initial fair values of the embedded debt derivative of $13,200 was allocated as a debt discount up to the proceeds of the note with the remainder $16,017 charged to operations as interest expense.

On March 24, 2016, the Company issued an aggregate of $12,100 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $17,671 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.64%

The initial fair values of the embedded debt derivative of $6,515 was allocated as a debt discount with the remainder $11,156 charged to operations as interest expense.

On March 28, 2016, the Company issued an aggregate of $40,700 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $36,293 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions:

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.65%

The initial fair values of the embedded debt derivative of $21,915 was allocated as a debt discount with the remainder $14,378 charged to operations as interest expense.

During the three and nine months period ended March 31, 2016 the Company amortized the debt discount on all the notes of $78,688 and $399,010 to operations as interest expense, respectively.

During the three and nine months period ended March 31, 2015 the Company amortized the debt discount on all the notes of $(101,727) and $1,483,168 to operations as interest income and expense, respectively.

Derivative Liability- Debt

The fair value of the described embedded derivative on all debt was valued at $1,352,033 and $1,646,448 at March 31, 2016 and June 30, 2015, respectively, which was determined using the Black Scholes Model with the following assumptions:

	March 31, 2016	June 30, 2015
Dividend yield:	0%	0%
Volatility	346.6 – 453.3%	258.89%
Risk free rate:	0.39%- 0.66%	0.11% - 0.64%

At March 31, 2016 and 2015, the Company adjusted the recorded fair value of the derivative liability on debt to market resulting in non-cash, non-operating gain of $828,693 and loss of $904,458 for the nine months ended March 31, 2016 and 2015, respectively and for the three months ending March 31, 2016 and March 31, 2015, the non-cash, non-operating loss of $241,359 and $723,955 was recorded respectively.

During the nine months ended March 31, 2016 the Company issued 6,088,220 no of shares of the Company common stock in settlement of $151,165 of convertible note and interest.

During the nine months ended March 31, 2016 the Company reclassed the derivative liability of $302,262 to additional paid in capital on conversion of convertible note.

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of March 31, 2016 and June 30, 2015:

		Derivative
		Liability (convertible
		promissory notes)
Balance, June 30, 2014	$	3,066,171
Initial fair value at note issuances		1,227,384
Fair value of liability at note conversion		(3,174,990	)
Mark-to-market at June 30, 2015		527,883
Balance, June 30, 2015	$	1,646,448
Initial fair value at note issuances		836,980
Fair value of liability at note conversion		(302,262	)
Mark-to-market at March 31, 2016		(829,133	)
Balance, March 31, 2016	$	1,352,033
Net gain for the period included in earnings relating to the liabilities held at March 31, 2016	$	829,133

Derivative Liability- Warrants

Along with the promissory notes, the Company issued warrants that bear a cashless exercise provision. The warrants also include anti-dilution protection with respect to lower priced issuances of common stock or securities convertible or exchangeable into common stock, which provision resulted in derivative liability treatment under ASC 480. The warrants are recorded at fair value using the Black-Scholes option pricing model and marked-to-market at each reporting period, with the changes in the fair value recorded in the consolidated statement of operations and comprehensive income (loss).

During the nine months ended March 31, 2016 no warrants were issued along with convertible note.

The fair value of the described embedded derivative on all warrants was valued at $395,535 at March 31, 2016 and $143,375 at June 30, 2015 which was determined using the Black Scholes Model with the following assumptions:

	March 31, 2016	June 30, 2015
Dividend yield:	0%	0%
Volatility	248.0 – 272.2%	288.96%
Risk free rate:	.87 – 1.21%	1.01 - 1.63%

	Warrants			Weighted	Weighted
	Outstanding			Average	Average
				Exercise	Remaining
				Price	life
Balance, June 30, 2014	15,204		$	242.57	2.62 years
Warrants issued	19,104			236.92	4.46 years
Exercised	(5,927	)		257.08	-
Cancelled	-			-	-
Expired	(1,289	)		240.00	-
Balance, June 30, 2015	27,092		$	100.98	3.79 years
Warrants issued	-			-	-
Exercised	-			-	-
Cancelled	-			-	-
Expired	-			-	-
Balance, March 31, 2016	27,092		$	100.99	3.04 years

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of March 31, 2016 and June 30, 2015:

		Derivative
		Liability (warrants)
Balance, June 30, 2014	$	5,416,000
Initial fair value of warrant derivatives at note issuances		791,407
Fair value of warrant exercised		(2,730,022	)
Mark-to-market at June 30, 2015 – warrant liability		(3,334,009	)
Balance, June 30, 2015	$	143,376
Initial fair value of warrant derivatives at note issuances		-
Fair value of warrant exercised		-
Mark-to-market at March 31, 2016 – warrant liability		252,160
Balance, March 31, 2016	$	395,536
Net loss for the period included in earnings relating to the liabilities held at March 31, 2016	$	252,160

At March 31, 2016 and 2015, the Company adjusted the recorded fair value of the derivative liability on warrants to market resulting in non-cash, non-operating loss of $252,160 and gain of $1,987,656 for the nine months ended March 31, 2016 and 2015, respectively. Non-cash, non-operating gain of $354,046 and loss of $1,111,145 was recorded for the three months ended March 31, 2016 and March 31, 2015 respectively.

During the nine months ended March 31, 2016 the Company reclassed the derivative liability on warrants of $0 to additional paid in capital on exercise of warrants.

XML

Related Party Transactions

9 Months Ended

Mar. 31, 2016

Related Party Transactions [Text Block]

7.   Related Party Transactions

During the nine months ended March 31, 2016, the Company incurred consulting fees of $1,115 (June 30, 2015 - $157,086) with directors and officers out of which there were no stock payments (June 30, 2015 - $58,990 were paid by issuance of 2,167 shares of the Company common stock).

As of March 31, 2016, the Company repaid to a director for a non-interest bearing demand loan of $nil (Note 9) (June 30, 2015 – payable $47,537).

These transactions are in the normal course of operations and are measured at the exchange amount of consideration established and agreed to by the related parties.

XML

Going Concern and Liquidity Considerations

9 Months Ended

Mar. 31, 2016

Going Concern and Liquidity Considerations [Text Block]

8.   Going Concern and Liquidity Considerations

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As at March 31, 2016, the Company had a working capital deficiency of $2,942,788 (June 30, 2015 - $2,456,477) and an accumulated deficit of $50,457,687 (June 30, 2015 - $49,504,350). The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the next twelve months.

The ability of the Company to emerge from the exploration stage is dependent upon, among other things, obtaining additional financing to continue operations, explore and develop the mineral properties and the discovery, development and sale of ore reserves.

In response to these problems, management intends to raise additional funds through public or private placement offerings.

These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML

Commitments and Contingencies

9 Months Ended

Mar. 31, 2016

Commitments and Contingencies [Text Block]

9.   Commitments and Contingencies

Employment Agreements

On January 12, 2014, the Company entered into an employment agreement with a director and officer. Commencing on January 12, 2014, the director and officer will be employed for 24 months ending on January 12, 2016. Pursuant to the agreement, annual salary of US$120,000 is payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock.

Consulting Agreements

On January 1, 2014, the Company entered in a consulting agreement with a consultants to provide services as members of the Board of Directors in regards to the Company’s management and operations. The compensation for the services to be provided will be $12,000 payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. The consulting agreement was amended on October 22, 2014 to include an additional aggregate of $30,000 payable as of October 22, 2014 in cash or in shares of the Company’s common stock, and changed the term of agreement from 12 months to 10 months. Effective November 1, 2014, the consultant resigned as member of the Board of Directors.

On April 28, 2014, the Company entered into a consulting agreement with a consultant to provide services as members of the Board of Directors in regards to the Company’s management and operations. Pursuant to the terms of the agreement, the consultant will receive compensation of $12,000 in unregistered restricted common shares of the Company's common stock at a deemed value of $200.0 per share, issuable on May 15, 2014, effective April 28, 2014 to April 27, 2015. The consultant resigned as member of the Board of Directors and these shares were not issued.

On May 30, 2014, the Company entered into a consulting agreement with a consultant to provide services as member of the Board of Directors in regards to the Company’s management and operation. The compensation for the services to be provided will be $10,000 per month payable in common stock of the Company from a period of six months from the effective date of May 30, 2014.

On August 1, 2014, the Company entered into a consulting agreement with a consultant to provide advice relative to corporate and business services and to perform other related activities. Pursuant to the terms of the agreement, the Company will issue 500 common shares of the Company valued at $68,000. These shares were issued in full effective October 22, 2014.

Lease Commitment

On May 15, 2014, the Company entered into a sublease agreement for a term of twenty four and one half months and expiring on May 31, 2016. Future minimum rental payments required under operating lease (exclusive of other additional rent payments) are $4,563.

Litigation

From time to time we may be a defendant and plaintiff in various other legal proceedings arising in the normal course of our business. Except as disclosed above, we are currently not a party to any material legal proceedings or government actions, including any bankruptcy, receivership, or similar proceedings. In addition, we are not aware of any known litigation or liabilities involving the operators of our properties that could affect our operations. Furthermore, as of the date of this Annual Report, our management is not aware of any proceedings to which any of our directors, officers, or affiliates, or any associate of any such director, officer, affiliate, or security holder is a party adverse to our company or has a material interest adverse to us.

XML

Loan Receivable

9 Months Ended

Mar. 31, 2016

Loan Receivable [Text Block]

10.  Loan Receivable

Secured Bridge Loan Agreement

On December 18, 2013, the Company entered into an agreement with GD Glottech International Ltd (“GDGI”) whereby the Company loaned to GDGI the sum of $20,000. GDGI will repay the total amount of the loan plus interest in the amount of $333.34 (representing a 10% annual interest rate), within sixty (60) days from the receipt of the loan funds or within five (5) days of Sonic Cavitation, LLC receiving a 5% Capital Contribution.

On April 21, 2014, the Company entered into an amended agreement with Sonic Cavitation, whereby Sonic Cavitation agreed to facilitate the construction of one sonic cavitation generator. The Company agreed to pay Sonic Cavitation a consulting fee of $20,000 upon execution of the agreement and forgive the sum of $20,000 debt upon delivery of the prototype by Sonic Cavitation. The agreement has been executed, however the delivery of the prototype has not yet fulfilled.

During the nine months ending March 31, 2016, the directors of the company decided that the loan is irrecoverable and has been written off to $nil.

XML

Discontinued Operations

9 Months Ended

Mar. 31, 2016

Discontinued Operations [Text Block]

11. Discontinued Operations

On September 4, 2015, the Company entered into an Asset Purchase agreement whereby the Company sells the net assets of Alta Disposal Morinville Ltd. (of which the Company had acquired 51% interest on October 18, 2013) for total purchase price of CDN$10,000.

Operating results for the period ended March 31, 2016 and 2015 for Alta Disposal Morinville Ltd. are presented as discontinued operations and the assets and liabilities classified as held for sale are presented separately in the consolidated balance sheet.

A breakdown of the discontinued operations is presented as follow:

Consolidated Statements of Operations and Comprehensive Loss

		March 31, 2016			March 31, 2015
		(unaudited)			(unaudited)
Revenue	$	-		$	54,476
Selling, general and administrative	$	(78,860	)		(363,442	)
Loss from discontinued operations	$	(78,860	)	$	(305,966	)

Consolidated Balance Sheets		March 31, 2016		June 30, 2015
		(unaudited)		(restated)
Current assets:
Cash and cash equivalents	$	5,731	$	46,731
Receivable, net		653		28,160
Prepaid expenses		683		-
GST Receivable		16,284		-
Impairment of net assets		-		(60,178	)
	$	23,351	$	14,713
Current liabilities:
Accounts payable	$	6,439	$	6,696

XML

Subsequent Events

9 Months Ended

Mar. 31, 2016

Subsequent Events [Text Block]

12. Subsequent Events

On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,000, with an issuance discount of $2,500 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On May 16, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,250, with an issuance discount of $2,750 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock.

On August 12, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $42,500, with an issuance discount of $4,250 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock.

On September 1, 2016, our company entered into letter agreements with five separate investors with the intent to buyout their notes and warrants. Pursuant to the terms of the agreement, the investors have agreed to a standstill period until September 16, 2016. The buyout will take place over a six month period of time and will result in an aggregate of $252,856 in debt being retired, an aggregate of $195,500 in warrants being retired and an aggregate buyout amount of $460,000 will be paid over the period. Additionally the Company will also issue an aggregate of $232,500 in new convertible debt. Conversion Price for note will be 65% of the lowest trading price of the Common Stock as reported on the OTC Markets electronic quotation service or such marketplace. Note will have no prepayment penalties and can be purchased from the holder at face value.

On September 2, 2016 our company entered into a bridge loan in the amount of $50,000 with 10% interest per annum due November 2, 2016.

The following conversions took place subsequent to the period ending March 31, 2016.

On April 4, 2016 the Company issued 160,043 common shares at a deemed price of $0.0126 per share for promissory note conversion.

 On April 4, 2016 the Company issued 650,000 common shares at a deemed price of $0.026 per share for promissory note conversion.

On April 4, 2016 the Company issued 641,025 common shares at a deemed price of $0.0252 per share for promissory note conversion.

On April 5, 2016 the Company issued 227,770 common shares at a deemed price of $0.011 per share for promissory note conversion.

On April 6, 2016 the Company issued 490,027 common shares at a deemed price of $0.01807 per share for promissory note conversion.

On April 7, 2016 the Company issued 267,396 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 8, 2016 the Company issued 591,620 common shares at a deemed price of $0.009329 per share for promissory note conversion.

On April 8, 2016 the Company issued 769,230 common shares at a deemed price of $0.0126 per share for promissory note conversion.

On April 11, 2016 the Company issued 500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 12, 2016 the Company issued 776,000 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 13, 2016 the Company issued 775,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 13, 2016 the Company issued 669,222 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 13, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion.

On April 11, 2016 the Company issued 575,327 common shares at a deemed price of $0.010985 per share for promissory note conversion.

On April 14, 2016 the Company issued 790,000 common shares at a deemed price of $0.007500 per share for promissory note conversion.

On April 14, 2016 the Company issued 803,725 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 14, 2016 the Company issued 846,153 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 17, 2016 the Company issued 1,128,205 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 18, 2016 the Company issued 819,493 common shares at a deemed price of $0.010595 per share for promissory note conversion.

On April 19, 2016 the Company issued 850,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 19, 2016 the Company issued 1,041,960 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 19, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion.

On April 20, 2016 the Company issued 750,000 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 21, 2016 the Company issued 469,119 common shares at a deemed price of $0.010595 per share for promissory note conversion.

On April 21, 2016 the Company issued 1,048,416 common shares at a deemed price of $0.007500 per share for promissory note conversion.

On April 22, 2016 the Company issued 1,140,474 common shares at a deemed price of $0.0075 per share for promissory note conversion.

On April 22, 2016 the Company issued 1,100,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 22, 2016 the Company issued 256,410 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On April 26, 2016 the Company issued 923,077 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 26, 2016 the Company issued 1,600,000 common shares at a deemed price of $0.00715 per share for promissory note conversion.

On April 28, 2016 the Company issued 1,500,000 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 28, 2016 the Company issued 1,007,941 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 29, 2016 the Company issued 769,231 common shares at a deemed price of $0.0065 per share for promissory note conversion.

On April 29, 2016 the Company issued 1,214,575 common shares at a deemed price of $0.0076 per share for promissory note conversion.

On April 29, 2016 the Company issued 1,529,480 common shares at a deemed price of $0.007500 per share for promissory note conversion.

On April 29, 2016 the Company issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion.

On May 2, 2016 the Company issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion.

On May 2, 2016 the Company issued 1,514,380 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 3, 2016 the Company issued 1,586,538 common shares at a deemed price of $0.0026 per share for promissory note conversion.

On May 3, 2016 the Company issued 1,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 5, 2016 the Company issued 2,302,321 common shares at a deemed price of $0.00145 per share for promissory note conversion.

On May 5, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 5, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion.

On May 9, 2016 the Company issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion.

On May 9, 2016 the Company issued 5,500,000 common shares at a deemed price of $0.00115 per share for promissory note conversion.

On May 9, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00125 per share for promissory note conversion.

On May 9, 2016, the Company issued 6,100,000 common shares at a deemed price of $0.00075 per share for promissory note conversion $4575.

On May 10, 2016 the Company issued 3,200,000 common shares at a deemed price of $0.000750 per share for promissory note conversion.

On May 10, 2016 the Company issued 3,100,000 common shares at a deemed price of $0.000975 per share for promissory note conversion.

On May 10, 2016 the Company issued 6,600,000 common shares at a deemed price of $0.00075 per share for promissory note conversion.

On May 11, 2016 the Company issued 6,000,000 common shares at a deemed price of $0.00075 per share for promissory note conversion.

On May 11, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion.

On May 12, 2016 the Company issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion.

On May 12, 2016 the Company issued 4,000,000 common shares at a deemed price of $0.000845 per share for promissory note conversion.

On May 13, 2016 the Company issued 9,717,385 common shares at a deemed price of $0.00055 per share for promissory note conversion.

On May 12, 2016 the Company issued 7,900,000 common shares at a deemed price of $0.0065 per share for promissory note conversion.

Subsequent to the issuance of June 30, 2015 financial statements, management determined that the warrants issued were incorrectly valued and derivative liability on the conversion option embedded in convertible notes was not recognized and during the nine months period ending March 31, 2016, these warrants were revalued and a derivative liability on the conversion option was calculated. As a result of revaluation of the warrants, the consolidated balance sheet for the year ending June 30, 2015, the consolidated statements of operations and comprehensive income (loss) and consolidated statement of cash flows for the nine months period ending March 31, 2015 and consolidated statements of changes in stockholders’ deficit for the period ending June 30, 2014 and June 30, 2015 were restated.

The Company has evaluated subsequent events from April 1, 2016, through the date of this report, and determined there are no other items to disclose.

XML

Restatement to previously issued financial statements

9 Months Ended

Mar. 31, 2016

Restatement to previously issued financial statements [Text Block]

13. Restatement to previously issued financial statements

The following tables reflect the corrections to the affected line items in the previously issued financial statements as of and for the years ended June 30, 2015 and for the period ended March 31, 2015.

Effect on Condensed Consolidated Balance Sheet

		Year ended June 30, 2015
		As previously			Effect of			As Restated
		reported			Restatement
ASSETS
Current
Cash and cash equivalents	$	64,099		$	-		$	64,098
Receivable		13,421			-			13,421
Loan receivable		20,000			-			20,000
Prepaid expenses		2,788			-			2,788
Current assets held for sale		14,713			-			14,713
Total current assets		115,021			-			115,020
Total Assets	$	115,021		$	-		$	115,020
LIABILITIES AND DEFICIT
Current
Accounts payable and accrued liabilities	$	65,962		$	-		$	65,962
Derivative liability – warrants		3,134			140,241			143,375
Derivative liability – convertible promissory notes		-			1,646,448			1,646,448
Due to related party		115,000			-			115,000
Convertible promissory notes		300,887			233,107			533,994
Accrued interest – convertible promissory notes		60,022			-			60,022
Liabilities of discontinued operations		6,696			-			6,696
Total Current Liabilities	$	551,701		$	2,019,796		$	2,571,497
STOCKHOLDERS DEFICIT
Capital stock
Nil preferred shares		-			-			-
7,574,353 common shares		7,575			-			7,575
Additional paid-in capital		43,165,743			4,217,489			47,383,232
Accumulated other comprehensive loss		(29,484	)		-			(29,484	)
Deficit accumulated during the exploration		(43,267,064	)		(6,237,285	)		(49,504,349	)
Total Lithium Exploration Group, Inc. Stockholders’ Deficit		(123,230	)		(2,019,796	)		(2,143,027	)
Non-controlling interest		(313,450	)		-			(313,450	)
Total Deficit		(436,680	)		(2,019,796	)		(2,456,477	)
Total Liabilities and Deficit	$	115,021		$	-		$	115,020

Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)

		Nine months ended March 31, 2015
		As previously reported			Effect of Restatement			As Restated
Revenue	$	57,476		$	(57,476	)	$	-
Operating Expenses:
Mining (Notes 3 & 5)		31,212			-			31,212
Selling, general and administrative (Notes 3 & 5)		1,308,405			(363,441	)		944,964
Impairment Loss		624,429			-			624,429
Total operating expenses		1,964,046			(363,441	)		1,600,605
(Loss) from operations		(1,906,570	)		(305,965	)		(1,600,605	)
Other income (expenses)
Interest expense (Note 6)		(2,818,008	)		1,484,816			(1,333,192	)
Other Income		80,524			-			80,524
Gain on change in the fair value of derivative liability (Note 6)		3,638,090			(1,763,485	)		1,874,605
Fair Value of Warrants issued		(962,309	)		170,902			(791,407	)
Amortization of discount on debt discount		-			(1,483,168	)		(1,483,168	)
Equity in income of investment held for sale		(324	)		-			(324	)
Loss before income taxes		(1,968,597	)		(1,284,971	)		(3,253,568	)
Provision for Income Taxes (Note 4)		-			-			-
Loss from continuing operations		(1,968,597	)		(1,284,971	)		(3,253,568	)
Loss from discontinued operations		-			(305,966	)		(305,966	)
Net loss		(1,968,597	)		(1,590,937	)		(3,559,534	)
Less: Net loss attributable to the non-controlling interest		(149,923	)		-			(149,923	)
Net loss attributable to Lithium Exploration Group, Inc. Common shareholders	$	(1,818,674	)	$	(1,590,937	)	$	(3,409,611	)
Basic and Diluted loss per Common Share		0.04			(15.24	)		(15.28	)
Basic and Diluted Weighted Average Number of Common Shares Outstanding		44,636,800			(44,413,616	)		223,184
Comprehensive loss :
Net loss		(1,968,597	)		(1,590,937	)		(3,559,534	)
Foreign currency translation adjustment		(21,831	)		-			(21,831	)
Comprehensive loss		(1,990,428	)		(1,590,937	)		(3,581,365	)
Comprehensive loss attributable to non-controlling interest		(149,923	)		-			(149,923	)
Comprehensive loss attributable to Lithium Exploration Group, Inc.	$	(1,840,505	)	$	(1,590,937	)	$	(3,431,442	)

Effect on Condensed Consolidated Statements of Cash Flows

		Nine months ending March 31, 2015
		As previously			Misstatement			As Restated
		reported			Adjustment
Cash Flows from Operating Activities
Net loss from continuing operations	$	(1,968,597	)	$	(1,284,971	)	$	(3,253,568	)
Loss from discontinued operations		-			(305,966	)		(305,966	)
Adjustments to reconcile net loss to net cash used in operating
activities:
Equity in income of investment held for sale		324			-			324
Common shares issued for consulting fees		118,990			-			118,990
Common shares issued for investor relations		5,000			-			5,000
Interest expense		2,611,775			(1,484,818	)		1,126,957
Amortization of discount on derivative liabilities		-			1,483,168			1,483,168
Bad debt written-off		-			-			-
Common shares issued for interest expenses		103,048			-			103,048
Gain on change in the fair value of derivative liability		(3,638,090	)		1,763,485			(1,874,605	)
Fair value of warrants issued		962,309			(170,902	)		791,407
Due to related party		115,000			-			115,000
Impairment Loss		624,429			-			624,429
Changes in operating assets and liabilities:
Receivable, net		(7,412	)		7,412			-
Prepaid expenses		19,074			(2,464	)		16,610
Accrued interest		103,185			2			103,187
Accounts payable and accrued liabilities		52,968			(5,790	)		47,178
Net cash used in operating activities from continuing operations		(887,997	)		(843	)		(898,840	)
Net cash used in operating activities from discontinued operations		-			(8,212	)		(8,212	)
Net cash used in operating activities		(897,997	)		(9,055	)		(907,052	)
Cash Flows from Financing Activities
Repayment of related party		(45,332	)		-			(45,332	)
Proceed from issuance of convertible promissory notes		954,000			-			954,000
Net cash provided by financing activities		908,668			-			908,668
Effect of foreign exchange		(21,831	)		-			(21,831	)
Decrease in cash and cash equivalents		(11,160	)		(9,055	)		(20,215	)
Cash and cash equivalents - beginning of period		69,732			(12,100	)		57,632
Cash and cash equivalents - end of period	$	58,572			(21,155	)	$	37,417
Supplementary disclosure of cash flow information:
Cash paid during the period for:
Interest	$	2,205			(2,205	)	$	-
Income taxes	$	-					$	-
Supplementary non- cash Investing and Financing Activities:
Non-cash investing and financing activities :
Common stock issued for debt conversion	$	2,536,097		$	(1,036,895	)	$	1,499,202
Transfer of beneficial conversion feature to fair value of note	$	518,808		$	(518,808	)	$	-
Common stock issued on cashless exercise of warrants	$	779,600		$	1,663,170		$	2,442,770
Derivative liability re-classed to additional paid in capital	$	-		$	2,312,157		$	2,312,157
Debt discount on convertible note and warrants	$	-		$	901,327		$	901,327
Initial derivative liability on note issuance	$	-		$	2,018,791		$	2,018,791

Effect on Condensed Consolidated Statements of Changes in Stockholders’ Deficit

		Year ended June 30, 2015
		As previously			Misstatement
		reported			Adjustment			As Restated
Additional Paid in Capital
Beginning Balance	$	38,573,856		$	538,043		$	39,111,899
Common shares issued for debt conversion		3,636,984			(1,457,586	)		2,179,398
Common shares issued for exercise of warrants		767,879			1,962,041			2,729,920
Common shares issued for reclassification of derivative liability on convertible notes		-			3,174,990			3,174,990
Closing Balance	$	43,165,743		$	4,217,488		$	47,383,231
Accumulated deficit
Beginning Balance	$	(40,821,871	)	$	(6,166,108	)	$	(46,987,979	)
Net Income (Loss) for the year		(2,445,193	)		(71,176	)		(2,516,369	)
Closing Balance	$	(43,267,064	)	$	(6,237,283	)	$	(49,504,347	)
Total Equity
Beginning Balance	$	(2,355,136	)	$	(5,628,065	)	$	(7,983,201	)
Common shares issued for consulting fees		118,990						118,990
Common shares issued for investor relations		68,000						68,000
Common shares issued for exercise of warrants		767,981			1,962,039			2,730,020
Common shares issued for debt conversion		3,644,405			(1,457,585	)		2,186,820
Common shares issued for reclassification of derivative
liability on convertible notes		-			3,174,990			3,174,990
Common shares issued to trust		38			-			38
Foreign exchange translation		(23,715	)					(23,715	)
Net Income (Loss) for the year		(2,657,243	)		(71,176	)		(2,728,419	)
Closing Balance	$	(436,680	)	$	(2,019,797	)	$	(2,456,477	)

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Mar. 31, 2016

Basis of presentation and consolidation [Policy Text Block]

Basis of presentation and consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

These interim financial statements as of and for the nine months ended March 31, 2016 and 2015 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the nine months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to March 31, 2016 and 2015 in these footnotes are unaudited.

These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015.

The condensed consolidated balance sheet as of June 30, 2015 was restated during the period ending September 30, 2015 and has been carried forward for the period ending March 31, 2016, and do not include all disclosures required by the accounting principles generally accepted in the United States of America.

Principal of Consolidation [Policy Text Block]

Principal of Consolidation

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework.

Use of Estimates [Policy Text Block]

Use of Estimates

The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments.

Cash and Cash Equivalents [Policy Text Block]

Cash and Cash Equivalents

Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $7,301 and $64,098 in cash and cash equivalents at March 31, 2016 and June 30, 2015, respectively.

Concentration of Risk [Policy Text Block]

Concentration of Risk

The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of March 31, 2016 and June 30, 2015, the Company had no deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts.

Prepaid expenses [Policy Text Block]

Prepaid expenses

Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period.

Start-Up Costs [Policy Text Block]

Start-Up Costs

In accordance with FASC 720-15-20 “ Start-Up Costs,” the Company expenses all costs incurred in connection with the start-up and organization of the Company.

Mineral Acquisition and Exploration Costs [Policy Text Block]

Mineral Acquisition and Exploration Costs

The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves.

Concentrations of Credit Risk [Policy Text Block]

Concentrations of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

Net Income or (Loss) per Share of Common Stock [Policy Text Block]

Net Income or (Loss) per Share of Common Stock

The Company has adopted FASC Topic No. 260, “ Earnings Per Share ,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.

Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive.

Foreign Currency Translations [Policy Text Block]

Foreign Currency Translations

The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ deficit as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized.

Translation of Foreign Operations

The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows:

-      assets and liabilities are translated at period-end exchange rates prevailing at that reporting date; and
-      income and expenses are translated at average exchange rates for the period.

Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations.

The relevant translation rates are as follows: For the period ending March 31, 2016 closing rate at 0.771 CDN$: US$, average rate at 0.7468 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$.

Comprehensive Income (Loss) [Policy Text Block]

Comprehensive Income (Loss)

FASC Topic No. 220, “ Comprehensive Income,” establishes standards for reporting and display of comprehensive income and its components in a full set of general-purpose financial statements. As at March 31, 2016 and June 30, 2015, the Company had no material items of other comprehensive income except for the foreign currency translation adjustment.

Risks and Uncertainties [Policy Text Block]

Risks and Uncertainties

The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure.

Environmental Expenditures [Policy Text Block]

Environmental Expenditures

The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures.

Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.

Warrants [Policy Text Block]

Warrants

The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the unaudited condensed consolidated statements of operations and comprehensive Income (Loss).

Convertible Instruments [Policy Text Block]

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption.

Fair Value of Financial Instruments [Policy Text Block]

Fair Value of Financial Instruments

ASC 820, “Fair Value Measurements and Disclosures” requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities;

Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and

Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments.

The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

Revenue Recognition [Policy Text Block]

Revenue Recognition

The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required.

Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured.

Income Taxes [Policy Text Block]

Income Taxes

The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.

Receivables [Policy Text Block]

Receivables

Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts.

Recent Accounting Pronouncements [Policy Text Block]

Recent Accounting Pronouncements

In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.

In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.

FASB Statements [Policy Text Block]

FASB Statements:

In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented.

Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.

XML

Provision For Income Taxes (Tables)

9 Months Ended

Mar. 31, 2016

Mar. 31, 2015

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

		For the nine months ended March 31, 2016
		Amount			Tax Effect ( 35%)
Net loss	$	913,120		$	319,592
Shares issued for consulting fees, mining expenses, investor relation and director fees
Interest expense		(699,718	)		(244,901	)
Gain on derivative liability		576,533			201,787
Amortization of debt discount		(399,010	)		(139,654	)
Impairment		7,468			2,614
Total		398,393			139,438
Valuation allowance		(398,393	)		(139,438	)
Net deferred tax asset (liability)	$	-		$	-

		For the nine months ended March 31, 2015
		Amount			Tax Effect ( 35%)
Net loss	$	3,253,568		$	1,138,749
Shares issued for consulting fees, mining expenses, investor relation and director fees		(118,990	)		(41,647	)
Shares issued for interest expenses		(103,048	)		(36,067	)
Amortization of discount		(1,483,168	)		(519,109	)
Interest expense		(1,333,192	)		(466,617	)
Impairment Loss		(624,429	)		(218,550	)
Gain on derivative liability
		1,083,198			379,119
Total		673,938			235,878
Valuation allowance		(673,938	)		(235,878	)
Net deferred tax asset (liability)	$	-		$	-

XML

Convertible Promissory Notes (Tables)

9 Months Ended

Mar. 31, 2016

Schedule of Summary of Convertible Promissory Note [Table Text Block]

		June 30,			Principal		Interest		Total converted			Total		March 31, 2016
		2015			Issued		Converted to					repaid
							Principal
February 13, 2013	$	67,913		$	-	$	-	$	(33,680	)	$	-	$	34,233
March 15, 2014		29,394			-		5,681		(29,938	)		-		5,137
July 22, 2014		540,498			-		-		(52,872	)		-		487,626
August 22, 2014		37,242			-		-		(5,200	)		-		32,042
February 6, 2015		75,000			-		-		(26,475	)		-		48,525
February 24, 2015		100,000			-		-					-		100,000
March 3, 2015		29,000			-		-		(3,000	)		-		26,000
August 3, 2015		-			36,000		-		-			-		36,000
September 9, 2015		-			30,000		-		-			-		30,000
September 30, 2015		-			27,000		-		-			-		27,000
November 06,2015		-			12,000		-		-			-		12,000
December 01, 2015		-			18,000		-		-			-		18,000
December 01, 2015		-			18,000		-		-			-		18,000
December 03, 2015		-			17,000		-		-			-		17,000
January 27, 2016		-			24,750		-		-			-		24,750
January 27, 2016		-			5,000		-		-			-		5,000
March 01, 2016		-			13,200		-		-			-		13,200
March 24, 2016		-			12,100		-		-			-		12,100
March 28, 2016		-			40,700		-		-			-		40,700
	$	879,047		$	253,750	$	5,681	$	(151,165	)	$		$	987,313
Less: Unamortized debt discount	$	(345,053	)										$	(176,047	)
Total note payable, net of debt discount	$	533,994											$	811,265
Current portion	$	533,994											$	811,265
Long term portion	$	-											$	-

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	March 31, 2016	June 30, 2015
Dividend yield:	0%	0%
Volatility	346.6 – 453.3%	258.89%
Risk free rate:	0.39%- 0.66%	0.11% - 0.64%

Schedule of Changes in Fair Value of Convertible Promissory Notes [Table Text Block]

		Derivative
		Liability (convertible
		promissory notes)
Balance, June 30, 2014	$	3,066,171
Initial fair value at note issuances		1,227,384
Fair value of liability at note conversion		(3,174,990	)
Mark-to-market at June 30, 2015		527,883
Balance, June 30, 2015	$	1,646,448
Initial fair value at note issuances		836,980
Fair value of liability at note conversion		(302,262	)
Mark-to-market at March 31, 2016		(829,133	)
Balance, March 31, 2016	$	1,352,033
Net gain for the period included in earnings relating to the liabilities held at March 31, 2016	$	829,133

Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block]

	March 31, 2016	June 30, 2015
Dividend yield:	0%	0%
Volatility	248.0 – 272.2%	288.96%
Risk free rate:	.87 – 1.21%	1.01 - 1.63%

Schedule of Stockholders' Equity Warrants Activity [Table Text Block]

	Warrants			Weighted	Weighted
	Outstanding			Average	Average
				Exercise	Remaining
				Price	life
Balance, June 30, 2014	15,204		$	242.57	2.62 years
Warrants issued	19,104			236.92	4.46 years
Exercised	(5,927	)		257.08	-
Cancelled	-			-	-
Expired	(1,289	)		240.00	-
Balance, June 30, 2015	27,092		$	100.98	3.79 years
Warrants issued	-			-	-
Exercised	-			-	-
Cancelled	-			-	-
Expired	-			-	-
Balance, March 31, 2016	27,092		$	100.99	3.04 years

Schedule of Changes in Fair Value of Financial Liabilities [Table Text Block]

		Derivative
		Liability (warrants)
Balance, June 30, 2014	$	5,416,000
Initial fair value of warrant derivatives at note issuances		791,407
Fair value of warrant exercised		(2,730,022	)
Mark-to-market at June 30, 2015 – warrant liability		(3,334,009	)
Balance, June 30, 2015	$	143,376
Initial fair value of warrant derivatives at note issuances		-
Fair value of warrant exercised		-
Mark-to-market at March 31, 2016 – warrant liability		252,160
Balance, March 31, 2016	$	395,536
Net loss for the period included in earnings relating to the liabilities held at March 31, 2016	$	252,160

August 3, 2015 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	269.35%
Risk free rate:	0.17%

September 9, 2015 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	275.84%
Risk free rate:	0.39%

September 30, 2015 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	375.79%
Risk free rate:	0.33%

November 6, 2015 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	383.46%
Risk free rate:	0.47%

December 1, 2015 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	392.28%
Risk free rate:	0.51%

December 1, 2015 Embedded Derivatives (2) [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	392.28%
Risk free rate:	0.51%

December 3, 2015 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	394.55%
Risk free rate:	0.57%

January 27, 2016 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	383.68%
Risk free rate:	0.47%

January 27, 2016 Embedded Derivatives (2) [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	383.68%
Risk free rate:	0.47%

March 1, 2016 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.68%

March 24, 2016 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.64%

March 28, 2016 Embedded Derivatives [Member]

Schedule of Valuation Assumptions [Table Text Block]

Dividend yield:	0%
Volatility	371.21%
Risk free rate:	0.65%

XML

Discontinued Operations (Tables)

9 Months Ended

Mar. 31, 2016

Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss [Table Text Block]

		March 31, 2016			March 31, 2015
		(unaudited)			(unaudited)
Revenue	$	-		$	54,476
Selling, general and administrative	$	(78,860	)		(363,442	)
Loss from discontinued operations	$	(78,860	)	$	(305,966	)

Schedule of Discontinued Operations, Consolidated Balance Sheets [Table Text Block]

Consolidated Balance Sheets		March 31, 2016		June 30, 2015
		(unaudited)		(restated)
Current assets:
Cash and cash equivalents	$	5,731	$	46,731
Receivable, net		653		28,160
Prepaid expenses		683		-
GST Receivable		16,284		-
Impairment of net assets		-		(60,178	)
	$	23,351	$	14,713
Current liabilities:
Accounts payable	$	6,439	$	6,696

XML

Restatement to previously issued financial statements (Tables)

9 Months Ended

Mar. 31, 2016

Schedule of Effect on Condensed Consolidated Balance Sheet [Table Text Block]

		Year ended June 30, 2015
		As previously			Effect of			As Restated
		reported			Restatement
ASSETS
Current
Cash and cash equivalents	$	64,099		$	-		$	64,098
Receivable		13,421			-			13,421
Loan receivable		20,000			-			20,000
Prepaid expenses		2,788			-			2,788
Current assets held for sale		14,713			-			14,713
Total current assets		115,021			-			115,020
Total Assets	$	115,021		$	-		$	115,020
LIABILITIES AND DEFICIT
Current
Accounts payable and accrued liabilities	$	65,962		$	-		$	65,962
Derivative liability – warrants		3,134			140,241			143,375
Derivative liability – convertible promissory notes		-			1,646,448			1,646,448
Due to related party		115,000			-			115,000
Convertible promissory notes		300,887			233,107			533,994
Accrued interest – convertible promissory notes		60,022			-			60,022
Liabilities of discontinued operations		6,696			-			6,696
Total Current Liabilities	$	551,701		$	2,019,796		$	2,571,497
STOCKHOLDERS DEFICIT
Capital stock
Nil preferred shares		-			-			-
7,574,353 common shares		7,575			-			7,575
Additional paid-in capital		43,165,743			4,217,489			47,383,232
Accumulated other comprehensive loss		(29,484	)		-			(29,484	)
Deficit accumulated during the exploration		(43,267,064	)		(6,237,285	)		(49,504,349	)
Total Lithium Exploration Group, Inc. Stockholders’ Deficit		(123,230	)		(2,019,796	)		(2,143,027	)
Non-controlling interest		(313,450	)		-			(313,450	)
Total Deficit		(436,680	)		(2,019,796	)		(2,456,477	)
Total Liabilities and Deficit	$	115,021		$	-		$	115,020

Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) [Table Text Block]

		Nine months ended March 31, 2015
		As previously reported			Effect of Restatement			As Restated
Revenue	$	57,476		$	(57,476	)	$	-
Operating Expenses:
Mining (Notes 3 & 5)		31,212			-			31,212
Selling, general and administrative (Notes 3 & 5)		1,308,405			(363,441	)		944,964
Impairment Loss		624,429			-			624,429
Total operating expenses		1,964,046			(363,441	)		1,600,605
(Loss) from operations		(1,906,570	)		(305,965	)		(1,600,605	)
Other income (expenses)
Interest expense (Note 6)		(2,818,008	)		1,484,816			(1,333,192	)
Other Income		80,524			-			80,524
Gain on change in the fair value of derivative liability (Note 6)		3,638,090			(1,763,485	)		1,874,605
Fair Value of Warrants issued		(962,309	)		170,902			(791,407	)
Amortization of discount on debt discount		-			(1,483,168	)		(1,483,168	)
Equity in income of investment held for sale		(324	)		-			(324	)
Loss before income taxes		(1,968,597	)		(1,284,971	)		(3,253,568	)
Provision for Income Taxes (Note 4)		-			-			-
Loss from continuing operations		(1,968,597	)		(1,284,971	)		(3,253,568	)
Loss from discontinued operations		-			(305,966	)		(305,966	)
Net loss		(1,968,597	)		(1,590,937	)		(3,559,534	)
Less: Net loss attributable to the non-controlling interest		(149,923	)		-			(149,923	)
Net loss attributable to Lithium Exploration Group, Inc. Common shareholders	$	(1,818,674	)	$	(1,590,937	)	$	(3,409,611	)
Basic and Diluted loss per Common Share		0.04			(15.24	)		(15.28	)
Basic and Diluted Weighted Average Number of Common Shares Outstanding		44,636,800			(44,413,616	)		223,184
Comprehensive loss :
Net loss		(1,968,597	)		(1,590,937	)		(3,559,534	)
Foreign currency translation adjustment		(21,831	)		-			(21,831	)
Comprehensive loss		(1,990,428	)		(1,590,937	)		(3,581,365	)
Comprehensive loss attributable to non-controlling interest		(149,923	)		-			(149,923	)
Comprehensive loss attributable to Lithium Exploration Group, Inc.	$	(1,840,505	)	$	(1,590,937	)	$	(3,431,442	)

Schedule of Effect on Condensed Consolidated Statements of Cash Flows [Table Text Block]

		Nine months ending March 31, 2015
		As previously			Misstatement			As Restated
		reported			Adjustment
Cash Flows from Operating Activities
Net loss from continuing operations	$	(1,968,597	)	$	(1,284,971	)	$	(3,253,568	)
Loss from discontinued operations		-			(305,966	)		(305,966	)
Adjustments to reconcile net loss to net cash used in operating
activities:
Equity in income of investment held for sale		324			-			324
Common shares issued for consulting fees		118,990			-			118,990
Common shares issued for investor relations		5,000			-			5,000
Interest expense		2,611,775			(1,484,818	)		1,126,957
Amortization of discount on derivative liabilities		-			1,483,168			1,483,168
Bad debt written-off		-			-			-
Common shares issued for interest expenses		103,048			-			103,048
Gain on change in the fair value of derivative liability		(3,638,090	)		1,763,485			(1,874,605	)
Fair value of warrants issued		962,309			(170,902	)		791,407
Due to related party		115,000			-			115,000
Impairment Loss		624,429			-			624,429
Changes in operating assets and liabilities:
Receivable, net		(7,412	)		7,412			-
Prepaid expenses		19,074			(2,464	)		16,610
Accrued interest		103,185			2			103,187
Accounts payable and accrued liabilities		52,968			(5,790	)		47,178
Net cash used in operating activities from continuing operations		(887,997	)		(843	)		(898,840	)
Net cash used in operating activities from discontinued operations		-			(8,212	)		(8,212	)
Net cash used in operating activities		(897,997	)		(9,055	)		(907,052	)
Cash Flows from Financing Activities
Repayment of related party		(45,332	)		-			(45,332	)
Proceed from issuance of convertible promissory notes		954,000			-			954,000
Net cash provided by financing activities		908,668			-			908,668
Effect of foreign exchange		(21,831	)		-			(21,831	)
Decrease in cash and cash equivalents		(11,160	)		(9,055	)		(20,215	)
Cash and cash equivalents - beginning of period		69,732			(12,100	)		57,632
Cash and cash equivalents - end of period	$	58,572			(21,155	)	$	37,417
Supplementary disclosure of cash flow information:
Cash paid during the period for:
Interest	$	2,205			(2,205	)	$	-
Income taxes	$	-					$	-
Supplementary non- cash Investing and Financing Activities:
Non-cash investing and financing activities :
Common stock issued for debt conversion	$	2,536,097		$	(1,036,895	)	$	1,499,202
Transfer of beneficial conversion feature to fair value of note	$	518,808		$	(518,808	)	$	-
Common stock issued on cashless exercise of warrants	$	779,600		$	1,663,170		$	2,442,770
Derivative liability re-classed to additional paid in capital	$	-		$	2,312,157		$	2,312,157
Debt discount on convertible note and warrants	$	-		$	901,327		$	901,327
Initial derivative liability on note issuance	$	-		$	2,018,791		$	2,018,791

Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit [Table Text Block]

		Year ended June 30, 2015
		As previously			Misstatement
		reported			Adjustment			As Restated
Additional Paid in Capital
Beginning Balance	$	38,573,856		$	538,043		$	39,111,899
Common shares issued for debt conversion		3,636,984			(1,457,586	)		2,179,398
Common shares issued for exercise of warrants		767,879			1,962,041			2,729,920
Common shares issued for reclassification of derivative liability on convertible notes		-			3,174,990			3,174,990
Closing Balance	$	43,165,743		$	4,217,488		$	47,383,231
Accumulated deficit
Beginning Balance	$	(40,821,871	)	$	(6,166,108	)	$	(46,987,979	)
Net Income (Loss) for the year		(2,445,193	)		(71,176	)		(2,516,369	)
Closing Balance	$	(43,267,064	)	$	(6,237,283	)	$	(49,504,347	)
Total Equity
Beginning Balance	$	(2,355,136	)	$	(5,628,065	)	$	(7,983,201	)
Common shares issued for consulting fees		118,990						118,990
Common shares issued for investor relations		68,000						68,000
Common shares issued for exercise of warrants		767,981			1,962,039			2,730,020
Common shares issued for debt conversion		3,644,405			(1,457,585	)		2,186,820
Common shares issued for reclassification of derivative
liability on convertible notes		-			3,174,990			3,174,990
Common shares issued to trust		38			-			38
Foreign exchange translation		(23,715	)					(23,715	)
Net Income (Loss) for the year		(2,657,243	)		(71,176	)		(2,728,419	)
Closing Balance	$	(436,680	)	$	(2,019,797	)	$	(2,456,477	)

XML

Organization (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)	Mar. 31, 2016 CAD
Organization 1	1,617,437	1,617,437
Organization 2	51.00%	51.00%
Organization 3 | CAD		CAD 10,000
Organization 4 | $	$ 7,466
Organization 5	100.00%	100.00%
Organization 6	50.00%	50.00%
Organization 7	50.00%	50.00%
Organization 8	20	20
Organization 9	50.00%	50.00%
Organization 10	100.00%	100.00%

XML

Significant Accounting Policies (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Significant Accounting Policies 1	51.00%
Significant Accounting Policies 2	$ 7,301
Significant Accounting Policies 3	$ 64,098
Significant Accounting Policies 4	0.771
Significant Accounting Policies 5	0.7468
Significant Accounting Policies 6	0.8017
Significant Accounting Policies 7	0.8518
Significant Accounting Policies 8	$ 0
Significant Accounting Policies 9	$ 18,984

XML

Capital Stock (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($) yr $ / shares shares
Capital Stock 1	20
Capital Stock 2	1
Capital Stock 3	200
Capital Stock 4	1
Capital Stock 5	2,734,123,494
Capital Stock 6	13,670,617
Capital Stock 7	100,000,000
Capital Stock 8	100,000,000
Capital Stock 9 | $ / shares	$ 0.001
Capital Stock 10	600,000,000
Capital Stock 11	500,000,000
Capital Stock 12 | $ / shares	$ 0.001
Capital Stock 13	100,000,000
Capital Stock 14 | $ / shares	$ 0.001
Capital Stock 15	20,000,000
Capital Stock 16 | $ / shares	$ 0.001
Capital Stock 17 | $ / shares	$ 100
Capital Stock 18 | $	$ 0.001
Capital Stock 19	2,000,000
Capital Stock 20 | $ / shares	$ 0.001
Capital Stock 21 | $	$ 0.001
Capital Stock 22	1
Capital Stock 23 | $	$ 1
Capital Stock 24	500,000,000
Capital Stock 25 | $	$ 0.001
Capital Stock 26	2,000,000,000
Capital Stock 27 | $	$ 0.001
Capital Stock 28	2,000,000,000
Capital Stock 29	100,000,000
Capital Stock 30 | $	$ 0.001
Capital Stock 31	50,000,000
Capital Stock 32	100,000,000
Capital Stock 33 | $	$ 0.001
Capital Stock 34	62
Capital Stock 35 | yr	1
Capital Stock 36	75.00%
Capital Stock 37	2,000,000,000
Capital Stock 38 | $	$ 0.001
Capital Stock 39	10,000,000,000
Capital Stock 40 | $	$ 0.001
Capital Stock 41	125,000
Capital Stock 42 | $ / shares	$ 0.04
Capital Stock 43	201,465
Capital Stock 44 | $ / shares	$ 0.04
Capital Stock 45	250,000
Capital Stock 46 | $ / shares	$ 0.04
Capital Stock 47	100,000
Capital Stock 48 | $ / shares	$ 0.05
Capital Stock 49	298,269
Capital Stock 50 | $ / shares	$ 0.04
Capital Stock 51	250,000
Capital Stock 52 | $ / shares	$ 0.04
Capital Stock 53	80,801
Capital Stock 54 | $ / shares	$ 0.04
Capital Stock 55	434,084
Capital Stock 56 | $ / shares	$ 0.03
Capital Stock 57	438,000
Capital Stock 58 | $ / shares	$ 0.03
Capital Stock 59	486,623
Capital Stock 60 | $ / shares	$ 0.02
Capital Stock 61	475,000
Capital Stock 62 | $ / shares	$ 0.03
Capital Stock 63	394,231
Capital Stock 64 | $ / shares	$ 0.03
Capital Stock 65	8,044
Capital Stock 66 | $ / shares	$ 0.0001
Capital Stock 67	554,000
Capital Stock 68 | $ / shares	$ 0.01
Capital Stock 69	500,000
Capital Stock 70 | $ / shares	$ 0.01
Capital Stock 71	600,000
Capital Stock 72 | $ / shares	$ 0.03
Capital Stock 73	450,748
Capital Stock 74 | $ / shares	$ 0.01
Capital Stock 75	450,000
Capital Stock 76 | $ / shares	$ 0.01
Capital Stock 77	50,000,000
Capital Stock 78	100,000,000
Capital Stock 79 | $	$ 0.001
Capital Stock 80	62
Capital Stock 81 | yr	1
Capital Stock 82	75.00%
Capital Stock 83	130,000
Capital Stock 84 | $	$ 0.001
Capital Stock 85	0

XML

Provision For Income Taxes (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Provision For Income Taxes 1	$ 13,287,598
Provision For Income Taxes 2	464,277
Provision For Income Taxes 3	$ 1,130,089

XML

Mineral Property Costs (Narrative) (Details) - 9 months ended Mar. 31, 2016	USD ($) d $ / shares shares	CAD d shares
Mineral Property Costs 1	100.00%	100.00%
Mineral Property Costs 2	$ 90,000
Mineral Property Costs 3	$ 90,000
Mineral Property Costs 4 | CAD		CAD 40,000
Mineral Property Costs 5 | CAD		60,000
Mineral Property Costs 6 | CAD		100,000
Mineral Property Costs 7 | CAD		300,000
Mineral Property Costs 8 | CAD		50,000
Mineral Property Costs 9 | CAD		100,000
Mineral Property Costs 10 | CAD		20,000
Mineral Property Costs 11 | CAD		CAD 80,000
Mineral Property Costs 12	15.00%	15.00%
Mineral Property Costs 13	15.00%	15.00%
Mineral Property Costs 14 | CAD		CAD 80,000
Mineral Property Costs 15	75.00%	75.00%
Mineral Property Costs 16 | CAD		CAD 100,000
Mineral Property Costs 17	$ 95,008
Mineral Property Costs 18 | CAD		20,000
Mineral Property Costs 19	19,164
Mineral Property Costs 20 | CAD		80,000
Mineral Property Costs 21	75,844
Mineral Property Costs 22 | CAD		106,667
Mineral Property Costs 23	101,125
Mineral Property Costs 24	26,667
Mineral Property Costs 25 | CAD		3,058
Mineral Property Costs 26	2,899
Mineral Property Costs 27 | CAD		80,000
Mineral Property Costs 28	75,844
Mineral Property Costs 29 | CAD		3,058
Mineral Property Costs 30	2,899
Mineral Property Costs 31 | CAD		CAD 83,058
Mineral Property Costs 32	$ 78,743
Mineral Property Costs 33 | shares	239	239
Mineral Property Costs 34 | $ / shares	$ 330
Mineral Property Costs 35	$ 25,000
Mineral Property Costs 36	$ 75,000
Mineral Property Costs 37 | d	180	180
Mineral Property Costs 38	$ 700,000
Mineral Property Costs 39 | d	10	10
Mineral Property Costs 40 | shares	500	500
Mineral Property Costs 41	$ 1.00
Mineral Property Costs 42 | shares	500	500
Mineral Property Costs 43	$ 4,940,000
Mineral Property Costs 44 | shares	500	500
Mineral Property Costs 45	$ 2.00
Mineral Property Costs 46	150,000
Mineral Property Costs 47	$ 15,000
Mineral Property Costs 48 | shares	10,000	10,000
Mineral Property Costs 49	25	25
Mineral Property Costs 50	$ 20,000
Mineral Property Costs 51	$ 30,000

XML

Convertible Promissory Notes (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Convertible Promissory Notes 1	$ 36,000
Convertible Promissory Notes 2	10.00%
Convertible Promissory Notes 3	$ 52,720
Convertible Promissory Notes 4	33,231
Convertible Promissory Notes 5	19,489
Convertible Promissory Notes 6	$ 30,000
Convertible Promissory Notes 7	10.00%
Convertible Promissory Notes 8	$ 54,495
Convertible Promissory Notes 9	30,000
Convertible Promissory Notes 10	24,495
Convertible Promissory Notes 11	$ 27,000
Convertible Promissory Notes 12	10.00%
Convertible Promissory Notes 13	$ 306,808
Convertible Promissory Notes 14	27,000
Convertible Promissory Notes 15	279,808
Convertible Promissory Notes 16	12,000
Convertible Promissory Notes 17	115,109
Convertible Promissory Notes 18	12,000
Convertible Promissory Notes 19	103,109
Convertible Promissory Notes 20	18,000
Convertible Promissory Notes 21	72,119
Convertible Promissory Notes 22	18,000
Convertible Promissory Notes 23	54,119
Convertible Promissory Notes 24	18,000
Convertible Promissory Notes 25	72,119
Convertible Promissory Notes 26	18,000
Convertible Promissory Notes 27	54,119
Convertible Promissory Notes 28	17,000
Convertible Promissory Notes 29	27,706
Convertible Promissory Notes 30	17,000
Convertible Promissory Notes 31	10,706
Convertible Promissory Notes 32	24,750
Convertible Promissory Notes 33	45,731
Convertible Promissory Notes 34	22,846
Convertible Promissory Notes 35	22,885
Convertible Promissory Notes 36	5,500
Convertible Promissory Notes 37	9,239
Convertible Promissory Notes 38	4,615
Convertible Promissory Notes 39	4,623
Convertible Promissory Notes 40	13,200
Convertible Promissory Notes 41	29,217
Convertible Promissory Notes 42	13,200
Convertible Promissory Notes 43	16,017
Convertible Promissory Notes 44	12,100
Convertible Promissory Notes 45	17,671
Convertible Promissory Notes 46	6,515
Convertible Promissory Notes 47	11,156
Convertible Promissory Notes 48	40,700
Convertible Promissory Notes 49	36,293
Convertible Promissory Notes 50	21,915
Convertible Promissory Notes 51	14,378
Convertible Promissory Notes 52	78,688
Convertible Promissory Notes 53	399,010
Convertible Promissory Notes 54	(101,727)
Convertible Promissory Notes 55	1,483,168
Convertible Promissory Notes 56	1,352,033
Convertible Promissory Notes 57	1,646,448
Convertible Promissory Notes 58	828,693
Convertible Promissory Notes 59	904,458
Convertible Promissory Notes 60	241,359
Convertible Promissory Notes 61	$ 723,955
Convertible Promissory Notes 62	6,088,220
Convertible Promissory Notes 63	$ 151,165
Convertible Promissory Notes 64	302,262
Convertible Promissory Notes 65	395,535
Convertible Promissory Notes 66	143,375
Convertible Promissory Notes 67	252,160
Convertible Promissory Notes 68	1,987,656
Convertible Promissory Notes 69	354,046
Convertible Promissory Notes 70	1,111,145
Convertible Promissory Notes 71	$ 0

XML

Related Party Transactions (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($) shares
Related Party Transactions 1	$ 1,115
Related Party Transactions 2	157,086
Related Party Transactions 3	$ 58,990
Related Party Transactions 4 | shares	2,167
Related Party Transactions 5	$ 0
Related Party Transactions 6	$ 47,537

XML

Going Concern and Liquidity Considerations (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Going Concern And Liquidity Considerations 1	$ 2,942,788
Going Concern And Liquidity Considerations 2	2,456,477
Going Concern And Liquidity Considerations 3	50,457,687
Going Concern And Liquidity Considerations 4	$ 49,504,350

XML

Commitments and Contingencies (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($) mo $ / shares $ / mo shares
Commitments And Contingencies 1 | mo	24
Commitments And Contingencies 2	$ 120,000
Commitments And Contingencies 3	12,000
Commitments And Contingencies 4	$ 30,000
Commitments And Contingencies 5 | mo	12
Commitments And Contingencies 6 | mo	10
Commitments And Contingencies 7	$ 12,000
Commitments And Contingencies 8 | $ / shares	$ 200
Commitments And Contingencies 9 | $ / mo	10,000
Commitments And Contingencies 10 | shares	500
Commitments And Contingencies 11	$ 68,000
Commitments And Contingencies 12	$ 4,563

XML

Loan Receivable (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Loan Receivable 1	$ 20,000
Loan Receivable 2	$ 333.34
Loan Receivable 3	10.00%
Loan Receivable 4	5.00%
Loan Receivable 5	$ 20,000
Loan Receivable 6	20,000
Loan Receivable 7	$ 0

XML

Discontinued Operations (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 CAD
Discontinued Operations 1	51.00%
Discontinued Operations 2	CAD 10,000

XML

Subsequent Events (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($) $ / shares shares
Subsequent Events 1	10.00%
Subsequent Events 2 | $	$ 50,000
Subsequent Events 3 | $	$ 5,000
Subsequent Events 4	10.00%
Subsequent Events 5 | $	$ 50,000
Subsequent Events 6 | $	$ 5,000
Subsequent Events 7	10.00%
Subsequent Events 8 | $	$ 30,000
Subsequent Events 9 | $	2,500
Subsequent Events 10 | $	$ 2,500
Subsequent Events 11	10.00%
Subsequent Events 12 | $	$ 30,250
Subsequent Events 13 | $	2,750
Subsequent Events 14 | $	$ 2,500
Subsequent Events 15	10.00%
Subsequent Events 16 | $	$ 42,500
Subsequent Events 17 | $	4,250
Subsequent Events 18 | $	2,500
Subsequent Events 19 | $	252,856
Subsequent Events 20 | $	195,500
Subsequent Events 21 | $	460,000
Subsequent Events 22 | $	$ 232,500
Subsequent Events 23	65.00%
Subsequent Events 24 | $	$ 50,000
Subsequent Events 25	10.00%
Subsequent Events 15 | shares	160,043
Subsequent Events 16 | $ / shares	$ 0.0126
Subsequent Events 17 | shares	650,000
Subsequent Events 18 | $ / shares	$ 0.026
Subsequent Events 19 | shares	641,025
Subsequent Events 20 | $ / shares	$ 0.0252
Subsequent Events 21 | shares	227,770
Subsequent Events 22 | $ / shares	$ 0.011
Subsequent Events 25 | shares	490,027
Subsequent Events 26 | $ / shares	$ 0.01807
Subsequent Events 27 | shares	267,396
Subsequent Events 28 | $ / shares	$ 0.0075
Subsequent Events 29 | shares	591,620
Subsequent Events 30 | $ / shares	$ 0.009329
Subsequent Events 31 | shares	769,230
Subsequent Events 32 | $ / shares	$ 0.0126
Subsequent Events 35 | shares	500,000
Subsequent Events 36 | $ / shares	$ 0.00975
Subsequent Events 37 | shares	776,000
Subsequent Events 38 | $ / shares	$ 0.0075
Subsequent Events 39 | shares	775,000
Subsequent Events 40 | $ / shares	$ 0.00975
Subsequent Events 41 | shares	669,222
Subsequent Events 42 | $ / shares	$ 0.0075
Subsequent Events 43 | shares	750,312
Subsequent Events 44 | $ / shares	$ 0.009329
Subsequent Events 45 | shares	575,327
Subsequent Events 46 | $ / shares	$ 0.010985
Subsequent Events 47 | shares	790,000
Subsequent Events 48 | $ / shares	$ 0.007500
Subsequent Events 49 | shares	803,725
Subsequent Events 50 | $ / shares	$ 0.0075
Subsequent Events 51 | shares	846,153
Subsequent Events 52 | $ / shares	$ 0.00975
Subsequent Events 53 | shares	1,128,205
Subsequent Events 54 | $ / shares	$ 0.00975
Subsequent Events 55 | shares	819,493
Subsequent Events 56 | $ / shares	$ 0.010595
Subsequent Events 57 | shares	850,000
Subsequent Events 58 | $ / shares	$ 0.00975
Subsequent Events 59 | shares	1,041,960
Subsequent Events 60 | $ / shares	$ 0.0075
Subsequent Events 61 | shares	750,312
Subsequent Events 62 | $ / shares	$ 0.009329
Subsequent Events 63 | shares	750,000
Subsequent Events 64 | $ / shares	$ 0.0075
Subsequent Events 65 | shares	469,119
Subsequent Events 66 | $ / shares	$ 0.010595
Subsequent Events 67 | shares	1,048,416
Subsequent Events 68 | $ / shares	$ 0.007500
Subsequent Events 69 | shares	1,140,474
Subsequent Events 70 | $ / shares	$ 0.0075
Subsequent Events 71 | shares	1,100,000
Subsequent Events 72 | $ / shares	$ 0.00975
Subsequent Events 73 | shares	256,410
Subsequent Events 74 | $ / shares	$ 0.00975
Subsequent Events 75 | shares	923,077
Subsequent Events 76 | $ / shares	$ 0.0065
Subsequent Events 77 | shares	1,600,000
Subsequent Events 78 | $ / shares	$ 0.00715
Subsequent Events 79 | shares	1,500,000
Subsequent Events 80 | $ / shares	$ 0.0065
Subsequent Events 81 | shares	1,007,941
Subsequent Events 82 | $ / shares	$ 0.0065
Subsequent Events 83 | shares	769,231
Subsequent Events 84 | $ / shares	$ 0.0065
Subsequent Events 85 | shares	1,214,575
Subsequent Events 86 | $ / shares	$ 0.0076
Subsequent Events 87 | shares	1,529,480
Subsequent Events 88 | $ / shares	$ 0.007500
Subsequent Events 89 | shares	1,700,000
Subsequent Events 90 | $ / shares	$ 0.00494
Subsequent Events 91 | shares	1,700,000
Subsequent Events 92 | $ / shares	$ 0.00494
Subsequent Events 93 | shares	1,514,380
Subsequent Events 94 | $ / shares	$ 0.002
Subsequent Events 95 | shares	1,586,538
Subsequent Events 96 | $ / shares	$ 0.0026
Subsequent Events 97 | shares	1,000,000
Subsequent Events 98 | $ / shares	$ 0.002
Subsequent Events 99 | shares	2,302,321
Subsequent Events 100 | $ / shares	$ 0.00145
Subsequent Events 101 | shares	2,000,000
Subsequent Events 102 | $ / shares	$ 0.002
Subsequent Events 103 | shares	2,000,000
Subsequent Events 104 | $ / shares	$ 0.002
Subsequent Events 105 | shares	2,500,000
Subsequent Events 106 | $ / shares	$ 0.001625
Subsequent Events 107 | shares	5,500,000
Subsequent Events 108 | $ / shares	$ 0.00115
Subsequent Events 109 | shares	3,500,000
Subsequent Events 110 | $ / shares	$ 0.00125
Subsequent Events 122 | shares	6,100,000
Subsequent Events 123 | $ / shares	$ 0.00075
Subsequent Events 124 | $	$ 4,575
Subsequent Events 111 | shares	3,200,000
Subsequent Events 112 | $ / shares	$ 0.000750
Subsequent Events 113 | shares	3,100,000
Subsequent Events 114 | $ / shares	$ 0.000975
Subsequent Events 115 | shares	6,600,000
Subsequent Events 116 | $ / shares	$ 0.00075
Subsequent Events 117 | shares	6,000,000
Subsequent Events 118 | $ / shares	$ 0.00075
Subsequent Events 119 | shares	3,500,000
Subsequent Events 120 | $ / shares	$ 0.00975
Subsequent Events 121 | shares	2,500,000
Subsequent Events 122 | $ / shares	$ 0.001625
Subsequent Events 123 | shares	4,000,000
Subsequent Events 124 | $ / shares	$ 0.000845
Subsequent Events 125 | shares	9,717,385
Subsequent Events 126 | $ / shares	$ 0.00055
Subsequent Events 127 | shares	7,900,000
Subsequent Events 128 | $ / shares	$ 0.0065

XML

Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	35.00%
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	$ 913,120
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	319,592
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	(699,718)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	(244,901)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	576,533
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7	201,787
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8	(399,010)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9	(139,654)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10	7,468
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11	2,614
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12	398,393
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13	139,438
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14	(398,393)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15	(139,438)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16	0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17	$ 0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1		35.00%
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2		$ 3,253,568
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3		1,138,749
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4		(118,990)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5		(41,647)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6		(103,048)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7		(36,067)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8		(1,483,168)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9		(519,109)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10		(1,333,192)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11		(466,617)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12		(624,429)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13		(218,550)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14		1,083,198
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15		379,119
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16		673,938
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17		235,878
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 18		(673,938)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 19		(235,878)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 20		0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 21		$ 0

XML

Schedule of Summary of Convertible Promissory Note (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 1	$ 67,913
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 2	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 3	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 4	(33,680)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 5	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 6	34,233
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 7	29,394
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 8	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 9	5,681
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 10	(29,938)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 11	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 12	5,137
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 13	540,498
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 14	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 15	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 16	(52,872)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 17	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 18	487,626
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 19	37,242
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 20	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 21	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 22	(5,200)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 23	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 24	32,042
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 25	75,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 26	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 27	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 28	(26,475)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 29	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 30	48,525
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 31	100,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 32	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 33	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 34	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 35	100,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 36	29,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 37	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 38	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 39	(3,000)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 40	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 41	26,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 42	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 43	36,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 44	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 45	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 46	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 47	36,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 48	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 49	30,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 50	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 51	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 52	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 53	30,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 54	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 55	27,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 56	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 57	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 58	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 59	27,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 60	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 61	12,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 62	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 63	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 64	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 65	12,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 66	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 67	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 68	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 69	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 70	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 71	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 72	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 73	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 74	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 75	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 76	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 77	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 78	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 79	17,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 80	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 81	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 82	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 83	17,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 84	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 85	24,750
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 86	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 87	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 88	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 89	24,750
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 90	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 91	5,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 92	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 93	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 94	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 95	5,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 96	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 97	13,200
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 98	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 99	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 100	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 101	13,200
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 102	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 103	12,100
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 104	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 105	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 106	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 107	12,100
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 108	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 109	40,700
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 110	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 111	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 112	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 113	40,700
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 114	879,047
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 115	253,750
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 116	5,681
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 117	(151,165)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 118	987,313
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 119	(345,053)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 120	(176,047)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 121	533,994
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 122	811,265
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 123	533,994
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 124	811,265
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 125	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 126	$ 0

XML

Schedule of Valuation Assumptions (Details)	9 Months Ended
	Mar. 31, 2016
August 3, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, August 3, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, August 3, 2015 2	269.35%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, August 3, 2015 3	0.17%
September 9, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 9, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 9, 2015 2	275.84%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 9, 2015 3	0.39%
September 30, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 30, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 30, 2015 2	375.79%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 30, 2015 3	0.33%
November 6, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, November 6, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, November 6, 2015 2	383.46%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, November 6, 2015 3	0.47%
December 1, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 2015 2	392.28%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 2015 3	0.51%
December 1, 2015 Embedded Derivatives (2) [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 20152 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 20152 2	392.28%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 20152 3	0.51%
December 3, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 3, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 3, 2015 2	394.55%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 3, 2015 3	0.57%
January 27, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate $24,750 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate $24,750 2	383.68%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate $24,750 3	0.47%
January 27, 2016 Embedded Derivatives (2) [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate Of $5,500 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate Of $5,500 2	383.68%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate Of $5,500 3	0.47%
March 1, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 1, 2016 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 1, 2016 2	371.21%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 1, 2016 3	0.68%
March 24, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 24, 2016 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 24, 2016 2	371.21%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 24, 2016 3	0.64%
March 28, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 28, 2016 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 28, 2016 2	371.21%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 28, 2016 3	0.65%

XML

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1	$ 0
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2	$ 0
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3	346.6
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4	453.3
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5	258.89
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6	0.39%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7	0.66
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8	0.11%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9	0.64

XML

Schedule of Changes in Fair Value of Convertible Promissory Notes (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 1	$ 3,066,171
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 2	1,227,384
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 3	(3,174,990)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 4	527,883
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 5	1,646,448
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 6	836,980
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 7	(302,262)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 8	(829,133)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 9	1,352,033
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 10	$ 829,133

XML

Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 1	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 2	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 3	248
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 4	272.2
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 5	288.96
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 6	0.87
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 7	1.21
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 8	1.01
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 9	1.63

XML

Schedule of Stockholders' Equity Warrants Activity (Details)	9 Months Ended
	Mar. 31, 2016 USD ($) yr
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 1	$ 15,204
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 2	242.57
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 3 | yr	2.62
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 4	$ 19,104
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 5	236.92
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 6 | yr	4.46
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 7	$ (5,927)
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 8	257.08
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 9	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 10	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 11	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 12	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 13	$ (1,289)
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 14	240.00
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 15	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 16	$ 27,092
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 17	100.98
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 18 | yr	3.79
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 19	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 20	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 21	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 22	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 23	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 24	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 25	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 26	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 27	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 28	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 29	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 30	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 31	$ 27,092
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 32	100.99
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 33 | yr	3.04

XML

Schedule of Changes in Fair Value of Financial Liabilities (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 1	$ 5,416,000
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 2	791,407
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 3	(2,730,022)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 4	(3,334,009)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 5	143,376
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 6	0
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 7	0
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 8	252,160
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 9	395,536
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 10	$ 252,160

XML

Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 1	$ 0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 2	54,476
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 3	(78,860)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 4	(363,442)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 5	(78,860)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 6	$ (305,966)

XML

Schedule of Discontinued Operations, Consolidated Balance Sheets (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 1	$ 5,731
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 2	46,731
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 3	653
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 4	28,160
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 5	683
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 6	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 7	16,284
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 8	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 9	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 10	(60,178)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 11	23,351
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 12	14,713
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 13	6,439
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 14	$ 6,696

XML

Schedule of Effect on Condensed Consolidated Balance Sheet (Details)	9 Months Ended
	Mar. 31, 2016 USD ($) shares
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 1	$ 64,099
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 2	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 3	64,098
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 4	13,421
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 5	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 6	13,421
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 7	20,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 8	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 9	20,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 10	2,788
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 12	2,788
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 13	14,713
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 14	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 15	14,713
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 16	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 17	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 18	115,020
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 19	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 20	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 21	115,020
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 22	65,962
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 24	65,962
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 25	3,134
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 26	140,241
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 27	143,375
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 28	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 29	1,646,448
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 30	1,646,448
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 31	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 32	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 33	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 34	300,887
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 35	233,107
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 36	533,994
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 37	60,022
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 39	60,022
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 40	6,696
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 41	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 42	6,696
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 43	551,701
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 44	2,019,796
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 45	2,571,497
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 46	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 47	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 48	$ 0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 49 | shares	7,574,353
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 50	$ 7,575
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 51	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 52	7,575
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 53	43,165,743
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 54	4,217,489
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 55	47,383,232
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 56	(29,484)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 57	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 58	(29,484)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 59	(43,267,064)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 60	(6,237,285)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 61	(49,504,349)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 62	(123,230)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 63	(2,019,796)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 64	(2,143,027)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 65	(313,450)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 66	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 67	(313,450)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 68	(436,680)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 69	(2,019,796)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 70	(2,456,477)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 71	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 72	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 73	$ 115,020

XML

Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 1	$ 57,476
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 2	(57,476)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 3	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 4	31,212
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 5	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 6	31,212
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 7	1,308,405
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 8	(363,441)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 9	944,964
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 10	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 12	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 13	1,964,046
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 14	(363,441)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 15	1,600,605
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 16	(1,906,570)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 17	(305,965)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 18	(1,600,605)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 19	(2,818,008)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 20	1,484,816
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 21	(1,333,192)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 22	80,524
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 24	80,524
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 25	3,638,090
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 26	(1,763,485)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 27	1,874,605
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 28	(962,309)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 29	170,902
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 30	(791,407)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 31	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 32	(1,483,168)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 33	(1,483,168)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 34	(324)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 35	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 36	(324)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 37	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 38	(1,284,971)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 39	(3,253,568)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 40	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 41	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 42	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 43	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 44	(1,284,971)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 45	(3,253,568)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 46	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 47	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 48	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 49	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 50	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 51	(3,559,534)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 52	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 53	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 54	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 55	(1,818,674)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 56	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 57	$ (3,409,611)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 58	0.04
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 59	(15.24)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 60	(15.28)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 61	$ 44,636,800
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 62	(44,413,616)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 63	223,184
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 64	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 65	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 66	(3,559,534)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 67	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 68	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 69	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 70	(1,990,428)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 71	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 72	(3,581,365)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 73	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 74	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 75	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 76	(1,840,505)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 77	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 78	$ (3,431,442)

XML

Schedule of Effect on Condensed Consolidated Statements of Cash Flows (Details)	9 Months Ended
	Mar. 31, 2016 USD ($)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 1	$ (1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 2	(1,284,971)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 3	(3,253,568)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 4	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 5	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 6	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 7	324
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 8	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 9	324
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 10	118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 12	118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 13	5,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 14	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 15	5,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 16	2,611,775
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 17	(1,484,818)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 18	1,126,957
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 19	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 20	1,483,168
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 21	1,483,168
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 22	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 24	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 25	103,048
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 26	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 27	103,048
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 28	(3,638,090)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 29	1,763,485
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 30	(1,874,605)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 31	962,309
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 32	(170,902)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 33	791,407
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 34	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 35	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 36	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 37	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 39	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 40	(7,412)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 41	7,412
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 42	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 43	19,074
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 44	(2,464)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 45	16,610
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 46	103,185
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 47	2
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 48	103,187
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 49	52,968
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 50	(5,790)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 51	47,178
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 52	(887,997)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 53	(843)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 54	(898,840)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 55	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 56	(8,212)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 57	(8,212)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 58	(897,997)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 59	(9,055)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 60	(907,052)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 61	(45,332)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 62	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 63	(45,332)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 64	954,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 65	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 66	954,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 67	908,668
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 68	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 69	908,668
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 70	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 71	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 72	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 73	(11,160)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 74	(9,055)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 75	(20,215)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 76	69,732
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 77	(12,100)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 78	57,632
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 79	58,572
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 80	(21,155)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 81	37,417
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 82	2,205
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 83	(2,205)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 84	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 85	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 86	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 87	2,536,097
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 88	(1,036,895)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 89	1,499,202
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 90	518,808
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 91	(518,808)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 92	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 93	779,600
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 94	1,663,170
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 95	2,442,770
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 96	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 97	2,312,157
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 98	2,312,157
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 99	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 100	901,327
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 101	901,327
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 102	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 103	2,018,791
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 104	$ 2,018,791

XML

Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit (Details)	9 Months Ended
	Mar. 31, 2016 USD ($) shares
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 1	$ 38,573,856
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 2	538,043
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 3	39,111,899
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 4	3,636,984
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 5	(1,457,586)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 6	2,179,398
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 7	767,879
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 8	1,962,041
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 9	2,729,920
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 10	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 11	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 12	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 13	43,165,743
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 14	4,217,488
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 15	47,383,231
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 16	(40,821,871)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 17	(6,166,108)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 18	(46,987,979)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 19	(2,445,193)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 20	(71,176)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 21	(2,516,369)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 22	(43,267,064)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 23	(6,237,283)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 24	(49,504,347)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 25	(2,355,136)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 26	$ (5,628,065)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 27 | shares	(7,983,201)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 28	$ 118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 29	118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 30	68,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 31	68,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 32	767,981
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 33	1,962,039
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 34	2,730,020
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 35	3,644,405
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 36	(1,457,585)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 37	2,186,820
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 39	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 40	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 41	38
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 42	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 43	38
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 44	(23,715)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 45	(23,715)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 46	(2,657,243)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 47	(71,176)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 48	(2,728,419)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 49	(436,680)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 50	(2,019,797)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 51	$ (2,456,477)